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Staphylococci 3re widespread in nature, although they are mainly found 
living on the skin and mucous membranes. The coagulase-positive Staphylococcus 
aureus is well known as a human pathogen. Serious infections produced by S. 
aureus include bacteraemia, pneumonia, osteomyelitis, endocarditis, mastitis, 
scalded skin syndrome and abscesses of the muscle, urinogenital tract, postoperative 
wound infection, conjunctivitis, keratitis, endophthalmitis and various nosocomial 
infections. The organism causes severe diseases in animal, such as suppurative 
disease, mastitis, arthritis, and UTI that are associated with numerious virulence 
factors. 
Humans are a natural reservoir of S. aureus, with 30% to 50% of healthy 
adults colonized, 10% to 20% persistently so. Its importance as a human pathogen 
has increased in the previous century as a result of the evolution of antimicrobial 
resistance to penicillin and subsequently methicillin in particular. Methicillin-
Resistant Staphylococcus aureus (MRSA) was isolated one year after methicillin 
was introduced. Methicillin resistance in staphylococci is caused by expression of 
PBP2a encoded by the mecA gene. mecA is located on a genetic element called the 
staphylococcal cassette chromosome (SCC) in ,S". aureus. To date, five different 
types of SCCwec (I-V) have been defined by the particular combination according 
to their putative recombinase genes (ccr AB) and overall genetic composition of two 
parts; the ccr complex and the mec complex. Community- acquired MRSA strains 
posses novel, small, mobile SCCmec type IV or V genetic elements which contain 
the mecA with or without additional antibiotic resistance genes and are more easily 
transferred to other strains of S. aureus, whereas larger SCCmec types I, II, and III 
elements are associated with nosocomial infection. MRSA had markedly reduced 
affinity for all currently available |3-lactam antibiotics while maintaining effective 
cell wall-building activity. 
Now MRSA is known to be of the most prevalent nosocomial pathogens 
throughout the world. Since 1961, successive waves of epidemic MRSA have spread 
throughout hospitals and other chronic healthcare facilities worldwide to the extent 
that it is now the most commonly isolated antimicrobial-resistant pathogen in many 
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countries. MRSA has now also become established outside the hospital environment 
and is appearing in community populations without identifiable risk factors. 
Transmission of MRSA is thought to occur primarily from colonized or infected 
persons to others. In the hospital setting, the most common mode of transmission of 
resistant S. aureus is close contact with infected persons or with health-care workers 
with contaminated hands or clothing. Evidence suggests, however, that airborne 
dispersal and transmission may also be important in implicating airborne 
transmission in hospital setting 
In animals staphylococcal mastitis either a clinical or sub-clinical form is an 
important infection that incur considerable economic losses in dairy industry. Many 
sources of 5'. aureus spread exist, including housing materials and fodder, equipment 
and air, bovine skin, non bovine animals, and humans. The isolation of MRSA from 
non-human sources including foodstuff and animals has been reported with an 
increased tendency. The existence of MRSA in non-human sources has aroused 
curiosity as to whether these MRSA isolates originated from a common source. The 
S. aureus in water resources may also serve as a source for colonizing residents 
exposed to contaminated water. 
Of the total 4885 sampling we isolated 1160 S.aureus strains, the prevalence 
of methicillin resistant (MRSA) among these isolates was 176 (15.1%). The 
distribution of MRSA in various specimen studied can be summarized as follows: 
clinical specimen (31.4%) > nosocomial (18.5%) > ocular specimen (11.45) > 
community personnel (10.2%) > veterinary (5.4%) > food and food handlers (3.2%) 
> air (2.1%). The highest prevalence was found in clinical specimen and lowest in 
air, while no MRSA was found in water sources. 
According to the results obtained highest resistance was found to penicillin-
G, while zero resistance was found to vancomycin when applied to selective 
sources. Multiple drug resistance in all S. aureus (n=1160) and MRSA (n=176) 
isolates were detected. 
The demographic result showed the carriage of S. aureus was higher in males than 
females (57.6%: 42.3%)) while, children in the community were the higher colonizer 
(28.3%). The ocular patients of 45 years and above were found to have higher rate of 
infection. 
The results indicated that major reservoir of MRSA in nosocomial infections 
are colonized/ infected inpatients and colonized health care workers with carriers at 
risk for developing endogenous infection or cross transmitting MRSA to health care 
workers and patients. The rate of colonization of MRSA in community personnel 
was found lower than nosocomial MRSA prevalence (10.2% vs 18.5%)). Highest 
percentage of MRSA (8.3%) was found in clinical dairy herd while carriage rate of 
MRSA in dairy personnel was insignificant. Major food animals such as cattle meat 
(10.2%) and chicken (9.0%) were found to be the source of MRSA prevalence. No 
MRSA dispersion was seen in air from different environment except hospital wards 
(22.2%, 2/9). 
The MIC values of Oxacillin was observed between 4fil/ml to 256nl/ml in 
which 23.2% MRSA isolates were borderline resistance (2-8txl/ml) and 76.7% were 
methicillin resistant (>16|il/ml). The most common resistance pattern "PGMETCl" 
(n=22) in MRSA isolates was frequently encountered in various sources. 
Biotyping: Selective methicillin sensitive S. aureus (n=196) and MRSA 
(n=176) were subjected to crystal violet test biotying. The majority of the isolates 
MSSA (79.5%) and MRSA (80.0%) were classified into human biotype -A, 
whereas, only 7.1% of MSSA and 0.6% of MRSA of biotype -C (animal origin) was 
seen among personnel. Biotypic distribufion of MRSA (n=165) as described by Coia 
et al. resulted into 4 groups. Maximum strains represented biotype B group 
(43.6%) followed by group D (30.9%). 
Bacteriophage typing: A total of 302 S. aureus with methicillin sensitive and 
resistant were subjected to bacteriophage typing as many as 51.8%) of MSSA and 
32.1% of MRSA was found typable at RTD and 100 RTD. Phage group III was 
predominant in both MSSA and MRSA isolates. Phage patterns 6/75/84, 6, 6/83A 
(phage group III) were found prevalent in MSSA and 30/33/38 MRSA phage 
complex resulted predominantly in MRSA isolates of every source. 
SCCmec typing: A selective 93 MRSA isolates were subjected to 
Staphylococcal cassette chromosome mec complex (SCCmec complex). The 
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SCCmec Type III cassette with Type III-A variant was predominantly found in 
clinical and ocular specimen and nosocomial isolates. However, few MRSA isolates 
possessing Type III cassette from community, veterinary and foods sources were 
resulted. SCCmec Type IV variant IVa was observed in community MRSA isolates 
and IVb variant was found in veterinary and food MRSA isolates. The results 
showed that, by and large these, SCCmec cassette complexes were mostly confined 
to their respective environments. One MRSA isolate from ocular specimen was 
found to contain SCCmec Type II cassette. The PCR results also showed the positive 
correlation between MIC values and mecA gene. A 6 MRSA strains with low MIC 
value were found mecA gene negative. 
Furthermore, 70 MRSA strains (Type III) and one MRSA isolate (Type II) 
were confirmed by specificity of mec gene complex to Class A complex, and 16 
MRSA isolates (Type IV) were found to possess Class B complex. The cassette 
chromosome recombinase (ccrAB) typing, showed 70 MRSA isolates (Type III) 
containing ccrAB type 3 complex, and 16 MRSA (Type IV) and one MRSA (Type 
II) possessing ccrAB type 2 complex. The mec complex and ccrAB complex typing 
showed a positive correlation with SCCmec cassette. 
Random Amplified Polymorphic DNA assay (RAPD): the RAPD analysis of 
selective 15 MRSA isolates resulted into two cluster. Pattern I with 9 MRSA isolates 
of same antibiogram predominated in our finding. 
Pulsed Field Gel Eletrophoresis (PFGE): Nine PFGE patterns were identified 
among 71 MRSA (Type III & II) strains. The largest similarity in diverse sources 
was found in Pattern D (n=14) followed by pattern C (n=12). The results of 
pulsotype B (n=7) depicted clonal similarity to the Hungarian clone (Type III). 
The 16S rDNA gene analysis of ocular isolate MRSAOC-9 (Type II) had 
showed >99% homology to N315 (Type II) referral strain. Furthermore, 
phylogenetic analysis of 16S rDNA gene of 5 selective MRSA strains (Type III) one 
each from clinical, nosocomial, community, veterinary and food were found to be 
above 99% similar. Isolates of clinical, nosocomial and community were observed in 
one cluster, indicating maximum homology among them. 
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INTRODUCTION 
Staphylococcus aureus is a gram-positive coccoid bacterium named for its 
tendency to form clusters ("staphyle'" is the Greek expression for "bunch of grapes") 
and its golden pigmentation ("aureus" is Latin for "golden") on culture plates. S. 
aureus is a versatile and dangerous bacterial pathogen with a genome consisting of a 
circular chromosome of approximately 2,800 base pairs and additional prophages, 
plasmids, and transposons. Genes governing virulence and antibiotic resistance 
reside on both the chromosome and extrachromosomal elements, and these genes are 
transferred between staphylococcal strains or other bacterial species via 
extrachromosomal elements. Humans are a natural reservoir oi S aureus, with 30% 
to 50% of healthy aduhs colonized, 10% to 20% persistently so'. Its importance as a 
human pathogen has increased in the previous century as a resuh of the evolution of 
antimicrobial resistance - to penicillin and subsequently methicillin in particular. 
Though, Methicillin-Resistant Staphylococcus aureus (MRSA) was isolated 
one year after methicillin was introduced, but the mechanism of methicillin 
resistance was not elucidated until 1981, when Hartman and co-workers discovered 
altered penicillin-binding proteins (PBP2') in MRSA that had markedly reduced 
affinity for all currently available beta-lactam antibiotics while maintaining efective 
cell wall-building activity. Five SCCmec subtypes have officially been identified to 
date, varying in size from -20 kilobase pairs (kb) to 68 kb. SCCmec types I, IV and 
V possess no antimicrobial resistance determinants other than mecA, whereas 
SCCmec types 11 and 111 possess multiple other resistant determinants such as Tn554 
(encodes for macrolide resistance)''. This pardally accounts for the larger sizes of the 
latter, which is thought to have limited their capability for horizontal transference. It 
is currently postulated that methicillin resistance did not arise within S. aureus, but 
was transferred from other staphylococcal species. 
Since 1961 , successive waves of epidemic MRSA have spread throughout 
hospitals and other chronic healthcare facilities worldwide to the extent that it is now 
the most commonly isolated antimicrobial-resistant pathogen worldwide". l")espite 
the apparent success of MRSA in the nosocomial setting, it was originally hardly 
ever isolated from the community. This observation was attributed to the much 
Ontroducbon 
slower growth rates of earlier MRSA isolates (probably a result of the fitness costs 
of SCCwec I to III) compared to methicillin-susceptible S. aureus (MSSA) isolates, 
a factor which may be of crucial ecological importance in settings where antibiotic 
selection pressure is not the main evolutionary imperative. 
The emergence and spread of methicillin-resistant Staphylococcus aureus 
(MRSA) isolates from the community that are distinct from their archetypal 
healthcare associated counterparts (HA-MRSA) marked a critical evolutionary 
milestone for the organism'''. In less than 2 decades, particularly in the last 3 years, 
this initially sporadic phenomenon of community-associated methicillin-resistant 
Staphylococcus aureus (CA-MRSA) has become a global reality, leading to 
paradigm shifts in the perception and management of staphylococcal infections in 
countries where CA-MRSA has reached epidemic proportions'. For several decades, 
there has been considerable controversy over whether or not contaminated 
environmental surfaces contribute to transmission of healthcare-associated 
pathogens. The proportion of hospital surfaces contaminated with MRSA has varied 
Q Q 
considerably in published reports ' , ranging from 1% to 27% of surfaces in patient 
rooms on regular hospital wards. 
Staphylococcus aureus is an important cause of bacterial keratitis and 
conjunctivitis. This organism infects compromised corneas, such as those with 
bullous keratopathy, chronic herpetic keratitis, keratoconjunctivitis sicca, ocular 
rosacea, or atopic keratoconjunctivitis'^. MRSA warrants particular attention 
because these strains are frequently resistant to multiple antibiotics, leaving limited 
treatment options. MRSA is as yet an infrequent cause of external ocular 
infections". Patients typically have underlying ocular risk factors and/or are 
medically debilitated. Different strains infect young and old age groups with 
characteristic antimicrobial sensitivity, this highlights the need for more work to 
establish the role of MRSA commensals and ocular infections. 
Staphylococcus aureus causes severe animal diseases, such as suppurative 
disease, mastitis, arthritis, and urinary tract infection that are associated with 
numerous virulence factors, such as the production of extracellular toxins and 
enzymes. In animals staphylococcal mastitis either a clinical or sub-clinical form is 
2 
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an important infection that incur considerable economic losses in dairy industry. 
Many sources of S. aureus spread exist, including housing materials and fodder, 
equipment and air, bovine skin, non bovine animals, and humans. Teat skin has been 
suggested as an important reservoir for intra-mammary infection, while bovine-to-
human transmission has also been proposed'^'^. 
For humans, this organism is an important cause of food poisoning. Recently, 
the isolation of MRSA from non-human sources including foodstuff and animals has 
been reported with an increased tendency''*''. The existence of MRSA in non-
human sources has aroused curiosity as to whether these MRSA isolates originated 
from a common source. A survey on the non-human MRSA will provide some 
meaningful data on the importance and similarity between the MRSA strains in the 
veterinary field. The epidemiological aspects of MRSA infections in animals have 
not been studied in details; a few veterinary reports have been published on MRSA 
infections in dairy herds with mastitis and in companion animals. Transmission 
through food products has not been thoroughly investigated. Therefore, this study 
examined the characteristics of MRSA isolated from retail meat shops and compared 
the epidemiological similarity between human and animal isolates. 
In the hospital setting, the most common mode of transmission of resistant 5*. 
aureus is close contact with infected persons or with health-care workers with 
contaminated hands or clothing. Recent evidence suggests, however, that airborne 
dispersal and transmission may also be important and case studies implicating 
airborne transmission in the hospital settings have been published in the literature'^. 
Although drug-resistant S. aureus has historically been a significant problem only in 
hospitals, the urgent need for further study of the ambient airborne concentrations 
and the role of airborne transmission of this organism in non-hospital environments 
is demonstrated by the increasing prevalence of methicillin-resistant S. aureus 
(MRSA) infections in the community . Most alarming about this trend is that 
infection has been observed among individuals with and without known risk factors. 
5". aureus in water ecosystems may also serve as a source for colonizing residents 
exposed to contaminated water . In environmental settings polluted by human or 
animal waste or both, high frequencies of multiple antibiotic resistance phenotypes 
3 
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exist. These environments include surface waters receiving runoff from lands 
occupied by livestock, polluted estuaries, and contaminated water supplies. 
In view of the above mentioned lacunae the present study is being 
undertaken with the aim to extend the knowledge of epidemiology of 
Staphylococcus aureus with the following objectives ; 
• Isolation, identification and biochemical characterization of S. aureus 
from clinical specimen and healthy personnel and from various 
environmental sources. 
• Incidence of drug resistance in isolated strains of S. aureus against 
various classes of antibiotics and evaluation of minimum inhibitory 
concentrations (MIC). 
• Biotypic differentiation of S. aureus strains from various sources. 
• Epidemiological investigation of 5". aureus isolates to trace the source 
of strain by bacteriophage typing. 
• Characterization of methicillin-resistant S. aureus (MRSA) strains on 
the basis of epidemiological marker Staphylococcal cassette 
chromosome mec (SCCwec) complex element by Multiplex PCR 
strategy. 
• Clonal relationship of MRSA isolates among different sources on the 
basis of randomly amplified polymorphic DNA (RAPD) assay. 
• Macrorestriction analysis by Smal digests MRSA isolates by Pulsed 
Field Gel Electrophoresis (PFGE). 
• Phylogenetic analysis of MRSA isolates under study among various 
sources to establish the genetic relationship. 
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2.1: STAPHYLOCOCCI 
Staphylococci were first observed and cultured by Pasteur and Koch. But 
Ogston in 1881 and Rosenbach in 1884 made the first thorough studies on 
staphylococci. The genus Staphylococcus was given its name by Ogston in 1881 
when he observed grape-like clusters of bacteria in pus from human abscesses. 
Three years later, Rosenbach was able to isolate and grow these microorganisms in 
pure culture. He gave these bacteria the specific epithet Staphylococcus aureus 
(S.aureus) and showed that S. aureus was responsible for wound infections and 
furunculosis, and that S. epidermidis was a normal colonizer of the skin. Ever since 
he first described the growth of this 'golden' coccus, surgeons have feared 
staphylococcal wound infections after surgery; Staphylococci also caused life-
threatening disease after trauma and fatal pneumonia during the influenza season, 
killing young people in the prime of their lives. Therefore, in the pre-antibiotic era, 
S. awrews was known as a major life threatening pathogen. ' ' 
Because of penicillin's important contribution to the fight against S. aureus 
disease, the period between 1946 and 1950 was referred to as a golden age for the 
treatment of staphylococcal disease. However, the rapid spread of resistant 
staphylococci soon led to the return of a major pathogen.^^ 
TAXONOMY 
Staphylococci are Gram-positive non mobile cocci that characteristically 
divide in different patterns to form, irregular grape-like clusters. They usually 
produce catalase. They are facultative anaerobes, but grow better under aerobic 
than under anaerobic conditions. 
Traditionally, they have been divided into coagulase-positive and coagulase-
negative staphylococci. Of the large number of staphylococci only three are 
commonly associated with human disease. 
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1. Staphylococcus, aureus 
2. Staphylococcus, epidermidis 
3. Staphylococcus saprophyticus 
2.2:ANTIBIOTIC RESISTANCE: HISTORIC EVIDENCES; 
Paul Ehrlich gave the first account of microbial drug resistance in 1907 when 
he encountered the problem soon after the development of arsenical chemotherapy 
against Trypanosomiasis. As the sulphonomides and antibiotics were brought into 
medical and veterinary practice resistance against these agents began to emerge. The 
first antibiotic resistance mechanism was identified a little more than 60years ago in 
1940, when Abraham and Chain described the presence of a penicillinase, an 
enzyme that inactivates penicillin, in E. coli. Just 4 years later, Kirby reported the 
presence of a similar type of enzyme in S. aureus. Therefore, even before penicillin 
came into widespread use, resistance to this drug already was recognized in both 
Gram-positive and Gram-negative organisms. Thus soon after the introduction of 
penicillin for clinical use, a large-scale World Health Organization survey showed 
that approximately 8% of strains were resistant; by 1986 the value was about 70%. 
In the 1970s reports of organisms resistant not only to the penicillin-type drugs, but 
multiple other classes of antimicrobial agents, were common, as nosocomial 
pathogens which were responsible for many outbreaks of hospital infections, 
acquired a number of new resistance genes, such as those to aminoglycosides, 
chloramphenicol, and tetracycline.^^ The predominance of P-lactamase-producing 
staphylococci in the 1950s led to an urgent search for (3-Lactamase - stable 
penicillins that could be used for chemotherapy. The discovery and introduction of 
such compounds, e.g. methicillin, caused a major decline in the incidence of 
multiple resistant 5*. aureus strains during 1960s. Although Jevons"* first reported 
methicillin resistance in 5". aureus in 1961, but during the late 1970s and early 1980s 
strains of S. aureus resistant to multiple antibiotics including methicillin and 
gentamicin emerged that were responsible for outbreaks of hospital infections 
throughout the world. Such strains, referred to as MRSA, not only caused difficulty 
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in hospitals but spread from there to nursing homes and to surrounding 
communities. 
Vancomycin which is somewhat toxic antibiotic requiring intravenous 
administration is often the only drug effective against such staphylococci. However, 
there are several recent reports of vancomycin intermediate S. aureus (VISA) 
infections from different parts of the world. ' Moreover in the past few years a 
handful of organisms resistant to all known antimicrobial agents have emerged . 
Infections caused by some strains of Enterococci, Acinetobacter, and Pseudomonas 
aeruginosa, are now virtually untreatable. Fortunately, these organisms remain 
rare; however, the conditions that favor the development and spread of such 
organisms are abundant. Therefore, we can expect resistant organisms to continue to 
emerge. 
REASONS FOR THE EMERGENCE OF-ANTIBIOTIC RESISTANCE 
At least six pathways may be involved in the appearance or spread of resistance in 
bacteria. 
1. Introduction of a few resistant organisms into a population where 
resistance previously was not present. 
2. Acquisition of resistant by a few previously susceptible strains through 
genetic mutation. 
3. Acquisition of resistance by previously susceptible strains through transfer 
of genetic material. 
4. Emergence of inducible resistance that is already present in a few strains in 
the population. 
5. Selection of a small, resistant subpopulation of organisms. 
6. Dissemination of inherently resistant organisms locally within the setting. 
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2.3:EMERGENCE OF MULTIDRUG-RESISTANT STAPHYLOCOCCUS 
AUREUS 
Before the antibiotic era of medicine began some 60 years ago, the prognosis 
for patients with severe staphylococcal infections was extremely poor. The 
introduction of penicillin into clinical use in the early 1940s brought about a 
dramatic reversal in invasive iS". aureus infection, such as those that develop from 
accidental or operative trauma, burns and other serious skin lesions . The period of 
universally effective penicillin therapy was short-lived and within a few year the 
appearance of penicillin-resistant S. aureus was reported ' and by 1946 it was 
estimated that 60% of hospital isolates in the United Kingdom were resistant to 
penici llin^^ the successive introduction of streptomycin, tetracycline, 
chloramphenicol and macrolides was similarly attended by the emergence of 
resistant organism^'''^^The strains which had acquired resistance to these antibiotics 
were resistant to penicillin through the production of P-lactamse(penicillinase). As a 
result the organism was able to survive with a wide spectrum of resistance and 
spread in the hospital environment .^ 
The introduction of the semisynthetic |3-lactam resistant pinicillins, such as 
methicillin and oxacillin brought decline in the prevalence of multiple resistant S. 
aureus during the early 1960^^ But by the late 60s and early 70s however strains 
resistant to semisynthetic P-lactams were isolated with increasing frequency in a 
number of countries such as Australia"''', Belgium^^, France''^, Poland'*'*, the United 
Kingdom'*', the United States'* '^'*^ Denmark'*'* and Switzerland'* '^'*^ 
Neomycin-resistant 5*. aureus strain was first detected in the United States in 
1959-60 . Resistance to related aminoglycosides like kanamycin and paronomycin, 
had emerged after lOyears of its introduction and was attributed to the widespread 
topical use of neomycin on the skin nose'* '* . Similarly, Gentamicin introduced in 
1964 and outbreaks of hospital infection by gentamicin resistant S. aureus were 
reported in 1975 to 1976 along with kanamycin and tobramycin^"'^''^". Reports of 5". 
aureus resistant to both gentamicin and methicillin along with a wide range of other 
antibiotics including penicillin, tetracycline and streptomycin were initially come 
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from Australia and England in 1976. Few years later such strains of .S. aureus 
resistant to multiple antibiotics were increasingly responsible for outbreaks of 
hospital infections in countries around the world. 
2.4: RESISTANCE TO p-LACTAM ANTIBIOTICS 
There are three clinically significant mechanisms of resistance to the p-lactam 
antibiotics in S. aureus. 
(a) The inactivation of the penicillin through ^-lactamase hydrolysis of the P-
lactam ring. 
(b) Intrinsic mechanism involving a lowering of the affinity or the amounts of 
penicillin binding protein (PBPs). 
(c) Tolerance to the bacterial effect of [3-lactam antibiotics. 
P -lactamase-mediated resistance to p-Iactam antibiotics; 
The staphylococcal p-lactamases are extracellular enzymes which have been divided 
into four types (A to D) based on'^ 
•J* Immunological studies 
• Differences in inoculum effect 
• Differences in substrate profile 
<• Differences in inhibitory profile 
The enzymes of serotypes A and C are of high activity and were found to be 
produced by hospital S. aureus strains (phage group I & III) whereas, the lower 
efficiency B type enzyme was produced exclusively by phage group II organism, 
cr en 
which has limited incidence in the hospital setting ' . These enzymes hydrolyze 
benzyl penicillin (penicllinG) and ampicillin with high activity, but demonstrate 
poor activity against the semisynthetic penicillin's (methicillin and oxacillin). The 
four P-lactamases are believed to be closely related with the small variations being 
attributed to minor differences in amino acid residues"'^^. 
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Unlike the P-lactamases of Gram-negative bacteria which are generally 
expressed constitutively, the staphylococcal p-lactamases with the exception of the 
type D enzyme are expressed at high levels following induction by penicillin or its 
analogs'" .^ A study showed that with the aid of heterolipids, the inducible wild state 
was dominant to the mutant constitutive state and consequently proposed that beta-
lactamase synthesis in S. aureus was under the negative control of a diffusible 
repressor molecule. Another study^" suggested that penicillin and its analogs 
promote the induction of p lactamase synthesis by specifying the confirmation of a 
P-lactamase antirepressor protein, which subsequently inactivates the p-lactamases 
repressor. The possibility that the genetic determinant for p-lactamase production 
was carried by a plasmid was not recognized until the transduction experiments 
implicated extra-chromosomal inheritance^'. A variety of p-lactamase plasmids have 
subsequently been found in naturally occurring strains of penicillin- resistant S. 
aureus . 
Resistance to methicillin and other p lactamase resistant penicillins:-
The mode of action of the semisynthetic P-lactamase resistant penicillins 
(methicillin, oxacillin, cloxacillin and naficillin) and cephalosporins (cefotaxime, 
ceftizoxime, moxalactam, ceftriaxone, cefminoxime) is similar to that of penicillin 
G. The initial step consists of binding of the drug to cell receptors, which are also 
known as penicillin-binding proteins (PBP). PBPs are the enzymes essential for cell 
wall synthesis. These enzymes, including D-alanine carboxypeptidases and 
peptidoglycan transpeptidases, are thereby inhibited resulting in cell lysis^ '^^ "*. 
Studies on such PBPs in S. aureus have shown that there are 3 to 6 
distinguishable species (MW 4-12 X 10^/\ It is not known which of the PBPs is the 
lethal target for the penicillins but PBPl and PBP4 may be the non-essential proteins 
whereas PBP2 and PBP3 may be the crucial targets. PBPs are membrane bound 
enzyme and MRS A produce a unique low affinity penicillin binding protein called 
PBP 2a or PBP 2'. PBP 2a is a high molecular weight PBP of 78 kD and probably 
has peptidoglycan transpeptidase activity. It acts as a substitute for the activities of 
one or more essential PBPs. It has low affinity for P-lactamase resistant antibiotics 
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and remains unsaturated with P-lactams at concentrations that would otherwise kill 
MSSA^ .^ Abnormal PBP2a production can be induced by various agents including 
P-Iactams such as ceftizoxime, cefazolin, cefmetazol, imipenem, and methicillin. 
Various ^-lactamases induce PBP2a optimally at different concentrations. This may 
account for the double zone phenomenon on disc susceptibility tests; the 
concentration of p- lactamases necessary to saturate PBP2 and PBP3 themselves 
may play a role in transmitting the necessary signal across the cell membrane.The 
phenotypic expression of methicillin resistance among MRSA isolates varies 
widely '^^ "^ It is affected by many physical and chemical factors such as temperature, 
visible light, osmolality (5% NaCI, 20% sucrose, KCl), chelating agents, trace 
elements and -^lactams*" .^ 
Heterogenous and Homogenous Resistance: 
Heterogenous resistance is a common feature of MRSA. It occurs when only 
a small proportion of bacterial population (such as one out of every 10 to 10 cells) 
in a given culture manifests high-level resistance under standard test conditions^ '^ •^ *'. 
Methicillin resistance is expressed by a minority of cells at 37°C but uniformly by 
the entire population in hypertonic media or at 30°C. Homogenous resistant strains 
on the other hand, are those where methicillin resistance is expressed by 
approximately 100% of the organisms, both at 30°C and at 37°C. 
The failure of the entire population to express phenotypic resistance may be 
explained by a requirement for a second unidentified factor. This factor may act by: 
> Controlling the rate of transcription of the functional gene for PBP2a 
> Modifying an initially non-functional PBP to enzymatically active form. 
> Regulating autolytic or other irreversible activity until PBP2a is available 
to continue cell wall synthesis. 
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2.5: Origins and evolution of Staphylococcus aureus resistance determinants: 
The genetic determinants of resistance to many antimicrobial agents are 
believed to have evolved prior to the era of antibiotic chemotherapy in organisms 
other than those m which they are now commonly detected ' . A number of 
resistant pathogens are similar to those used by antibiotic synthesizing members of 
the genus Streptomyces to protect their own cellular functions^^. Many soil bacteria 
which compete with antibiotic producing organisms have also been found to 
maintain plasmids encoding antibiotic resistance, presumably to help them survive 
in the environment^ '*'^ '^^  . The transmission of antibiotic resistance genes from the 
streptomycetes and soil bacteria to clinically important species may have occurred 
through the exchange of plasmids or transposable elements or both in relatively 
more recent time ' . 
(A) Intergenetic transfer of antibiotic resistance genes: 
Evidence for the exchange of resistance determinants and replicons between 
soil bacteria and staphylococci has been reported for example comparison of the 
amino acid sequence of the P-lactamases produced by B. licheniformis and S. aureus 
has indicated that most likely diverged from a single ancestral gene and a close 
resemblance has also been noted with the B. cereus P-lactamase^^. 
Several plasmids of Staphylococcal origin, such as Tet"^  plasmid PT127 and 
Cm'^  plasmids Pc 194, Pc 223 and PUB 112 have been transformed into B. subtilis 
and shown to triplicate in and confer antibiotic resistance upon, the new host '^'. In 
addition the 4.5kb Nm"^  & Km"^  S. aureus plasmid pBC 16 were found to be 
replication incompatible in B.subtilis and completely homologous^''. Although 
pBC16 and the S. aureus Tc plasmid pT181 appeared to be unrelated but 
comparison of nucleotide sequences has indicated that the Tc*^  determinant of 
another Bacillus plasmid, pTHT 15 produce a polypeptide with strong amino acid 
sequence homology to the Tc"^  protein of pT181^°. 
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There is also a support for the notion that some resistance determinants in 
staphylococci are derived from genes present in antibiotic producing organisms. The 
5". aureus ermC methylase encoded on pE194 share, amino acid sequence homology 
with the analogous methylase encoded erythromycin producing organisms such as 
Streptomyces erythraeus ermE and some Arthobacter spp . Notably erniD which 
encodes a methylase in B. licheniformis with partial amino acid sequence homology 
to the ermC and ermE methylase ' are homologous with the S .erythraeus 
chromosome, this showed that MLS*^  is encoded on a transposon in these soil or 
microorganisms from which it may have spread to staphylococci . Strong sequence 
homology has also been reported between the APH gene from neomycin producer S. 
fradiae and the APH(3')I1I gene encoded by the S.aureus plasmid pSH2 as well as 
with determinants for APH(3')III encoded by transposons Tn5 and Tn903 from 
• 86 
gram negative species . 
The Tc*^  determinants found on the Streptococcus agalictiae chromosome 
and on the Streptococcus feacalis transposon Tn916 are homologous with the 
determinant carried by S. aureus and the CAT of Cm strains of 5*. agalictiae cross 
reacts immunologically with the staphylococcal CAT . The determinants of 
resistance to the MLS antibiotics in the streptococci are largely homologous with 
each other and in some cases with the staphylococcal MLS determinants . The 
AAC(6')-APH(2") polypeptides encoded by a self- transmissible plasmid from S. 
feacalis and the S. aureus GmTmRm"^  transposon Tn 4001^^'^''. The determinants of 
resistance to the MLS antibiotics in the Streptococci are largely homologous with 
each other and in some cases with the Staphylococcal MLS"^  determinants^^. 
(B) Interspecific Transfer of Antibiotic Resistance Gene: 
The identity or close similarity of Gm'^  plasmids found in epidemiologically 
related strains of 5. epidermidis and S. aureus had been demonstrated^'. The transfer 
of Pc and Cm plasmid in mixed cultures of 5. aureus and S. epidermidis was the first 
indication that a mechanism of genetic transfer operates between different 
staphylococcal species"^ .^ The transfer of Gm plasmids between S. aureus and S. 
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epidermidis in vitro and on human skin has also been demonstrated and a similar 
plasmid was transferred from a clinical isolate of S. hominis to several different S. 
aureus strains^^. In few cases, the interspecific transfer of Gm plasmids was shown 
to have occurred by a conjugation like process identical to that observed for 
intraspecific transfer in S. aureus^'^''^^. The ability of these conjugal Gm plasmids to 
mobilize smaller plasmids, including those encoding Tc, Cm, Em from 5". 
epidermidis to S. aureiis^^ suggests a possible mechanism for the interspecific spread 
of other resistance determinants. There are also reports of in vitro and in vivo 
transfer of resistance determinants between human and animal staphylococci, 
although such exchange was considered by Lacy^^ to make little contribution to the 
S. aureus genetic pool. 
(c) Evolution of S. aureus resistance plasmids and the multi-resistant 
chromosome: 
(i) Resistant plasmid 
The evolution of antibiotic resistance plasmids in S. aureus is thought to 
occur by the same mechanisms of recombination that operates in other bacterial 
species. The characterization of families of S. aureus plasmids which mediate 
resistance to penicillin and heavy metal ions ' and gentamicin and other 
aminoglycosides""'''^' has revealed much information about the possible 
evolutionary pathways followed by individual plasmids. Members of each family 
were found to be largely homologous, but often possessed differences which could 
be explained by the deletion or insertion of discrete segments of DNA. Such 
differences were correlated with the changes in plasmid phenotype and in some 
instances were resuh of the activity of translocatable elements 
Gentamicin resistance plasmids illustrate the part played by translocatable 
elements in staphylococcal plasmid evolution. Tn 4001 was present at various 
chromosomal sites in the Gm strains isolated in Australia between 1977-79 but 
thereafter they were commonly present on the pSKl family of quaternary 
ammonium (qacA) resistance plasmids, thereby implicating chromosome to plasmid 
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transposition. The pSKl family futher enlarged its repertoire of resistance 
determinants at some stage by the acquisition of trimethoprim resistance via Tn4003 
and penicillin resistance through the insertion of Tn 4002. Tn 4002 may well have 
integrated into the chromosome from an Inc 1 group p-lactamse plasmid, under the 
pressure of incompatibility with another Inc I group plasmid and subsequently 
translocated to a pSkI family plasmid to generate multiresistance plasmids such as 
pSK4. 
An evolutionary progression similar to Gm plasmids has been traced among 
the P-lactamse/heavy metal resistance plasmids; plasmids of this type have 
demonstrated a wide geographical distribution ' . 
An alternate mechanism to transposon insertion in the evolution of plasmid 
complexity has been suggested by the function of apparently irreversible co-
integrates between small staphylococcal plasmids'"'''"^^ Such interactions allude to a 
modular organization of these plasmids' ^ perhaps not like that seen in the co-
integrates plasmids of gram negative organism . 
(ii) Resistant Chromosome 
The mechanism of site-specific and generalized recombination have also 
played central role in the evolution of a multiresistant chromosome, a feature of S. 
aureus strains currently endemic in many hospital throughout the 
world ' ' • . There is evidence for transposition of resistant determinants 
from plasmid to chromosome, as seen in the case of Pc"^  (Tn4002) and Hg"^  
(Tn4004) which were originally detected on (3-lactamse/heavy metal resistance 
plasmids. The integration of an entire Tc plasmid is seen in the case of pT181 which 
presumably underwent generalized recombination with the chromosome at the 
integrated site. 
Chromosomal acquisition of some resistance characters may have only 
occurred on a single occasion for example as observed with Tn4002 (Pc), and 
pT181(Tc) each occupied a common site in all strains tested'"". Such evidence has 
also supported the notion that many methicillin resistant strains have a common 
origin ' and that the new multiresistant hospital staphylococci are in fact old 
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staphylococci that have acquired additional chromosomal resistance determinants by 
integration as well as by mutation, as in the case of rifampin and fusidic acid 
resistances"''""^" . 
The exact role of insertion sequences in providing regions of homology for 
integration and subsequent evolution of the multiresistant chromosome a-vvaited 
detail investigation for eg: IS 256 sequences have been detected at multiple sites on 
the chromosomes of some Mc Gm strains and such could represent either single 
insertion which results in genetic rearrangement of the neighbouring genes or 
unidentified transposons. IS256 therefore had provided a crucial component for 5*. 
aureus strains to fabricate new composite transposons carrying preexisting 
chromosome (or plasmid) resistance or virulence determinants. The IS 257 
sequences occur at limited sites on the chromosome and so far only in conjugation 
with the determinants for methicillin, mercury and tetracycline resistance . The 
detailed molecular organization and DNA sequence of the putative mec-mer-tet 
cluster like sequences in the establishment and evolution of the enigmatic methicillin 
resistance transposon has to be established thoroughly. 
1.6:Methicillin- Resistant Staphylococcus aureus (MRSA): Historical Milestones 
MRSA were first reported from British hospitals in the 1960s"^ and then 
from Irish hospitals in 1970s'"''. These strains were also resistant to the isoxazolyl 
penicillins such as oxacillin, cloxacillin and dicloxacillin. Methicillin resistant 
strains accounted for less than 0.1% in the 1960s, but by 1968-1969 they accounted 
for approximately 5% of the strains. 
The rise in methicillin resistance was not confined to Britain alone; reports 
from Europe also indicated a similar trend. Denmark in particular experienced a 
dramatic increase in methicillin resistance, so that by the late 1960s, MRSA was 
detected in about 40% of blood culture isolates of S. aureus in that country'^'. It 
subsequently declined in frequency in some of the European countries while 
becoming much more frequent in others such as Greece'^^. Serious epidemics 
caused by MRSA were also reported from parts of Australia in the 1960s'^^ The 
16 
'Review of/literature 
geographic variability in the presence of MRSA has long been noted but poorly 
understood, may be due to differences in the laboratory capabilities to detect the 
micro-organisms'^ . 
In US a retrospective review based on data from National Nosocomial 
Infections Surveillance (NNIS) system revealed that the percentage of 5*. aureus 
isolates that were found to be resistant to methicillin rose from 2.4% in 1975 to 29% 
in 1991'^^ 
In 1976, the first reports of gentamicin resistant 5*. aureus appeared in 
England'^^. Soon afterwards, there was an outbreak of hospital infection with 
methicillin and gentamicin resistant strain in London hospital (MGRSA).During the 
1980s, there was a sharp rise in these outbreaks in many parts of the world, and 
some of the hospitals reported up to 40% of their clinical isolates of S. aureus to be 
resistant to methicillin . 
The next milestone was the advent of a particular strain, now referred to as 
the epidemic MRSA-1 (EMRSA-1) to differentiate it from other methicillin resistant 
strains which do not necessarily cause endemic or epidemic problems. It has since 
caused major epidemics and endemics . MRSA has now become endemic in 
hospitals, especially in the tertiary care hospitals. The incidence of methicillin 
resistance among hospital isolates of S. aureus varies all over the world , ranging 
from less than 1% in Scandinavia to more than 30% in France and Italy'^ *', and about 
60% in Japan'^'. In the USA, the MRSA isolates have risen from 2% in 1975 to 35% 
in 1996'^l 
1.7:The genetic organization of Methicillin- Resistant Staphylococcus aureus 
(MRSA): 
Various mobile genetic elements carrying antibiotic resistance genes in 
staphylococci have been investigated extensively''^^''^'*.Completion of whole genome 
sequences of three MRSA strains has been achieved'^^'"^^provided the distribution 
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of the mobile genetic elements in the bacterial chromosome that encode antibiotic 
resistance as well as pathogenicity of 5*. aureus. 
1.7.1: Genomic background and genomic islands 
Whole genome sequences have been reported of two health-care-associated 
MRSA strains, N315 and Mu50, isolated in Japan in 1982 and 1996, respectively, 
and one community-acquired MRSA strain MW2 (MW standing for mid-west 
USA)^ *''^ ^^ The genomes of the three MRSA strains have low G + C content (32.8-
32.9%). The lengths of their chromosomes range from 2.81 to 2.88Mb and contain 
2595-2714 ORFs. There are five (N315 and Mu50) or six (MW2) rDNA operons on 
the chromosome'^ ^ '^'"^ .^ There are 99.7% nucleotide sequence identity between N315 
and Mu50, 94.8% between MW2 and N315, and 94.7% between MW2 and Mu50. 
Most of the nucleotide sequence differences are due to the insertion of some DNA 
regions that consist of putative exogenous genes as judged from the absence of the 
homologues in different S. aureus strains, different preference of codon usage, and 
different G + C content withm the ORFs'" . The S. aureus chromosome is composed 
of two categories of DNA: genetic background, transmitted from ancestral bacteria 
closely related to Bacillus species and Genomic Islands (GI), which originated 
from other bacteria and were acquired by lateral genetic transfer. 
1.7.2: Staphylococcal cassette chromosome mec (SCCmec) 
i. SCCmec as a vehicle for antibiotic resistance: 
The genetic determinant of mec has long been known to be localized on the 
chromosome of S. aureus . It was mapped to a locus between the genes encoding 
protein A (spa) and a protein involved in the biosynthesis of purines (pwrA)'^l The 
mecA gene, encoding penicillin-binding protein 2 or 2a, and its regulatory genes 
mecl and mecRl have been cloned and their nucleotide sequences have been 
determined I^ 9j40,i4i,i42,i43 ^^ ^j^^ J^^Q^^ .^^ .^ ^^  chromosome analysis of MRSA 
strains revealed that a substantial length of the chromosomal DNA segment (greater 
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than 30 kb) carrying mec had no allelic equivalence in methicillin-susceptible S. 
aureus strains, therefore, the segment was called additional DNA or wecDNA ' . 
The chromosome region surrounding mecA gene of the pre-MRSA strain N315 was 
sequenced and the sequence was compared to the corresponding region of the 
methicillin-susceptible S. aureus strain NCTC8325. This led to demarcate the 
Genomic island as a specific structure for the genetic trait of methicillin resistance 
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Subsequent experiments showed that the entire island was precisely excised 
from N315 chromosome by the function of two site-specific recombinases encoded 
by the island; thus named as island staphylococcal cassette chromosome mec 
(SCCmec) as a new family of staphylococcal GI and its recombinases as cassette 
chromosome recombinases A (ccrA) and B (ccrB) "* . Expression of both Ccr 
proteins also promoted site-specific integration (at the attBscc site) of a closed 
circular form harboring a head-to-tail junction (attSCC) of the terminal sequences of 
SCCmec. The boundary of SCCmec is demarcated by direct and inverted repeat 
sequences. One of the direct repeat sequences is present on the S.aureus 
chromosome and the other inside SCCmec. Experimental integration of a mini-
SCCmec element showed that it is integrated at the end of the chromosomal direct 
repeat sequence as well as direct repeat sequences in the SCCmec. SCCmec is 
present at a fixed site on the chromosome inside or/Ywith unknown function located 
near the origin of replication, which is 10 kb downstream of purA and 66-89 kb 
upstream of spa gene (encoding protein A) depending on the size of the integrated 
copy of SCCmec. The location of the integration site near the origin of replication 
provides advantage to the instant utilization of imported antibiotic resistance genes. 
Since it is known that the chromosomal region around origin of replication may be 
present in two or even four copies in the cell because of the uncoupled nature of cell 
division and DNA replication'''^ 
SCCmec is composed of two essential genetic components. The first is the 
mec gene complex composed of lS431mec, mecA, and intact or truncated sets of 
regulatory genes, mecR] and mecl. 
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Till date mec gene complexes are classified into five classes according to their 
structure (Fig-1)''*^: 
> Class A, lS43]-mecA-mecRl-mecI; 
> Class B, lS431-mecA-mecR]-lSJ272; 
> Class C, lS431-mecA~mecRlA843}-
> Class D, lS431-mecA~mecRl. 
> Class E, lS431-mecA-AmecR] 
The second essential region is the ccr gene complex, composed of two site-
specific recombinase genes, ccrA and ccrB, responsible for the mobility of SCCmec, 
There are five allotypes of the ccr gene complex: type 1, ccrAlccrBl; type 2, 
ccrA2ccrB2; type 3, ccrA3ccrB3\ type 4, ccrA4ccrB4; and type 5, ccrC, which was 
newly found in community-acquired MRSA'' and surrounding orjx of unknown 
funcfion (Fig-1). The rest of the SCCmec is designated J regions (J stands for 
junkyard) that contain various genes or pseudo genes whose presence does not 
appear essential or useful for the bacterial cell; the notable exceptions are resistance 
genes for non-P-lactam antibiotics or heavy metals, some of which are derived from 
plasmids or transposons. 
//. SCCmec allotypes: 
SCCmec is classified into allotypes by the combination of which class of mec 
gene complex and which type of ccr gene complex it possesses. It is further 
classified into subtypes based on the differences in J regions. SCCmec was classified 
into five allotypes according to the combination of the mec gene complex class and 
the ccr gene complex type: type I SCC777£'C', class B mec gene complex and type 1 
ccr gene complex; type II SCCmec, class A mec gene complex and type 2 ccr gene 
complex; type 111 SCCmec, class A mec gene complex and type 3 ccr gene complex; 
type IV SCCmec, class B mec gene complex and type 2 ccr gene complex; and type 
V SCCmec, class C2 (subtype of class C) mec gene complex and type 5 ccr gene 
complex.'^**"'' Variants of SCCmec types described include SCCmec lA, which 
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differs from SCC/wec I by the presence of an integrated plasmid, pUBllO, 
downstream of the mec complex; SCCmec IIIA, which differs from SCCwec III by 
the absence of pT181 and its flanking IS4J7 elements; and SCC/wec IIIB, which 
lacks integrated copies of Jr\554, pT181, and the mer operon with its associated 
insertion sequences . Variants of SCCmec IV include SCCwec IVa and SCCwec 
IVb differ in their DNA sequences from the left extremity to the ccr complex (L-C 
region) but which both, carry the downstream constant region {dcs)^^^\ Both 
SCCwec IVc and IVd also differ in their L-C regions (SCCmec IVc carries an 
integrated copy of Tn4001 flanked on either side by IS256) . SCCmec IV has a 
type 2 ccr complex and class B mec, but Oliveira and colleagues described a 
SCCmec IV element with type 4 ccr '^^''^' A type IVA SCCmec element has also 
been described that harbors the integrated plasmid pUB 110 
1.8: Role of Nasal carriage in Staphylococcus aureus infection: 
The association between S. aureus nasal carriage and staphylococcal disease was 
first reported by Danbolt in 1931, who studied furunculosis . Subsequently, 
numerous studies confirmed Danbolt's finding.'^ '^'^ '^'^ '^'^ '^^ ^^ A causal relation 
between S. aureus nasal carriage and infection is supported by the fact that the nasal 
S. aureus strain and the infecting strain share the same phage type or genotype. 
Furthermore, nasal application of an antistaphylococcal drug temporarily 
decolonises the nose and other body sites, which prevents infection""'. S. aureus 
colonises the skin and mucosae of human beings and several animal species.'" The 
anterior nares of the nose is the most frequent carriage site for 5'. aureus. Extra-nasal 
sites that typically harbour the organism include the skin, perineum, and pharynx. 
155,162,163,164 Q J^^ ^^ . carriage sites including the gastrointestinal tract,'^^''^^ vagina,'^^ 
and axillae'^'''^^'"^^ harbour S. aureus less frequently, longitudinal studies 
distinguish at least three S. aureus nasal carriage patterns in healthy individuals: 
persistent carriage, intermittent carriage, and non-carriage.' '^ '^^ '^ "'^ '^"'^  persistent 
carriers have higher S. aureus loads and a higher risk of acquiring S .aureus 
infection.'^^''^" 
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Longitudinal studies sliow that about 20% (range 12-30%) of individuals are 
persistent 5". aureus nasal carriers, approximately 30% are intermittent carriers 
(range 16-70%), and about 50% (range 16-69%) non-carriers.''^'^•'''•'^^ Children 
have higher persistent carriage rates than adults.'^ '^^ ^ '^'^ '* Rates vary substantially 
with age, falling from approximately 45%) during the first 8 weeks to 21%) by 6 
17S 
months. " More than 70%) of newborn babies have at least one positive nasal culture 
with S. aureus. There is a transition from persistent carriage to intermittent or non-
carriage states during adolescence. ' ' ' Persistent carriers are often colonized by a 
single strain of S. aureus over long time periods, whereas intermittent carriers may 
carry different strains over time. ' ' 
The mechanisms leading to 5'. aureus nasal carriage are multifactorial. A 
recent study in which volunteers (non-carriers and persistent carriers) were 
artificially inoculated with a mixture of S. aureus strains showed that non-carriers 
quickly eliminated the inoculated S. aureus strains, whereas most persistent carriers 
selected their original resident S. aureus strain from the inoculation mixture. ''' This 
view is further supported by the fact that S. aureus carriage rates vary between 
different ethnic groups, with higher rates in white people ' and in men, ' " ^ and 
depend on age.'^ ' ""''^ ^ Patients with diabetes mellitus (both insulin dependent and 
non-insulin dependent), haemodialysis ' or continuous peritoneal dialysis for 
end stage renal disease, with end stage liver disease, ' HIV, ' skin 
infections and skin disease (eg, eczema or psoriasis), ' ' and obesity and a 
history of cerebrovascular accident'^^ have been shown to have higher 5". aureus 
nasal carriage rates. In one community-based study, Boyko et al. found similar S. 
aureus carriage rates in diabetics and non-diabetics, by contrast with an earlier 
clinic-based study. 
There are four prerequisites to become a nasal carrier of 5. aureus. 
1. The nose has to come in contact with S. aureus. 
2. S. aureus needs to adhere to certain receptors in the nasal niche. 
3. S. aureus needs to overcome the host defences. 
4. 5". aureus should be able to propagate in the nose. 
23 
'Rfiview ofLihrature 
S. aureus cells can survive for months on any type of surface.'^^ Hands are 
the main vector for transmitting 5*. aureus from surfaces to the nasal niche (eg, nose 
picking) and also reach the nose directly through the air, but this probably occurs 
less frequently.'^^ However, airborne transmission is important for the dispersal of 
staphylococci to many different reservoirs, from where, via the hands can reach the 
nose. S. aureus nasal carriers with rhinitis can disperse high loads of S. aureus into 
the environment and may be the source of an outbreak of S. aureus infections— the 
so called "cloud" individual. Environmental factors also influence the S. aureus 
nasal carriage state. Up to 65% of people with positive cultures living within one 
household shared genotypically identical strains.'^^ Intrafamilial spread of MRSA 
from and to health-care workers has also been shown to be an important risk factor 
for the re-introduction of MRSA into hospitals.''^ 
1.9: Role of Staphylococcus aureus in Nosocomial Infections: 
S. aureus (MSSA as well as MRSA) ranks as the second most common cause 
of hospital-acquired (nosocomial) bloodstream infections. About 20% of patients 
undergoing surgery acquire at least one nosocomial infection, leading to increased 
morbidity, mortality, hospital stay, and costs.'^ ''"'^ '^'^ ^ Hospital treatment usually 
requires that first line barriers for pathogens-of which the skin is an important on-are 
intentionally breached, resulting in an increased risk of infection. Most of these 
nosocomial S. aureus infections are caused by the patient's own S. aureus cells, 
which were already present on the skin or mucosal membranes before hospital 
admission in at least 80% of the cases.'"'^^ It could well be that more infections are 
of endogenous origin, since 10% of the nasal S .aureus carriers have more than one 
genotype or phage type in their nose. '^ 
S. aureus nasal carriage has been identified as a risk factor for the 
development of nosocomial infections in general hospital populations, surgical 
patients (general,'^^''^^'^^ orthopaedic,^*" thoracic surgery,^ **^  and children^**''), 
patients on haemodialysis or continuous peritoneal dialysis, • • • > patients 
with liver cirrhosis and after liver transplantation,'^ •^^ '" '^^ " •^^ "^ HIV-infected 
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patients,"*'''^'' and patients admitted to intensive care units. '^'^ •^"' Second to 
coagulase-negative staphylococci, S. aureus is the most prevalent organism causing 
intravascular device associated bacteraemia.'^^'^''^" Pujol et al.^ *'^  looked at 
bacteraemia in an intensive care unit. Most of the S. aureus bacteraemias had an 
intravascular device as a source. In a study by Wertheim et al.'^^ the source of 
bacteraemia was device related in more than 50% of the cases. In the study of Perl et 
al.'^^ 53% of i*>. aureus surgical site infections occurred in the non-carrier group, and 
15%) of the S. aureus surgical infections in carriers was caused by a strain other than 
their resident strain. These infections probably resulted from exogenous 
transmissions from the hospital environment or undetected extra-nasal S. aureus 
carriage sites. Health-care workers can be important sources of transmission of S. 
aureus and cross-infection. 
1.10: Prevalence MRSA in Ocular infection: 
Reports of MRSA ophthalmic infections are increasing in the literature. 
Conjunctivitis is the most commonly reported manifestation '^•^ ' ''''^'^ and has been 
associated with long-term care units, especially in patients with neurologic 
impairment '^^ '^ '^ '^ '^ '2''^ ; nurseries 219.220,221 ^^^ neonatal ICUs^ ^ '^^ ^ ;^ and healthcare 
workers.^ '^* Maskin^ '^^  reported diabetic patient who developed MRSA infectious 
scleritis. MRSA keratitis has been described in nursing home patients without prior 
l l ')0^')'"' '7 TOO 
surgery. ' ' '' Sotozono et al. reported patients with conjunctival swabs that 
grew MRSA. Inoue^^^ observed cases of MRSA keratitis in keratoconus patients 
with atopic dermatitis as well as blepharoconjunctivitis. Labit et al. reported two 
of thirteen S .aureus isolates were methicillin-resistant from endophthalmitis case. 
T l 1 TXO 1 1 
Saitoh et al , Kubo et al and Shanmuganathan et al described the prevalence 
of MRSA dacryocystitis in healthy patients. 
MRSA orbital cellulitis is rarely reported in the literature. Mehra et al 
described odontogenic MRSA sinusitis with orbital extension. Kato et al.^ "^* found 
91 ^ 
1.3%> swabbed eyes preoperatively grew MRSA. Fukuda et al. found 6.6% of 
1,000 asymptomatic eyes swabbed grew MRSA. In a 1991 report, Insler et al. 
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described MRSA keratitis after uncomplicated phacoemulsification with posterior 
chamber intraocular lens insertion. 
More recently, MRSA wound infections have been reported with clear 
corneal phacoemulsification wounds.^ '^'^ ^^ Postoperative MRSA endophthalmitis 
following cataract surgery have also been reported. ' Fukuda et al reported 
MRSA endophthalmitis following vitrectomy in a patient with atopic dermatitis. 
Refractive surgery has not escaped complications from MRSA infection. 
MRSA keratitis has been reported afler laser in situ keratomileusis ' and 
photorefractive keratectomy (PRK) . Sotozono et al.^ ^^ reported MRSA keratitis 
following penetrating keratoplasty, according to them MRSA keratitis is 
characterized by superficial keratitis, minimal melting, and minimal scarring. 
Patients with atopic dermatitis are often colonized with S. aureus in their skin 
lesions '^"'^ 42,243 ^ ^ ^^n ^^  having conjunctival and eyelid colonization.^^^ Because 
of frequent use of antibiotics for long periods in combination with corticosteroids, 
the prevalence of MRSA colonization in population is increasing. 
1,11: Emergence of MRSA in the Community. 
The prevalence of MRSA has increased in hospitals worldwide, until 
recently strains were uncommon in the community. The absence of antibiotic 
selective pressure favoring their survival and attenuated virulence were thought to 
make resistant organisms unable to compete in the community . The first report of 
a highly virulent community-acquired methicillin-resistant Staphylococcus aureus 
(CA-MRSA) strain occurred in 1993 in Australia '^*^ In the mid-1990s reports began 
to appear in the United States, particularly among children of CA-MRSA infection 
in patients without identifiable risk factors ^'^^''^'^\ reminiscent of the appearance of 
penicillinase-producing strains of MRSA in the community two decades previously . 
Since then, CA-MRSA is on rise ^^^'^'^'^•-^'^^ jt is not feasible to determine the true 
947 9S1 
background rate of MRSA carriage in the community. ' 
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The most common manifestations of CA-MRSA are skin and soft tissue 
infections 248.249,250.252.253,254 p^^^Q^^^ ^ j ^ ^ CA-MRSA are often younger than 
patients with nosocomial infection . Prior exposure to antibiotics has been 
implicated as a risk factor for the development of CA-MRSA infection^ '^*'^ ^^ 
Other risk factors may include homelessness ' , low socioeconomic 
status^^ -^^ ^ '^^ ", intravenous drug user 248,249.250.256,258^  previous MRSA infection, 
diabetes, chronic hepatitis C, cancer and HIV infection . Outbreaks have been 
reported among jail inmates ' ' ' and among athletes who share 
equipments'^ ' . In one study of necrotizing fastitis caused by CA-MRSA, four of 
14 patients had no identifiable risk factors . CA-MRSA stram may occasionally 
cause pneumonia or death in previously healthy patients ' . Friedman et al. ' 
suggested that bloodstream infections be classified as hospital-associated, or 
community-acquired. 
The CA-MRSA isolates are distinct from typical nosocomial strains ' ' . 
The susceptibility of CA-MRSA isolates to non-^-lactam antimicrobial agents and 
genetic fingerprinting suggests that they are unrelated to hospital-associated 
strains '^'^ '^^ ^ .^ Moreover, the strains possess a small (21- to 24-kb) and mobile 
staphylococcal chromosome cassette mec type IV (SCCmecIV)-encoding penicillin-
binding protein'^^ suggesting the possibility of increased mobility and easier transfer 
via plasmids or bacteriophages'"^ '^'^ '''^ *'. 
1.12: ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCI OF ANIMAL 
ORIGIN 
Since the introduction of antimicrobials into human medicine, staphylococci 
have shown a frequent and rapid development and spread of antimicrobial 
resistance, particularly in nosocomial infections. But, this development has not been 
documented continuously in the veterinary field. 
Because of its pathogenicity for both humans and animals, S. aureus has 
been the main subject of studies on antibiotic resistance in staphylococci . In 
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veterinary medicine, however, MRSA, as well as multiresistant S. aureus strains, are 
reported only occasionally 270.271,272,273,274 jyjj^g^ isolates detected in animal 
staphylococci have mostly been assumed to originate from human sources '^'^ . 
5*. aureus isolates from bovine mastitis have been the subject of numerous 
studies on antimicrobial resistance for the last 20 years. During the 1980s, overall 
')lf\ "JH 77S 97Q 75in 
low resistance values were reported - - -
1.12.1 :Epi(iemiology of MRSA in animals: 
Given the importance of S. aureus as a cause of mastitis in cattle and the 
widespread usage of intramammary antibiotics in that species it is perhaps not 
surprising that the first isolations of MRSA from animals were in milk from mastitis 
cows "'"'"°^ Since then MRSA has been found in a variety of other domestic species 
including dogs ^^\ cats^^^ horses ^^^'^^\ sheep^^^ pigs^ "^^  and chickens''* leading to 
an upsurge of reports and interest in MRSA colonization and infection in animals. A 
recent survey of S. aureus isolates recovered from 65 patients attending seven 
veterinary teaching hospitals revealed that 14% of patients were infected with 
MRSA and that MRSA infections were most prevalent among canine and equine 
patients^^^. Although it is possible that part of the perceived increase in MRSA cases 
is due to increased awareness and testing, it does appear likely that MRSA infection 
is a disease of emerging importance in dogs, cats and horses ^ '' . 
90^ 
Summarized chronology of publications reporting MRSA infections in animals. 
Year Authors Comments 
1972 Devriese at al. Isolation of MRSA from cows with mastitis 
] 975 Devriese and Hommez Further isolations of MRSA irom dairy cows, suggested to be of 
human origin 
1988 Scott et al. Cat suspected to be source of MRSA outbreak in geriatric ward 
1989 Smith et al. Isolation of coagulase-positive Staphylococcus sp. (12% of 
isolates were oxacillin resistant) from orthopedic implant sites in 
dogs 
1994 Cefai et al. Repeated nasal carriage of MRSA in two nurses linked to pet dog 
28 
'Rfiview ofCShraiure 
1996 Anzaietal. 
1997 Hartmann et al. 
Shimizu et al. 
1998 Lilenbaum et al. 
1999 Sequin etal. 
Pak et al. 
Tomlin et al. 
Gortel et al. 
2003 Lee 
Manian 
2004 Goni et al. 
Van Duijkeren et al. 
Rich and Roberts 
Boag et al. 
Weese et al. 
2005 Voss et al. 
Bender et al. 
O'Mahony et al. 
Kwon et al. 
Loeffler et al. 
Middleton et al. 
Hanselmann et al. 
Weese et al. 
Weese et al. 
Baptiste et al. 
Isolation of MRSA from 13 mares with metritis and a stallion 
with a skin lesion 
MRSA isolated from leg wound of horse 
PGFE typing of equine MRSA isolates reveals pattern distinct 
from human isolates 
Isolation of MRSA from skin scrapings from clinically normal 
cats 
MRSA outbreak in equine patients attending a veterinary 
hospital. Closely related MRSA isolates also obtained from 
hospital personnel 
Isolation of MRSA from 12 dogs hospitalized due to a variety of 
clinical conditions 
MRSA infection in 11 dogs associated with surgery, traumatic 
wounds or recurrent pyoderma 
MRSA isolates from wounds and skin lesions in dogs 
MRSA isolated from dairy cows (milk samples) and chickens 
(muscle or joint samples) 
Identical PGFE type of MRSA isolated from pet dog of owners 
with recurrent MRSA infection 
MRSA isolated from case of ovine mastitis 
MRSA isolated from two dogs with wounds 
95 MRSA isolates reported from dogs, cats, a horse and arabbit. 
Most isolates obtained from wound infections, postoperative 
infections or from the skin 
12 MRSA isolates from dogs and cats 
Environmental contamination suggested as important source of 
MRSA in veterinary teaching hospital 
Association between pig farming and high MRSA carriage rates 
Isolation of MRSA from non-healing abscess in a cat 
MRSA isolated from dogs, horses, a cat, a rabbit and a seal. 
Isolates were also obtained from attendant veterinary personnel. 
Non-equine MRSA isolates had PGFE pattern indistinguishable 
from most prevalent MRSA strain in human population. Distinct 
PGFE pattern for equine MRSA isolates 
s e c mec characterization of MRSA from bovine milk 
MRSA isolated from staff, dogs and environment of a small 
animal referral hospital 
14% of patients with 5. aureus infection at 7 veterinary teaching 
hospitals infected with MRSA 
1% nasal MRSA carriage rate in dogs in referral hospitals 
MRSA isolates from horses and horse personnel typed as 
SCCmecIV and distinct from epidemic MRSA types predominant 
in human population 
4.7% isolation rate of MRSA in screened horses rising to 12% 
using targeted surveillance 
MRSA isolates from dogs and staff at veterinary hospital 
identical by PFGE analysis to epidemic MRSA type prevalent in 
human population. Five distinct MRSA strains isolated from 
horses 
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2006 Abbott et al. 0.6% MRSA carriage in dogs rising to 8% in dogs clinically 
assessed 
Leonard et al. MRSA isolates from postoperative infection sites in five dogs and 
from nares of veterinary surgeon indistinguishable by PFGE 
Cuny et al. Approx. 0.48% of equine cases presented at veterinary teaching 
hospital infected with MRSA. Long term nasal carriage of MRSA 
in two attending veterinarians 
Strommenger et al. MRSA isolates from dogs and cats closely resemble hospital-
derived isolates in local human population 
Weese et al. Skin infections and nasal carriage reported in personnel attending 
a foal with MRSA infection 
Weese et al. Animal to human and human to animal transmission of MRSA 
suspected following investigation of six instances of MRSA 
infection in pets 
Weese et al. Community-associated MRSA colonization rate of 27 per 1000 
equine admissions to veterinary teaching hospital. Incidence rate 
of nosocomial MRSA infection of 1.8 per 1000 admissions 
Malik et al. mecA gene in MRSA isolates from dogs and cats shown to be 
identical to that found in human strains 
Rich and Roberts Culture of 561 isolates of MRSA from clinical infections in 
animals between January 2003 and August 2006. One of 255 
healthy dogs sampled found to carry MRSA 
The transmission of MRSA strains from cow to human is recently reported by 
1 ^ 
Kaszanyitzky et al. 
\.\22:Staphylococcm aureus in poultry: 
Staphylococci are some of the most common causes of infections in birds. 
Most infections are caused by coagulase positive staphylococci, especially S .aureus, 
but also coagulase negative staphylococci seem to be associated with infections 
294,2 5,296,2 7 ^jjtimicrobial agents are v/idely used in the treatment and control of 
staphylococcal infections. However, only a few studies have determined the 
occurrence of antimicrobial resistance and presence of resistance genes among 
staphylococci isolated from poultry. Rodgers et al. did not find any evidence of 
nasal colonisation of broiler farm personnel with poultry S. aureus. However, strains 
from broilers could be isolated from the hands. Staphylococci are frequently found 
in poultry products for human consumption 9^9,300,301 ^^^ ^^^^ Wms, spread to humans 
through the food chain. It is not known to what degree staphylococci of animal 
origin cause infections in humans, but it is generally established that staphylococci 
of human and different animal origin are to a large extent distinct bacterial 
populations^°^ •"* •^'''''^°-^''^. However, the use of antimicrobial agents for food 
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animals will select for antimicrobial resistance genes among staphylococci of animal 
origin. These resistance genes might in some instances transfer from staphylococci 
of animal origin to staphylococci causing infections in humans and thereby 
compromise antimicrobial treatment. 
Several studies on the genetic basis for antimicrobial resistance in 
staphylococci of human origin have been performed, including resistance to 
macrolides '^'^ '^ '^ ^ tetracyclines^^^ and streptogramins'^'^. The distribution of 
tetracycline resistance determinants among Staphylococcus species from several 
different domestic animal species including birds has previously been reported . 
\.\1.2>:Staphylococcm aureus in food products: 
In many countries, S. aureus is the 2nd or 3rd common cause of food borne 
disease outbreaks behind Salmonella and in competition with C. perfringens^^^. 
The production of meat, milk, and eggs in modern agriculture has attained 
industrial dimensions, animals being kept in large numbers for the different stages 
of production (breeding, raising, fattening, milk, and egg production) in specific 
'farms'. The numbers of slaughtered and animals in stock reaches a total of about 
48 billion animals (cattle, pigs, sheep, goats, chicken, and turkeys) that live on 
farms and are potential consumers of drugs and antibiotics every year . 
Farming productivities have become dependent on the use of antibiotics for three 
• 1 1 - 1 
different purposes : 
> Therapeutic use to treat infected animals (diarrhea, pulmonary inflammation, 
skin and organ abscesses, bacteremia, mastitis of dairy cows). The broad-
and narrow-spectrum antibiotics used for systemic administration are the 
same as those employed in human medicine, but may vary according to law 
in different countries (penicillins, cephalosporins, tetracyclines, 
chloramphenicol, aminoglycosides, spectinomycin, lincosamides, 
macrolides, nitrofurans, nitroimidazoles, sulfonamides, trimethoprim-
sulfonamide combinations, polymyxin, and quinolones . 
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> Prophylactic use to avoid infection of a herd if one animal starts to show 
symptoms of infectious disease. In dairy cows, antibiotics are routinely 
administered directly into the udder to cure and avoid mastitis (e.g., in dry-
cow therapy). The same therapeutic antibiotics are delivered directly into the 
fodder or drinking water. 
> Nutritive use at subtherapeutic levels to induce growth promotion. Antibiotic 
addition to fodder at subtherapeutic levels is an integral part of modern 
agriculture worldwide. 
Antibiotics approved for lactating and dry cows as measures to avoid and 
treat mastitis include amoxicillin, cephapirin, cloxacillin, erythromycin, hetacillin, 
novobiocin, oxytetracyclin, pirlimycin, penicillin and its combinations with 
novobiocin or streptomycin. Due to the high prevalence of bovine mastitis and the 
associated antibiotic consumption, enrichment of antibiotic-resistant staphylococci is 
expected and has been observed. The phenomenon is dependent on the particular 
herd and the antibiotics being used for prophylaxis and treatment . 
/. Milk and milk products 
Milk and milk products can become contaminated by S. aureus if good 
hygiene control is not exercised on farms, the milk is inadequately pasteurized and 
precautions are not taken to prevent contamination during manufacturing process 
and in the finished product '^'^ . Individuals suffering from skin lesion, infected 
wounds and those who cough and sneeze are more likely to contaminate milk or 
milk products during production and processing. Hand milking obviously presents 
T I C , . 
a greater risk than machine milking in this respect . Besides these extrmsic 
sources of contamination of milk and milk products, an important intrinsic source 
is mastitis milk. Staphylococcal food poisoning outbreaks have been reported to be 
caused by consumption of raw milk, 316317.318 cheese,^'^ Fjellost (a type of 
cheese)^^°. Minas cheese,- '^^ '^ '^ ice cream ^^^and curd^^l 
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a. Meat and Meat products 
Ham has been the most common type of meat product implicated in 5*. 
aureus poisoning in the USA, cooked chicken was the most common in England. 
Red meat and poultry were responsible for 47.3% and 77.2% staphylococcal 
poisoning out breaks in USA and England, respectively . Raw pork and uncooked 
smoked ham were also incriminated in recent food poisoning episode ". High 
occurrence raite of S. aureus have been reported from various meat and meat 
products viz. chicken 43.100%^^"'^ ^ '^^ ^ '^^ '^''^ '^', turkey 32%^^^ ducks 52% ^^\ pork 
29.5- 36.3%^^-'^ '"°, beef 25%^^°, meat products 6.6 to 19.5%^^°'"''^^^ Sausage and 
frankfurters 50% •^'^ , market hamburger and fresh pork sausage 15Vo^^^. 
in. Other foods 
Due to the widespread nature of the 5*. aureus, it has been reported in variety 
of food items. In 1989, S. aureus outreaks occured by the consumption of imported 
canned mushrooms from China ^ indicating that staphylococcal enterotoxins may 
survive a commercial retort process^ *^^ . The presence of enterotoxigenic 
staphylococci has been reported in bakery products such as cakes, vegetable puffs, 
sweet puffs, cream bun. The organism was present in a considerable numbers along 
with the enterobacters in these products . A food poisoning due to consumption of 
cake having S. aureus counts at a level of 2.9 x 10^  cfu/g has been reported"'"'^  
/v. Food handlers 
The food preparer hands have been cited as the main contributory factor in 
upto 39% of domestic food poisoning outbreaks '^^ '^ . Human nasal cavity is the 
important reservoir of S. aureus. The organism is frequently transmitted to a 
person's hand and then is introduced into food during preparation'^''^'^'". 5*. aureus 
present on unclean fingertips can cross contaminate foods for upto 24 h'^ ''^ . 
Food poisoning staphylococci were isolated from the hands and nose from 
20-25% of apparently normal people '^^'^'^'^, Daniellson et al,^ "*^  investigated the 
frequency of enterotoxigenic S. aureus from nose, throat and hand lesions of 86 
meat cutters and dressers. They found that 22% of nose, 6% of throat and 12% of 
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hand swabs were positive for S. aureus. A higher carrier rate of S. aureus among 
food handlers has been reported by Marambio et al.^ "*^  among 75 nasal and 
nasopharyngeal swabs screened from food handlers, 54.6% were carrier of 5*. 
aureus out of these isolates 47.3% were enterotoxigenic. 
1.12.4:Incidence oiStaphylococcus aureus in Food products in India 
S. aureus has been isolated from various food products in India. 
Staphylococci present in milk products were identified as great potential source of 
health hazard to human being '^*^ . Nearly 30% of the milk and milk products viz. 
raw and pasteurized milk, ice cream, kulfi, cheddar cheese, butter and milk powder 
'1') 1 
were found to harbour enterotoxigenic S. aureus . The isolation of S. aureus had 
been made from other milk products such as the khoa (30.43%), paneer (25%), kulfi 
(48.14%), ice cream (23.07%). Occurrence of S. aureus has been reported from raw 
meat, frozen meat and meat products'^ ''^ '^ '^ ''. Examination of muscles and other 
organs from cattle, buffaloes, goats, pigs and poultry, collected from slaughter 
houses and meat stalls in Calcutta, revealed presence of coagulase positive S. 
aureus by Dasgupta et al^ ^". Bachhil^ '*'* found that various meat (raw and frozen) 
and meat products (Kababs and curry) harboured 5* .aureus with counts exceeding 
stipulated guidelines/standards. 
Microbiological quality of ready-to eat products such as chicken burger, 
chicken pizza, chicken lollypop, chicken patties, chicken roll, mutton chop, mutton 
burger, mutton kabab and mutton samosa sold on railway stalls, small shops, and in 
T O 1 
the streets of Mumbai in India were assessed by Kakar et al . Among these, 
coagulase positive S. aureus was isolated from 7.7% chicken roll and mutton chop 
samples, 7.1 % of mutton burgers and 6.6% of chicken pizzas. In another study on 
the assessment of microbiological quality of meat products in and around the city of 
Mumbai, India, Murugkar et aP"^ ^ found that 5". aureus was present in all the meat 
products. 
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1.13:Dissemination oiStaphylococcus aureus in Air. 
Airborne transmission of Staphylococcus aureus is considered rare^""'. 
However, previous studies showed that a viral infection can drastically increase the 
dispersion of S. aureus into the air by nasal 5'. aureus carriers ^ ^^ ,353,354 
Few staphylococci are disseminated directly into the air from the respiratory 
tract; much larger numbers reach the environment from the body surfaces carried on 
air-borne desquamated skin scales. Some individuals disperse organisms very 
efficiently in this way; some, but not all, are heavy nasal carriers and may contribute 
to environmental contamination in hospital wards^^^ Much dispersal results from 
friction of clothing removing scales from the skin surface but some dispersal takes 
place even from those who are naked. Nevertheless, only about 10% of air-borne 
staphylococci survive the first 24 h, about half dying during the initial desiccation 
'ICC 
process; the infectivity of these dried organisms is not known. 
In the hospital setting, the most common mode of transmission of resistant S. 
aureus is close contact with infected persons or with health-care workers with 
contaminated hands or clothing^^ .^ Recent evidence suggests, however, that airborne 
dispersal and transmission may also be important ' ' and case studies 
implicating airborne transmission in the hospital setting ' . Although drug-
resistant S. aureus has historically been a significant problem only in hospitals, the 
urgent need for further study of the ambient airborne concentrations and the role of 
airborne transmission of this organism in non-hospital environments is demonstrated 
by the increasing prevalence of methicillin-resistant 5". aureus (MRSA) infections in 
the community^. Most alarming about this trend is that infection has been observed 
among individuals with and without known risk factors^^'. 
1.14: Staphylococcus aureus in water ecosystem: 
The occurrence of multiple antibiotic-resistant (MAR) bacteria in the 
"XfiD 'Xf\'X 'Xf\A 
environment is certainly a well-known phenomenon ' ' . Many investigators 
believe that these drug-resistant organisms have become more common due to the 
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extensive use of antibiotics in medicine and agriculture throughout the world 
-J/-C 'if.f, "if-n "3*^0 ' 2 ^ ^ 
' ' ' . Grabow et al. emphasized the need to review water quaUty standards 
as they relate to the spread of antibiotic resistance genes in water- borne bacteria 
carrying transmissible R-factors. In environmental settings polluted by human or 
animal waste or both, high frequencies of MAR phenotypes exist in the coliform and 
fecal coliform populations ' ' ' . These environments include surface waters 
receiving runoff from lands occupied by livestock ' ' polluted estuaries ' , 
'inf. "Ill 1,19 
and contaminated water supplies ' ' . 
S. aureus in drinking water may serve as a source for colonizing residents 
exposed to contaminated water . Contaminated whirlpool water has been 
implicated as the route of transmission of MRSA in the community in a report of 
MRSA infection in a college football team'^. Furthermore, methicillin-sensitive 
Staphylococcus aureus (MSSA) was isolated in communal whirlpool water 
associated with a professional football team in the US^^ ,^ where there was an 
- l O I 
outbreak of skin abscesses due to MRSA infection. Tolba et al, have presented a 
data describing the survival dynamics of MRSA in aquatic, marine or swimming 
pool environments. Their investigations showed that MRSA survived better in sea 
water, than in river water. There was no significant difference observed by them in 
the survival dynamics between any of the HA-MRSA strains examined with any 
water milieu examined, nor was there any significant difference in the survival 
dynamics between HA-MRSA and CA-MRSA. Asymptomatic carriage of MRSA in 
individuals using such waters to swim in, would allow the contamination of waters 
with MRSA organisms. Such contaminated water may subsequently act as a 
transient environmental reservoir for MRSA, if not properly chlorinated. Thus 
allowing the colonization of new hosts, particularly those with open wounds or other 
skin trauma. 
1.15:Methicillin- Resistant Staphylococcus aureus: Indian Scenario 
The prevalence rate of MRSA was 11.84% between 1961 and 1963 in All 
India Institute of Medical Sciences (AIIMS) . These resistant strains possessed 
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some common characteristics in that all were resistant to a number of commonly 
used antibiotics. A large majority of strains were untypable. Only 24 out of 128 
strains were typable and belonged to phage group III'^ '^^ . 
Methicillin was not in use in India, yet the incidence was surprisingly high 
and it was concluded that those might be the naturally occurring resistant strains. 
The strains were also resistant to a number of antibiotics used in that hospital. 
Hence the only explanation of the increasing incidence of MRSA strains is that 
these antibiotics might have acted as the selecting agents for the resistant mutants'^ ^ .^ 
The incidence of methicillin resistant S. aureus was found to be 26.67% 
during 1981-82 by Bhatia et al^ ^^  in Maulana Azad Medical College, New Delhi. 
Chakravarthy et al reported methicillin resistance in 6.9% strains from primary 
health centre near New Delhi. Pal et al.^ ^^  studied a total of 1,770 strains of which 
404 (22.6%)) were methicillin resistant. Pullmood et al^ ^^  detected the incident of 
MRSA to be 24%) in his study from Christian Medical College and Hospital, 
Vellore. Prevalence of MRSA was found to be 20%o in JIPMER, Pondicherry by 
Udaya et al^^^ Basak et al (1997)^ ^^ found the prevalence rate of MRSA 30.6% in 
rural medical college. 
MRSA Surveillance Study Group from three centers across India presented 
a surveillance report of describing 31.8% MRSA isolates. Mehta et al^ ^" undertook a 
surveillance study of MRSA and reported 29% strains as MRS As. Gupta et aP^' 
reported an outbreak of post operative wound sepsis by MRSA in the surgical ward 
of LNJP Hospital, New Delhi. Agarwal et aP*^ ^ reported prevalence of MRSA to be 
10%) in Government Medical College, Amritsar. Majumdar et al undertook a 
study of antimicrobial susceptibility pattern among MRSA isolates in Assam. 
Methicillin resistance among S. aureus was found to be 52.9%o. Vidhani et al 
detected 51.6% MRSA incidence among high risk patients in bums and orthopedic 
units in LNJP Hospital, New Delhi. 
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1.16: Typing of MRS A isolates for Epidemiological investigations: 
Many techniques have been devised for the epidemiological typing of MRSA 
for confirming the identity of colonizing and infecting strains as it forms an 
important aspect of infection control. A typing system should be reproducible, easy 
to interpret, inexpensive, easy to perform and it must obviate the necessity of a 
second typing system to provide further discrimination. It is considered adequate if 
there is a high probability that two random isolates that are epidemiologically 
unrelated are indeed different. The typing systems have been broadly classified into 
phenotypic and genotypic methods. 
1.16,1: Phenotypic methods: 
1. Biotyping: 
Meyer (1967)''^ ^ used a 1: 100, 000 dilution of crystal violet in agar for the 
propagation of 5. aureus and found that 81.2 % of 618 bovine isolates, the majority 
of which were from bovine mastitis, gave rise to yellow colonies (crystal violet type 
A). He considered the crystal violet reaction to be one of the distinguishing 
characteristics for human and bovine S. aureus strains. Devriese et al.^ *^" observed 
that out of 94 S. aureus strains from mastitis in cattle, 69 % were crystal violet type 
A whereas 31 % were crystal violet type C. The biochemical characteristics such as 
fibrinolysin production, coagulation of different animal plasmas, hemolysin patterns, 
growth on crystal violet agar, and pigment formation have been used extensively to 
divide this organism into varieties or biotypes. 
A biotyping scheme for MRSA was proposed by Coia et al'^ ^^ , dividing them 
into four groups A to D based on properties namely Tween 80 hydrolysis, pigment 
production on Tween 80 agar, Urease production and Gentamicin resistance. In 
India, the first report of biotyping of MRSA is given by Krishna et al'^ ^l MRSA 
strains characterized by this technique were mostly found to belong to group B. 
MRSA biotyping in a study conducted in 1993 categorised 60% MRSA in B 
biotype^ '^ '^  while studies conducted in 1995, 1999 and 2001 reported all MRSA as 
biotype B^ '^-^ r^ 
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2. Bacteriophage Typing: 
It is one of the most common methods used to assess the relatedness of 
various strains of S. aureus and has been used since 1952. The standard set of 
conventional 23-phages is used for typing. However, it is well known that MRSA 
are poorly typable, if at all, by the conventional set of phages. Keeping this in view, 
in 1985 a new approach of using supplementary phages was adopted . 
Phage typing of MRSA isolates revealed that most of the staphylococci were 
closely related organisms Kayser et al'* . Peacock et al found 27 of 31 strains had 
a common phage type {6/47/54/75/83A} or a minor variant (+/- 2 numbers) there-
off, establishing the epidemic strains as phage group III. Craven et al performed 
bacteriophage typing on 52 isolates of OARSA (Oxacillin and Aminioglycoside 
resistant S. aureus). Group III phages, type 47/54/75/83A produced the same pattern 
for lysis in 47 isolates. Saravolatz et al described an outbreak of MRSA among 
drug abusers, phage typing revealed that the isolates were related to an epidemic 
strain (29/52/80/95). Boyce et al '^^'^ reported an outbreak of MRSA in the burn unit. 
In an intravenous drug abusers phage type 29/77/83A/84/85 was detected, which 
was distinct from the nosocomial MRSA and was probably acquired because of the 
use of infected needles '. Rossney et al ^ showed that 66% of the strains were non-
typable, 10% were of the type 83 A, and 12% were lysed by bacteriophages 8A and 
75. The study reported that phage type 8A became a problem in 1990-91; the 
incidence of gentamicin sensitive non-typable MRSA increased fourfold between 
1988 and 1991; and the incidence of gentamicin resistant MRSA rose sharply in 
1992. Cox et al"*"' reported an outbreak of MRSA infection caused by a novel phage 
type (now designated EMRSA-16) The particular strain responsible for this outbreak 
was a distinctive phage type showing inhibitory reactions with phages 29 and 52, 
and weak reactions with phages 75, 83A and 83C at 100 RTD. Wildemauwe et al""^ ^ 
isolated a total of 102 epidemic MRSA strains. Except five, all the strains belonged 
to a few distinct phage types of group III. Mathur et al.^ ^^ have demonstrated a 
increased percentage of typability from 17.6% with the conventional phage set to 
45.6%) with the MRSA set of phages in MRSA isolates. Phage type 622 was found 
to be the most prevalent. On reverse phage typing 73%) strains could not be typed, 
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with most strains belonging to one pattern - 83A complex with limited 
discrimination. Thus the phage typing helps in tracing the outbreaks and in 
deciphering the clonal spread of the organism. 
1.16.2: Genoitypic methods: 
Bacterial strain typing distinguishes epidemiologically related or clonal 
isolates from unrelated isolates. Epidemiologically related isolates are viewed as 
descendants fi-om a common precursor cell; thus, their genomic "fingerprints" will 
be indistinguishable but recognizably different from unrelated or random isolates 
from the same species '*°^ . Outbreak investigations of S. aureus and other 
nosocomial pathogens are viewed as short-term events or cases of local 
epidemiology, and in these settings most genotyping methods are able to distinguish 
clonal spread from unrelated isolates. Understanding genetic relatedness becomes 
more challenging when the strain study population is larger, separated further in 
time, and recovered from a larger geographic area. The long-term or global 
epidemiologic question is whether the strains causing disease in one geographic area 
are related to those causing disease in other regions. A combination of genotyping 
methods has been used to study global S. aureus transmission ' '. 
In addition to tracking outbreaks, genotyping is used to distinguish between 
contaminating and infecting isolates and between separate episodes of infection and 
relapse of disease . Genotyping is also able to link certain S. aureus clonal types 
and disease syndromes, such as in cases of food poisoning and toxic-shock 
syndrome. Numerous techniques are available to differentiate S. aureus, and 
specifically MRS A isolates. Some of them are mentioned below. 
1. Techniques Involving Polymerase Chain Reaction (PCR): 
PCR gave rise to a variety of techniques with many applications, amongst 
these, the discrimination between bacterial isolates. Typing techniques involving 
PCR can be divided into four main groups: PCR-RFLP, PCR ribotyping, AP-
PCR/RAPD and Rep-PCR ^^\ The arbitrarily primed PCR (AP-PCR) technique or 
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RAPD (Random Amplified Polymorphic DNA) is a variation of classic PCR and 
was proposed by Williams et al. """^  and by Welsh et al."*'^  The RAPD technique 
produces genetic identities for all MRSA and the results have good intra-laboratory 
reproducibility. The advantage of this technique over others is its relative simplicity 
and quickness. The discriminatory power is variable and depends on the number and 
nucleotide sequence of the primers used. In the investigation of outbreaks, RAPD 
has permitted the grouping of epidemiologically related isolates and the exclusion of 
unrelated isolates ""^  
2. Analysis of Chromosomal DNA by Pulsed-Field Gel Electrophoresis (PFGE): 
This technique is based on the digestion of bacterial DNA with restriction 
endonucleases that recognise few sites along the chromosome, generating large 
fragments of DNA (10-800 Kb) that can not be separated effectively by 
conventional electrophoresis. In PFGE, the orientation of the electric field across the 
gel is periodically changed (pulsed), allowing DNA fragments on the order of 
megabase pairs to be effectively separated according to the size 0^9,417,418,419,420.421 
Consequently, PFGE allows for the comparison of chromosomal DNA with much 
simpler profiles than those generated by high-frequency restriction endonucleases 
"^ '^  All bacteria can theoretically be typed by PFGE, and the results are highly 
reproducible '"''. PFGE has been used for the investigation of MRSA and has been 
compared with other methods in several studies 422,423,424 ^jj isolates are typable and 
standard strains are reproducible, even after extensive subculturing i^2,423,425,426 ^j^^ 
discriminatory power is equal to or superior to phenotypic techniques as well as to 
genotypic techniques such as ribotyping, RAPD, PCR-RFLP and inter-IS256 PCR 
422,423,427,428 -pj^ jg technique has been extensively used for the comprehension of the 
epidemiology of both endemic and epidemic MRSA strains. Tenover et al.''^ ^ 
proposed a standardised interpretation scheme in order to determine the genetic 
relationship between strains. 
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MATERIALS & METHODS 
In order to carry out the proposed research, for the determination of the 
spread of antibiotic resistant Staphylococcus aureus from various ecosystems to 
human beings in health and diseases. The attempts were made to characterize the 
organism thus isolated by cultural and biochemical characteristics. The subsequent 
experiments v/ere performed by standard methods mentioned in this chapter. 
MATERIALS 
Materials used during the study were listed below:-
3. a: Antibiotics 
The number of antibiotic discs used to carry out the study is listed below. All 
the antibiotic discs were purchased from Hi-Media, Pvt. Ltd, Mumbai, India. 
Amikacin 
Amoxycillin 
Ampicillin 
Cefazolin 
Ceftazidime 
Chloramphenicol 
Ciprofloxacin 
Clindamycin 
Co-trimoxazole 
Erythromycin 
Fusidic acid 
Gentamicin 
Imipenem 
Methicillin 
Ak 
Am 
A 
Cz 
Cd 
C 
Cf 
Cd 
Co 
E 
Fc 
G 
I 
M 
30 i^g 
30 ^g 
10 Mg 
30 ng 
30 ^ ig 
30 Mg 
5Mg 
2ng 
25|ig 
30 Mg 
10 Mg 
10 Mg 
10 ^g 
5lig 
42 
"Material 4: "Metftoc(s 
Novobiocin Nv 30 \ig 
Oxacillin Ox 30 \ig 
Penicillin G P 10 units 
Rifampin R 5 |j.g 
Roxithromycin Ro 30 |ig 
Tetracyclin T 30 [ig 
Vancomycin V 30 |ig 
3. b: Culture Media 
List of the culture media used for the isolation and identification of the organism 
was purchased from Hi-Media, Pvt. Ltd. Mumbai, India. 
Agar agar 
Baird-Parker with Egg -Yolk -Emulsion. 
DNase test agar 
Luria-Bertani broth 
Mannitol salt agar 
Mueller-Hinton agar 
Mueller-Hinton broth 
Nutrient agar 
Nutrient broth 
Oxacillin salt agar 
Phenolphthalein phosphate agar 
Tellurite-Polymyxin-Egg-Yolk-Emulsion (TPEY) 
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3. c: Chemicals and reagents used: 
Acetone 
Agarose 
Agarose PFGE grade 
Ammonium chloride 
Ammonium oxalate 
Ammonium persulphate 
Barium chloride 
Benzyl penicillin 
Boric acid 
Bromocresol purple 
Bromophenol blue 
CaCl2 
Chloroform 
Cotton swab 
Crystal violet 
DNA 
DNA ladder (100 bp) 
DNA ladder (lOObp) 
DNA ladder (Ikb) 
dNTPs 
EDTA 
Ethanol 
Ethedium bromide 
Glacial acetic acid 
Glycerol 
Hydrochloric acid 
Hydrogen peroxide 
Iodine crystals 
Isoamyl alcohol 
SRL, India 
Hi-Media, India 
Genei-Bangalore, India 
SRL, India 
SRL, India 
Hi-Media, India 
Hi-Media, India 
Hi-Media, India 
SRL, India 
Hi-Media, India 
Hi-Media, India 
SRL, India 
SRL, India 
Hi-Media, India 
Hi-Media, India 
Hi-Media, India 
Genei-Bangalore, India 
Fermentas, USA 
Genei-Bangalore, India 
Genei-Bangalore, India 
SRL, India 
E. Merck, India 
Sigma, USA 
E. Merck, India 
SRL, India 
SRL, India 
SRL, India 
Hi-Media, India 
SRL, India 
44 
JAaterials 4: JAeihods 
KCI 
KOH 
Lysostaphin 
Lysozyme 
MgCl2 
Na2HP04 
NaH2P04.H2O 
NaOH 
Oxacillin salt 
Phenol 
Phenol red 
Potassium iodide 
Proteinase K 
PCR buffer 
RNase 
Safranine 
SDS 
Sodium acetate 
Sodium bicarbonate 
Sodium chloride 
Sma\ 
Tris-HCl 
Taq Polymerase 
Xylene cyanol 
OPA- A Kit 
Gel extraction Kit 
SRL, India 
Hi-Media, India 
Sigma, USA 
Sigma, USA 
SRL, India 
Hi-Media, India 
Hi-Media, India 
SRL, India 
Ranbaxy, India 
SRL, India 
Hi-Media, India 
Hi-Media, India 
Sigma, USA 
Genei-Bangalore, India 
Sigma, USA 
Sigma, USA 
Hi-Media, India 
SRL, India 
Hi-Media, India 
Hi-Media, India 
Promega, Madison, USA. 
E. Merck, India 
Genei-Bangalore, India 
Bio-Rad, USA 
Operon Biotechnologies, Germany 
Genei-Bangalore, India 
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METHODS 
3.1: Procedure for Sample Collection: 
The cultures were obtained with moist cotton swabs or sterile loops under 
aseptic conditions. All the glasswares were thoroughly washed with tap water 
followed by distilled water and were sterilized in hot air oven at 170°C ± 10°C for at 
least one hr. The cotton swabs were sterilized by autoclaving at a temperature of 
121°C and 151 h/i" pressures for 20 mins. 
3.1.1: Sample collection and processing from clinical specimens: 
The isolation of staphylococci from various clinical specimens was 
performed as per routine operations in the concerned clinical laboratories. However, 
some recommended procedures for collecting and processing specimens as 
described in the American Society for Microbiology's Manual of Clinical 
Microbiology, were followed.'*'^ '^'*'*'^ ''''"'^  The cultures were obtained from 
Bacteriology Laboratory, Department of Microbiology, J.N. Medical College. 
A.M.U. Aligarh. The cultures from clinical specimens were taken with the help of 
cotton swabs or inoculation loops and streaked on blood agar and nutrient agar 
plates. The plates were incubated at 37°C for 24 hrs and then stored at room 
temperature for 2 to 4 days to enhance pigment production and colony morphology. 
3.1.2: Sample collection and processing from Ocular specimens: 
Samples were taken from the infected eye of the patients referred to 
Microbiology Laboratory, Institute of Ophthalmology, J. N. Medical College. 
A.M.U. Aligarh. The conjunctival cultures were inadequate in case of corneal ulcer; 
therefore, direct sampling from the corneal ulcer bed was done both for smears and 
cultures. Topical anaesthesia, xylocaine (4%) was used before taking culture, 
depending upon the response of patients. The exudates and necrotic material were 
removed from the ulcer crater with a moist swab loop, which was then cultured. 
Causative organism are often best recovered underneath this debris, therefore, 
additional specimens were obtained with a sterile swab or loop by taking care to 
avoid excess pressure especially with deep ulcers or severe thinning. The culture 
swab or loop was streak onto blood agar plate and nutrient agar (Hi-Media, 
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Mumbai) plate. The growths obtained were identified for S.aureus by conventional 
tests and culture characters. 
3.1.3: Sample collection and processing from Nasopharynx: 
A single sterile cotton swab moistened in nutrient broth was swirled in the 
anterior portion of each nares for five clockwise and five counter clockwise 
rotations'-'''•^"''*^^ The swab was immediately reintroduced into the culture tube 
transported to lab and processed within 2-3 hrs and inoculated on blood agar plates. 
The plates were incubated at 37°C for 48 h. S. aureus isolates were selected by 
marmitol salt agar and identified by catalase and coagulase testing of colonies with 
typical morphology. 
3.1.4: Sample collection and processing from Mastitis and Sub-clinical dairy cattle: 
One specimen per animal was collected from the intramammary glands or 
skin teats of inflamed (mastitis) and normal dairy cattle at the time of milking. For 
the collection of sample, sterile cotton swabs moistened with broth were swabbed on 
the surface area of 10 X 10 cm of every dairy cattle. All samples were immediately 
transported to laboratory aseptically. The culture swabs were inoculated into 10 ml 
of nutrient broth supplemented with 7% sodium chloride salt and allowed to 
incubate at 35°C for 24 hrs. The 0.1 ml or a loopful of inoculum was spread onto 
Baird-Parker agar with egg-yolk-emulsion and incubated at 35°C for 24 to 48 hrs. 
Distinct black coloured colonies appeared which were picked up for tests using 
conventional methods for S.aureus levels'" .^ 
3.1.5: Collection of samples from food and food handlers: 
The presence of S. aureus in meat, milk (mastitis & raw), milk products, raw 
vegetables, fruit chat and food handlers was done to know their public health 
importance. Attempts were made to characterize the isolated organism, by their 
cultural and biochemical characteristics. 
3.1.5.1: Collection and processing of meat samples: 
Meat samples (muscle) from retail meat shops at Aligarh city and hostel 
meat suppliers were collected from different types of meat (cattle and poultry). 
Approx. 10 gm. of each tissue was collected in sterile glass containers. The samples 
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were processed within 2-3 hrs after collection. From the time of collection to 
processing, the samples were kept in refrigerator. The surface of the collected meat 
samples was trimmed by sterile scissors and forceps. From each sample a small 
portion was taken and cut into small pieces. These samples were then grinded in an 
electrically operated sterile tissue grinder. About 0.1 ml each of processed meat 
sample was inoculated into 5 ml nutrient broth containing of 7% sodium chloride 
salt and allowed to incubate at 35°C for 24 hrs. The inoculum was spread onto 
Baird-Parker agar with egg-yolk-emulsion and incubated at 35°C for 24 to 48 hrs. 
Distinct black coloured colonies appeared with 24 hrs of incubation. These distinct 
black colonies were picked up for tests using conventional methods for S.aureus 
levels'^ 
3.1.5.2: Collection and processing of milk samples: 
At the time of milking, about 10 ml of raw milk from each dairy cattle was 
collected in sterile tubes, from un-organized dairy farmers from Aligarh city and its 
country sides. Samples were processed in laboratory within 1-2 hrs of collection. 
From the time of collection to processing, the collected samples were kept in the 
refrigerator. The collected raw milk samples were homogenized by gentle rubbing of 
tubes between the palms. This material was used for inoculation. After thorough 
mixing, 0.01 ml or loopful of each milk sample was inoculated on (1) blood agar 
plate and (2) tellurite Polymyxin-egg-yolk-agar (TPEY) (Gilbert et al , 1969)"*^ ^ The 
plates were then incubated at 37°C for 24 to 48 hrs. Colonies obtained on blood agar 
and TPEY agar plates were tested for S. aureus level. 
3.1.5.3: Collection and processing of milk products: 
About 2 gm each of sweet (burfi) and cheese were collected within the 
permissible aseptic precautions in sterile glass containers from Aligarh city 
confectionaries. Samples were processed in the laboratory within 1-2 hrs of 
collection. From the time of collection to processing, the collected samples were 
kept in the refrigerator. The collected sweet samples were homogenized at room 
temperature with 10 ml each of normal saline solution (0.85% NaCI) in sterile 
beaker. With sterile precautions, 0.1 ml each processed sample was inoculated into 5 
ml nutrient broth containing 7% sodium chloride salt and incubated at 35°C for 24 
hrs. Then a loopful of overnight broth cultures was streaked on Baird-Parker agar 
48 
IMateriafsSti JAdhods 
with egg-yolk-emulsion and incubated at 35°C for 24 to 48 hrs. Distinct black 
coloured colonies appeared within 24 hrs of incubation. These distinct black 
colonies were picked up for tests using conventional methods for S. aureus levels . 
3.1.5.4: Collection and processing of samples from Vegetables and Fruit Chats: 
Sampling was done from the retail vegetable shops and fruit chat vendors of 
the Aligarh city. Samples from ready to eat salad vegetables i.e.; cabbage, radish and 
cucumber and fruit chats comprising of slices of banana, guava, papaya and apple 
were taken for isolation of 5'. aureus. Samples were collected in zip lock sterile 
polythene bag and transported immediately to laboratory for processing. Portion of 
vegetables and fruit chats weighing 10 gm were suspended in 100ml of normal 
saline (0.85% NaCl) solution and homogenized for 10 min. after thorough mixing 
0.1 ml of each sample were suspended on Baird-Parker agar. The plates were then 
incubated at 37°C for 24 hrs. S. aureus identified by colour pigmentation and 
conventional biochemical tests. 
3.1.5.5: Collection and processing of samples from food handlers: 
From food handlers, samples of hand and nasal swabs were collected, these 
included the dining hall workers in a student's hostel, milkers, butchers and fruit 
vendors. Sterile cotton swabs soaked in normal saline solution (0.85% NaCI) was 
touched gently on the palm, finger tips and anterior nares of the workers. The swab 
was immediately reintroduced into the culture tube and transported to lab. The 
cotton swabs were then processed within 2 to 3 hr of collection and inoculated on 
blood agar plates. 
The same procedure was employed in isolation of staphylococci from 
washermen and other personnel's. 
3.1.5.6: Sample collection from Air: 
Observations on the number of bacteria-carrying particles in air were made 
in premises where safe working depends on the air's content of bacteria being kept 
at very low level, e.g. surgical theatres and premises where certain foods or 
pharmaceuticcil materials are prepared and in hospital wards where there is an 
outbreaks of cross infection, it is therefore required to examine the air for its content 
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of a particular pathogen. The organism is collected by settled plate method as 
described by May(1967)''^^. Petri plates containing blood agar and mannitol salt agar 
a selective medium were used in isolation procedure. The freshly prepared plates 
were dried for any surface moisture. The plates were left open for 30 min in hospital 
wards, dinning halls, homes, shops and offices, whereas they were left open for 60 
min in open spaces for collection of samples. The Petri plates were exposed about 1 
meter above the ground for collection of organism. The plates immediately 
transported to laboratory and incubated for 24 hrs at 37°C. Colonies obtained on the 
blood agar were morphologically identified, and colonies grown over selective 
medium were selected for further conventional tests for 5*. aureus levels. 
3.1.5.7: Collection of specimen and processing from water: 
When water is suspected of transmitting a particular infection, attempts were 
made to isolate the casual pathogen from it. 
A 100 ml of water sample was collected aseptically in sterile glass bottle from 
drinking water supply and ponds surrounded by the residential colony in Aligarh 
city. Extreme care was taken to avoid contamination of samples with bacteria from 
the environment. Bottles were transported to the laboratory within 2-3 hrs, for the 
processing. The S. aureus was enumerated by membrane filtration technique as 
described by LeChevallier et al(1980)''^''. Membrane filters of 47 mm diameter and 
pore size of approximately 0.45 |im were used for the filtration of the S. aureus. 
Method: 
A sterile membrane filter was placed on the filter base using aseptic blunt 
ended forceps. The membrane must overlap the entire circumference of the sintered 
filterable area so that the entire sample passes through the membrane. The water 
samples were mix thoroughly by inverting the bottles several times, and aseptically 
transferred to the filter funnel. By electric pump the water samples were drawn 
through the membrane. Using blunt-ended forceps, the membranes were placed onto 
Mannitol Salt Agar base and incubated at 35 "C for 24 to 48 hrs. Typical 
Staphylococcal colonies were selected for further conventional tests for S. aureus 
levels. 
50 
"hfaterials S^ J^etftocQ 
3.2: Media Employed for Culture Collection and Identification: 
There is a wide variety of media available for the growth of microorganisms 
in the laboratory. Most of these are available from the commercial sources with all 
the components premixed, and required only addition of water and sterilization for 
use. When it was desirable to grow bacteria on a solid medium, a solidifying agent 
such as agar (polysaccharide derived from a marine alga) was added to the medium. 
All the media used in the study were either prepared in the laboratory or supplied by 
Ms Hi-Media Pvt. Ltd. Mumbai. 
3.2.1: NUTRIENT BROTH 
Nutrient broth was used for growing the bacterial strains in isolation process 
and prior to testing their antibiotic sensitivity and minimum inhibitory 
concentrations (MIC's) of some antibacterial agents. 
Composition: (Ingredients/litre) 
Peptone 5 gm, Sodium chloride 5 gm, 
Beef extract 1.5 gm, Yeast extract 1.5 gm. pH 7.4±0.2 . 
Dissolved the ingredients in water, heated to obtain a homogenous solution 
and poured this solution into clean test tubes (3 to 5 ml in each tube) stoppered with 
cotton plugs. The tubes were autoclaved for 15-20 minutes. 
3.2.2: NUTRIENT AGAR 
The simple or basal medium was used in the present study, which contains all basic 
nutritional requirements, sources of energy, carbon, nitrogen and mineral salts. 
Composition: (Ingredients per litre) 
Peptone 5 gm, Sodium chloride 5 gm, Beef extracts 1.5 gm, 
Yeast extracts 1.5 gm, Agar 15 gm, pH (approx.) 7.4 ± 0.2 
Dissolved the ingredients in distilled water in a conical flask, plugged firmly with 
cotton, wrapped in almunium foil. Autoclaved it at 121 °C for 15 minutes and poured 
into sterile petri plates under aseptic conditions. Allowed to cool to form a 
homogenous layer about 4 mm in thickness. A few plates from each batch were 
incubated overnight at 37°C to check their sterility. 
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3.2.3: BLOOD AGAR 
Blood agar in addition to being an enriched medium is used as an indicator medium 
showing the hemolytic properties of bacteria. 
Composition 
Nutrient agar 100 ml 
Sheep a blood 5-10 ml 
The method of preparation of this medium was essentially the same as that 
for nutrient agar. The sterile citrated sheep's blood (5-10%) was added to autoclaved 
nutrient agar from a screw capped bottle after the mixture had cooled down to about 
50°C in a water bath and was poured aseptically into sterile petri plates. 
3.2.4: MANNITOL SALT AGAR (Ca:ppuccino et al, 1986)"^' 
It is both a selective and an indicator medium. Most strains of S. aureus ferment 
mannitol. 
Composition: (Ingredients per litre) 
Beef extract 1 gm, Protease peptone 10 gm, 
Sodium chloride 75 gm, D-Mannitol 10 gm, Phenol Red 0.025, Agar 15 gm, pH 7.4 
Dissolved the ingredients in distilled water and: adjusted the pH by adding dilute 
acid or base and autoclaved. 
3.2.5: PHENOLPHTHALEIN PHOSPHATE AGAR (Barber et al, 1951)^ ^^ 
This indicator medium assists the identification of 5. aureus in mixed cultures. 
Composition: (Ingredients/litre) 
Nutrient agar 980 ml, 
Sodium phenolphthalein diphosphate (0.6% soln.) 20 ml, pH 7.4 
Dissolved sodium phenolphthalein diphosphate in water to 0.6% concentration, 
filtered and at once added 20 ml of this solution to melted nutrient agar just before 
pouring into sterile petri plates. 
3.2.6: DNase AGAR (Jefferies, 1961)'*^ '^  
It was used for identifying S. aureus strains. 
Composition: (Ingredient/litre) 
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Tryptose 20 gm, DNA 2 gm. Sodium chloride 5 gm, Agar powder 12 gm, pH 7.3 
Dissolved the ingredients in distilled water and autoclaved for 15-20 minutes. 
3.2.7: MUELLER-HINTON AGAR 
The routine susceptibility testing of non-fastidious bacteria was done by Mueller 
Hinton Agar since recommended by ^CCL'S^^^''^^'^'^'^. 
Composition: (per litre) 
Casein acid hydrolysate 17.5 gm 
Beef heart infiasion 2.0 gm 
Starch, soluble 1.5 gm 
Agar 17.0 gm 
Final pH (at 25°C) 7.3±0.2 
Mueller-Hinton agar preparation: 
Mueller-Hinton agar was prepared from a commercially available 
dehydrated base according to the manufacture's instructions. Immediately after 
autoclaving, allowed it to cool in a 45 to 50°C water bath. Poured the freshly 
prepared and cooled medium into glass or plastic flat-bottomed petri dishes on a 
level, horizontal surface to give a uniform depth of approximately 4 mm. This 
corresponds to 60 to 70 ml of medium for plates with diameters of 150 mm and 25 
to 30 ml for plates with a diameter of 100 mm. The agar medium allowed to cool to 
room temperature and, unless the plate is used the same day, stored in a refrigerator 
(2 to 8 °C). Plates should be used within seven days after preparation unless 
adequate precautions, such as wrapping in plastic bags, have been taken to 
minimize drying of the agar and unless they have been shown to perform correctly 
with the quality control organisms. A representative sample of each batch of plates 
should be examined for sterility by incubating at 30 to 35°C for 24 hours or longer. 
3.2.8: BAIRD-PARKER WITH EEC-YOLK- EMULSION (Baird-Parker, 1962)^ ^^  
This selective medium was used for the isolation of organisms from food sources. 
Composition: (per litre) 
Tryptone 10 gm, Meat extract 5 gm. Yeast extract 1 gm, Lithium chloride 5 gm. 
Sodium pyruvate 10 gm. Glycine 12 gm. Agar 20 gm, pH 6.8 
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Baird- Parker agar was prepared from a commercially available dehydrated 
base according to the manufacture's instructions, the dehydrated base were 
suspended in water and heated to dissolve. It was sterilized in an autoclave at 12rC 
for 20 min. after cooling to 50°C, sterile potassium tellurite egg yolk emulsion 
supplied with the base was added before pouring into plates. 
3.2.9: CRYSTAL VIOLET AGAR 
It's a modified Nutrient agar media used by Hajek et al (1971/'*'* for the 
differentiation of 5*. aureus among human, bovine, ovine, poultry source. 
Composition: (per litre) 
Nutrient agar 990 ml 
Crystal violet (0.1% w/v aqueous solution) 10 ml 
Dissolved the crystal violet aqueous solution in a pre-dissolved nutrient agar and 
sterilized the solution by autoclaving at 12 TC for 20 min. Allowed it to cool at 45°C 
before pouring into plates. 
3.2.10: TELLURITE- POLYMYXIN-EGG-YOLK- EMULSION (Gilbert et al, 
1969)"*^ ^ 
The medium is used for the isolation of organism from milk. 
Composition: (per litre) 
Basal medium (per litre) 
Tryptone llgm. Yeast extract 5.5gm, Mannitol 5.5 gm. Sodium chloride 2.2 gm, 
Lithium chloride 2.2 gm, and Agar 20 gm. 
Add to 90 ml of basal medium 
Plymyxin B Sulphate (1% solution) 0.04 ml 
Egg Yolk: Saline emulsion (3:7) 10 ml 
Potassium Tellurite (1% solution) 1 ml 
Tellurite Polymyxin Egg Yolk emulsion agar was prepared from 
commercially available dehydrated base according to the manufacture's 
instructions, the dehydrated base were suspended in water and heated to dissolve. 
The medium was sterilized by autoclaving at 12rC for 20 min. and allowed to cool 
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until it attained 45-55°C temp. To this basal medium sterile Polymyxin B Sulphate-
Potassium Tellurite-Egg Yolk emulsion supplied with the base was added before 
pouring into plates. 
33: Identification and Characterization of Staphylococcus aureus. 
All the isolated staphylococci were studied for their morphological, culture 
and biochemical characteristics. 
3.3.1: Cultures Characters: 
The culture characters included the appearance of colonies to naked eyes, their size, 
outline, translucency, colour, pigmentation and hemolytic characters. 
3.3.1.1: Colony Morphology and Staining: 
Gram's staining was employed to determine whether a particular 
organism was Gram-positive or Gram-negative, its size, shape, arrangement of 
cells and grouping. ' 
(A). Staining Reagents: 
1. (a) Stock crystal violet solution: 
Crystal violet (85% dye) - 20 gm, Ethanol (95%) -100 ml 
(b) Stock oxalate solution: 
Ammonium oxalate - 1 gm, Distilled water -100 ml 
Working solution: 
Diluted the stock crystal violet solution .1: 10 with distilled water and mixed it 
with 4 volumes of stock oxalate solution and stored in a glass stopper bottle. 
2. Gram's Iodine solution: 
Iodine crystals - 1 gm. Potassium iodine - 2 gm 
Dissolved these two in 5 ml of distilled water. Then following solutions were 
added. 
Distilled water - 240 ml 
Sodium bicarbonate solution (5% aqueous) - 60 ml 
The contents v/ere mixed well and stored in amber glass bottles. 
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3. Decolourizer: 
Ethanol (95%) - 200 ml, Acetone - 200 ml 
Mixed well, and stored in glass stoppered bottles. 
4. Counter stain: 
Stock Safranine-D - 2.5 gm, Ethanol (95%) - 100 ml 
Working solution: 
Diluted the stock Safranine solution to 1:5 or 1:10 with distilled water and stored in 
glass stoppered bottles. 
(B). Staining Method 
A thin film of the material to be examined was prepared on a glass slide, 
dried and heat fixed. Flooded the slide with crystal violet stain and allowed to stand 
for 10 seconds. Poured off the stain by washing the slide with iodine solution. 
Rinsed off this mordant after 10 seconds with running water. The slide was then 
decolourized with alcohol-acetone solution for about 10-20 seconds. The slide was 
counterstained with safranine for 10 seconds and washed off with water. Blotted the 
slide between clean sheet or filter paper and examined microscopically, under oil 
immersion. 
3.3.2: Biochemical Characterization of Isolates: 
The biochemical reactions were studied by standard methods described 
elsewhere '^'^ '* '^^ ^^ 
3.3.2.1: Mannitol Fermentation Test: 
Mannitol fermentative capability of the test strains of staphylococci was 
examined according to the method described by Cappuccino et al (1986).''^' 
The inoculum under test was thinly spread over the mannitol salt agar plate 
and incubated for 18-24 hours at 37°C. Strains of Staphylococcus aureus fermented 
mannitol and exhibited yellow zones surrounding their growth in contrary to 
Staphylococcus epidermidis that do not ferment mannitol and hence did not 
produce change in colouration. 
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3.3.2.2: Catalase Test: 
The method employed for the catalase activity was as described by 
Cappuccino et al (1986). ' A loopful of bacteria from about 24 hrs old agar culture 
was mixed with a drop of 3 per cent hydrogen peroxide solution on a microscopic 
slide, production of gas bubbles within few seconds indicated the production of 
catalase by the culture. 
3.3.2.3: Coagulase Test: 
Coagulase plays an important role in the pathogenesis of staphylococcal 
infections. This test was performed for differentiating coagulase positive from 
coagulase negative strains, as the demonstration of coagulase production is the best 
single test to identity pathogenic Staphylococcus species.'*'*^ 
(a). Tube test Method 
The test method was followed as described by Gillespi(1943)'''^^. The rabbit 
or human plasma was collected asceptically in 0.15% EDTA (Ethyldiamine tetra 
acetic acid) solution as an anticoagulant and centrifuged. The collected plasma was 
diluted to 1:5 with normal saline solution (0.85% NaCl). Took 0.5 ml of the diluted 
plasma in each of the three test tubes and inoculated 0.1 ml of 18-24 h. broth culture 
(strain under test) into the plasma of first test tube. A control test was setup with 
ATCC 25923 in the second tube, whereas, the third tube was left unseeded as 
negative control to confirm that it did not coagulate spontaneously. All the three 
tubes were incubated, at 37 °C, and examined for coagulation at 1, 3 and 6 h and 
repeated or continued if still negative after standing overnight at room temperature. 
Examination at each of the prescribed times was .necessary as the coagulum may 
liquefy after it has been formed. The test was react positive in which plasma was 
converted into a stiff gel and negative when it remained liquid or free flowing. 
(b). Slide Test Method 
A test was conducted by the method described by Williams et al (1946)'*'* . 
Placed a drop of saline (0.85% NaCI) solution on a clean microscopic slide with 
minimum of spreading, emulsified the material obtained from one or two colonies of 
culture under test in it. Dipped the tip of inoculating wire into the undiluted plasma 
warmed to room temperature and added its traces to the bacterial suspension on -
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slide. Flamed the inoculating wire and repeated the procedure for the control 
bacterial suspension. Coagulase was demonstrated when clumping of staphylococci 
occurred within 20 seconds of adding a trace of undiluted plasma to a saline 
suspension of organism on glass slide after verifying that there is no spontaneous 
agglutination. 
3.3.2.4: Haemolysin production Test: 
At least three types of haemolysins are produced by S.aureus (a, P, 5). The 
culture under test was inoculated on 5% sheep blood agar plates with the help of 
sterile inoculating loop and incubated for 18-24 h at 37°C. Haemolysin producing 
organisms lysed red blood cells and thereby, exhibited clear zones around their 
colonies. 
3.3.2.5: Phosphatase Production Test: 
Plates of nutrient agar containing 0.01% Seitz filtered phenolphthalein 
diphosphate according to the Barber et al.(1951) method, were inoculated with 
24hr cultures of the isolates under test. The plates were incubated at 30°C for 3 
days, after which the Phosphatase production was detected by exposing the cultures 
to ammonia fumes for a minute or so. Colonies of S. aureus strains became bright 
pink due to liberation of phenolphthalein. 
3.3.2.6: Deoxyribonuclease Plate Test: 
Test was conducted according to the method of Jefferies (1961) .This test 
determines the ability of coagulase +ve strains of 5*. aureus to produce nuclease that 
hydrolyses DNA. The material from the test culture was inoculated by spotting it 
onto a small area in the middle of one of the marked sections of the DNA-agar 
plate. Similarly various cultures to be tested were spot inoculated on the other 
sections, including DNase positive control strain ATCC 25923. Plates were 
incubated aerobically for 18-24 hr at 37°C. After incubation, flooded the plate with 
3.6% hydrochloric acid to precipitate unhydrolysed DNA and let the plate to stand 
for a few minutes until a white cloudiness was seen in the agar. Examined the plates 
under strong indirect light against a dark background. Those spot cultures were read 
as DNase positive which were surrounded by a clear unclouded zone (3mm from 
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the edge of colony) comparable with those around control culture and cultures with 
markedly smaller zones and cloudiness were read as DNase negative strains. 
3.3.2.7: P-lactamase Test: 
P-lactamases are the main cause of bacterial resistance to penicillins and 
cephalosporins drugs. P-lactamase detection test is carried out by rapid acidometric 
filter paper test by the method of Sng et al (1981/^^ 
Acidometric test; Hydrolysis of the P-lactamase ring generated a carboxyl group, 
acidifying unbuffered systems. The resulting acidity can be tested in tubes or on 
filter papers. For the acidometric paper method, filter paper (Whatman No.l) was 
cut into 5x 1 cm strips and soaked in a freshly prepared solution containing 1.25% 
benzyl penicillin, 0.1 % (w/v) bromocresol purple and 1.25 mM NaOH. The strips 
are dried and can be stored at 4 °C for 6 months in a silica gel desiccant. Before use 
the strips must be moistened with non-acidic distilled water. Bacteria from agar 
cultures are smeared on the strip and development of a yellow colour within 5 min 
indicates P-lactmase activity. Control ATCC 25923 was run in parallel. 
3.3.2.8: Novobiocin Sensitivity Test: (Baird-ParkerJ979)^^' 
The resistance to novobiocin distinguishes S. saprophyticus from other 
clinically important Staphylococcus species. In routine identification of 
staphylococci from urine, it is generally sufficient to test by including a 5|^ g 
novobiocin disc in the disc diffusion test for antibiotic sensitivities. S. epidermidis 
showed a large zone of inhibition of growth, e.g. over 15 mm in diameter around 7 
mm disc, while S. saprophyticus showed a much smaller zone or grows right up to 
the disc. 
3.4 ANTIBIOTIC SUSCEPTIBILITY TESTING: 
A variety of laboratory methods can be used to measure the in vitro 
susceptibility of bacteria to anfimicrobial agents. However the method employed in 
the present study is the standardized method recommended by the NCCLS 
Subcommittee on Antimicrobial Susceptibility Testing'*'* -'^'^^-^^ which is based on 
the method originally described by Bauer et al.''^ '^  This is the most thoroughly 
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described disk method for which interpretive standards have been developed and 
supported by laboratory and clinical data. 
3.4.1: Method for Disc Diffusion Test: 
3.4.1.1: Storage of Antimicrobial Disks 
Cartridges containing commercially prepared paper disks specifically for 
susceptibility testing are generally packaged to ensure appropriate anhydrous 
conditions. Discs were stored at 8°C or below or froze at -14°C or below, until 
needed. The unopened disk containers were removed from the refrigerator 1 to 2 hr 
before use to equilibrate these to room temperature. Once a cartridge of discs has 
been removed from its sealed package, it was placed in tightly sealed, desiccated 
box. 
3.4.1.2: Turbidity Standard for Inoculum Preparation 
To standardize the inoculum density for a susceptibility test, the BaS04 
turbidity standard equivalent to a 0.5 McFarland standard was used by Andrews 
(2004)'''^ ^ BaS04 0.5 McFarland standard was prepared as follows; 
A 0.5 ml aliquot of 0.048 M BaCIa (1.175% w/v BaCl2.2H20) was added to 
99 ml of 0.18 M H2SO4 (1 % v/v) with constant stirring. The correct density of the 
0.5 McFarland standard was verified by determination of absorbance at 625 nm with 
a 1 cm path length and was found to be 0.08 to 0.10. The turbidity suspension was 
transferred in 4 to 6 ml aliquots into screw-cap tubes of the same size or those used 
in growing or diluting the bacterial inoculum. The tubes were tightly sealed and 
stored in the dark at room temperature. The turbidity standard was vigorously 
agitated on a mechanical vortex mixer before each use and inspected for a uniformly 
turbid appearance. 
3.4.1.3: Inoculum preparation 
Three to five isolated colonies of same morphological types were selected 
from an agar plate culture. The top of each colony was touched with a loop and the 
growth was transferred into a tube containing 5 ml of a suitable medium such as 
tryptic soy broth. The broth culture was incubated at 35°C until it achieved or 
exceeded the turbidity of the 0.5 McFarland standard (usually 2 to 6 hours). This 
results in a suspension containing approximately 1 to 2x10 CFU/ml. The turbidity 
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of the actively growing broth culture was adjusted with sterile saline or broth to 
obtain turbidity optically comparable to that of the 0.5 McFarland standard. This 
results in a suspension containing approximately 1.5x10^ CFU/ml. 
3.4.1.4: Inoculation of Test Plates 
Optimally, within 15 min after adjusting the turbidity of the inoculum 
suspension, a sterile cotton swab was dipped into the adjusted suspension. The swab 
was rotated several times and pressed firmly on the inside wall of the tube above the 
fluid level to remove excess inoculum from the swab. The dried surface of a 
Mueller-Hinton agar plate was inoculated by streaking the swab over the entire 
sterile agar surface. This procedure was repeated by streaking two more times, 
rotating the plate approximately 60° each time to ensure an even distribution of 
inoculum. As, a final step the rim of the jar was swabbed. The lid was kept ajar for 3 
to 5 minutes to allow for any excess surface moisture to be absorbed before applying 
the drug impregnated discs. 
3.4.1.5: Application of Discs to Inoculated Agar Plates 
Within 15 min after the inoculation of plates, the antibiotic disks were 
applied so that diffusion and growth could proceed simultaneously. The discs were 
applied with the help of sterile forceps. Nine discs were applied on each agar plate 
arranged at least 15 mm from the edge of the plate and apart from each other by a 
distance of 15 to 20 mm. The plates were inverted and placed in an incubator set at 
35°C within 15 minutes after the discs were applied. The incubation period was 
maintained for 18 to 24 hrs. 
3.4.1.6: Reading Plates and Interpreting Results 
After 18 to 24 hrs of incubation, each plate was examined. The zones of 
inhibition were uniformly circular due to a confluent lawn of grovs^ th. The diameters 
of the zones of complete inhibition were measured, including the diameter of the 
disc. The zones were measured to the nearest whole millimeter, using a ruler, which 
was held on the back of the inverted petri plate. The petri plates were held a few 
inches above a black, non reflecting background and illuminated with reflecting 
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light. Discrete colonies growing within a clear zone of inhibition were subcultured, 
re-identified, and retested. The sizes of the zones of inhibition were interpreted by 
referring to standard tables in NCCLS documents'*'*'^ ''''*'''''^  and the Staphylococci 
were reported as susceptible, intermediate or resistant to the agents that have been 
tested. 
3.4.1.7: Detection of Methicillin-Resistant Staphylococcus aureus (MRSA) 
For the detection of MRSA strains, oxacillin disc of |j.g along with 
methicillin were placed for the test. The inoculum was directly suspended instead of 
inoculum groAvth method and the tests strains were incubated for full 24 hr at 35°C. 
Table -I: Tests for MRSA identification 454,455 
Method Disc diffusion 
Medium Mueller Hinton 
Agar (MHA) 
Antibiotic 1 |ig oxacillin 
or 
5 |j,g methicillin 
o 
Inoculum 1x10 CFU/ml by 
swab inoculation 
on agar surface 
Temp & Time 35°C,24hrs 
Defining oxacillin zone 
MRSA < 10mm 
Methicillin zone 
<9mm 
Oxacillin asar screen Broth microdilution 
4% NaCl supplemented M H Broth with 2% 
MHA 
6 |ug/ml oxacillin 
in test medium 
1x10^ CFU/ml 
by direct spot 
35°C,24hrs 
distinct spot 
of growth on 
agar surface 
NaCl 
2-fold dilutions 
of oxacillin or 
methicillin 
5x10'CFU/ml 
by direct 
suspension 
35°C,24hrs 
oxacillin 
MIC>16^g/ml 
Methicillin 
MIC > 4|ig/ml 
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3.4.1.7.1: Agar screening method for MRSA: 
After confirming the strains as S.aureus, the strains were screened for 
Oxacillin resistance by agar screening method for the conformation of MRSA. 
(A) Medium: 
One litre of Mueller-Hinton Agar was prepared according to the 
manufacturer's instructions. To this 40gms of NaCl was added to obtain 4% 
concentration of NaCl. The media was sterilized by autoclaving and Oxacillin 
powder was added to provide a final concentration of 6[ig/ml. 
(B)Preparation of plates: 
The media was poured into sterile plates to a depth of 4 mm on a flat 
horizontal surface. Before inoculation, plates were dried in an incubator at 37°C 
with lids ajar so that no water droplets remained on the agar surface. The plates were 
refrigerated at 4°C. 
(C) Inoculation: 
The test strains were inoculated into 1 ml quantities of sterile normal saline 
(0.85% NaCl), conforming to turbidity standard of 0.5 McFarland unit. The strains 
were inoculated as spots onto the plates, which were incubated at 37°C for 24 hr. 
The strains which were able to grow on this medium were designated MRSA 
(Methicillin-Resistant Staphylococcus aureus) and those strains which were not able 
to grow were designated MSSA (Methicillin-Sensitive Staphylococcus aureus). 
Control Strains: The control strains Staphylococcus aureus ATCC 25923 
were used for the precision and accuracy of the disk test procedure and in 
interpretation of the resistant markers. The control strains were procured from Hi-
Media. Mumbai, India. 
3.5. DETERMINATION OF MINIMUM INHIBITORY CONCENTRATIONS 
Minimum inhibitory concentrations (MICs) are defined as the lowest 
concentration of an anti-microbial that will inhibit the visible growth of a 
microorganism after overnight incubation and minimum bactericidal concentrations 
(MBCs) as the lowest concentration of anti-microbial that will prevent the growth 
of an organism after subculture on to antibiotic free media. The range of antibiotic 
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concentrations used for determining MICs was a serial twofold dilutions indexed to 
the base 1 (e.g., 1,2,4,8,16 mg/ml, etc). Other dilution schemes have also been used, 
including use of as few as two widely separated or "breakpoint" concentrations 
between the usual values (e.g., 4, 6, 8, 12, 16 mg/ml/ The method described below 
was used in the present study to check the in vitro activity of few antimicrobials 
against methicillin-resistant Staphylococcus aureus isolates. 
Stock of antimicrobial agents and preparation of plates: 
Either of the following formulae was used to determine the amount of 
powder or diluent needed for a standard solution: 
Weight (mg) = Volume (ml) x Concentration f/ug I ml) 
Assay Potency (jug I mg) 
or 
Volume (ml) = Weight (ms.) x Assay Potency {/us I mg) 
Concentration (jug I ml) 
or 
Volume (ml) == Weight of powder (mg) x Activity (%) x 100 
Desired Concentration (fig I ml) 
Example: to prepare a stock solution containing 1,280 mg/ml of antimicrobial agent 
with antimicrobial powder that has a potency of 750 mg/mg, 182.6 mg of 
antimicrobial powder was dissolved in 107.0 ml of diluent. 
Volume (ml) = 182.6 mgx750 pg/mg 
(Actual wieghpfPotency) = 107.0 ml 
1280mg I ml (Desired concentration) 
Small volumes of the sterile stock solutions were dispensed into sterile 
polypropylene vials carefully sealed, and stored at - 70°C. Vials were thawed as 
needed and used the same day. Test dilutions were generally prepared from the 
antibiotic stock solutions as a series of doubling dilution's (Table3.2). For the sake 
of standardization and comparison of results the antimicrobial was diluted in order 
to provide doubling dilutions above and below a baseline concentration of 1 i^ g/ml, 
i.e., 0.25,0.5,1,2,4,8,16, 32, 64,128, 256; 
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Table -II: Scheme for Preparing Dilutions of Antimicrobial Agents to be used in Agar Dilution 
Susceptibility Tests. 
Antimicrobial solution 
Step 
1 
2 
-> 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
(l^g/mL) 
5120 
5120 
51120 
1280 
1280 
1280 
160 
160 
160 
20 
20 
20 
2.5 
Source 
Stock 
Step] 
Step 1 
Step 3 
Step 3 
Step 3 
Step 6 
Step 6 
Step 6 
Step 9 
Step 9 
Step 9 
Step 12 
Volume 
(ml) 
Distilled 
water 
(ml) 
1 
3 
1 
3 
7 
1 
3 
7 
1 
3 
7 
1 
Intermediate 
concentration 
(/Lig/ml) 
5120 
2560 • 
1280 
640 
320 
160 
80 
40 
20 
10 
5 
2.5 
1.25 
Final 
concentration 
at 1:10 dilution 
in agar or 
bfoth (lig/ml) a 
512 
256 
128 
64 
32 
16 
8 
4 
2 
1 
0.5 
.25 
0.125 
a; The final concentration is based on the addition of 2 ml of antibiotic solution plus water to 18 ml 
of melted agar or on the addition of 0.5 ml of antibiotic solution plus water to 4.5 ml of Muller-
Hinton broth. 
A standardized inoculum for the agar dilution and broth dilution methods 
was prepared by either growing microorganisms to the turbidity of the 0.5 
McFarland standard or suspending colonies directly to achieve the same density. 
Cultures adjusted to the 0.5 McFarland standard contain approximately 1 to 2x10^ 
CFU/ml with most species, and the final inoculum required is lO"* CFU per spot of 5 
to 8 mm in diameter which was obtained by diluting 0.5 McFarland suspension to 
1:10 in sterile broth or saline so as to get a concentration of 10 CFU/ml, and 
subsequently inoculated 1 to 2|j,l of the diluted suspension on the agar surface. In 
case of broth dilution method (microdilution) the adjusted inoculum suspension was 
diluted so that, after inoculation, each tube or well contained approximately 
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5xlO^CFU/ml. This was achieved by preparing antibiotic ranges one step higher 
than the final dilution range required, i.e.; if a. final dilution range of 0.5, 1, 2, 4 and 
16 fig/ml is required then a range of 1,2,4, and 16 and 32 mg/ml was prepared to 
compensate for the addition of an equal volume of inoculum. 
3.5.1: Agar Dilution Procedure: 
The agar dilution method for determining antimicrobial susceptibility is a 
wellestablished technique. The antimicrobial agent is incorporated into the agar 
medium with each plate containing a different concentration of the agent. The 
inocula can be applied rapidly and simultaneously to the agar surfaces using an 
inoculum-replicating apparatus. Most replicators currently available transfer 32 to 
36 inocula to each plate. 
Dilutions prepared as indicated in Table 3.2 were incorporated in melted agar 
allowed to cool to 45 °C to 50 °C. The antibiotic was added to this agar in a ratio of 
1/10, i.e., 2 ml of antibiotic solution plus 1-8 ml of melted agar when using 9 cm 
round petri plates. The plates were then set on a horizontal flat surface and allowed 
to harden undisturbed for at least 10 minutes. Before usage the plates were dried for 
10 minutes in an incubator. Two control plates, prepared under the same conditions 
but without the antibiotics, were prepared and included in every MIC determination. 
(A) Procedure for inoculation of agar plates: 
The tubes containing the adjusted and diluted bacterial suspensions (10^ 
CFU/ml) were arranged in order in a rack. The agar plates were marked for 
orientation of the inoculum spots. A 1- to 2-jal aliquot of each inoculum was applied 
to the agar surface with standardized loops or pipettes. A growth control plate (no 
antimicrobial agent) was inoculated first and then, starting with the lowest 
concentration, the plates containing the different antimicrobial concentrations were 
inoculated. A second growth control plate was inoculated last to ensure that there 
was no contamination or significant antimicrobial carry over during the inoculation. 
A sample of each inoculum was streaked on a suitable agar plate and incubated 
overnight to detect cultures and to provide freshly isolated colonies in case retesting 
proved necessary. The inoculated plates were allowed to stand at room temperature 
until the moisture in the inoculum spots was absorbed into the agar, i.e., unfil the 
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spots were dry, but not more than 30 min. The plates were inverted and incubated at 
<35°Cforl6to24hrs. 
(B) Interpretation of agar dilution end points: 
The plates were placed on a dark, non-reflecting surface to determine the 
end points. The MIC was recorded as the lowest concentration of antimicrobial 
agent that completely inhibited growth, disregarding a single colony or a faint haze 
caused by the inoculum. If two or more colonies persisted in concentrations of the 
agent beyond an obvious end point, or if there was no growth at lower 
concentrations but growth at higher concentrations, the culture purity was checked 
and test repeated. 
3.5.2: Micro-dilution procedure: 
Micro-dilution involves the use of small volumes of broth dispensed in 
sterile, plastic microdilution trays that have round or conical bottom wells. Each 
well contains 0.1 ml of broth. A growth control well (without antibiotic) and a 
negative (uninoculated) well were used for each test. The final two-fold dilutions of 
antibiotics were prepared by taking 50|il of diluted antibiotic solution Table 3.2 and 
50^1 of adjusted inoculum. The adjusted inoculum was prepared by diluting the 0.5 
McFarland suspension (1 xlO^ CFU/ml) to 1:10 to yield 10^  CFU/ml, and adjusted 
to 10^  CFU/ml by mixing 50|xl of diluted suspension and 45 fxl of Mueller-Hinton 
broth. .Within 15 minutes after the inoculum has been standardized as described 
above, 50 \i\ of adjusted inoculum was added to each well already containing 50 ^1 
of antimicrobial agent in the dilution series (and a positive control well containing 
only broth). This resulted in a 1:2 dilution of each antimicrobial concentration and a 
1:2 dilution of the inoculum (5x10^ CFU/ml). To prevent drying, each tray was 
sealed in a plastic bag, with plastic tape, or with a tight-fitting plastic cover before it 
was incubated. The inoculated microdilution trays were incubated at 35°C for 16 to 
24 hrs in an ambient air incubator. The MIC was determined as the lowest 
concentration of antimicrobial agent that completely inhibited growth of the 
organism in the microdilution wells containing antibiotic as compared to the 
amount of growth in the growth-control wells (no antibiotic) detected by the 
unaided eyes. 
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3.6: BIOTYPING 
3.6.1: Crystal Violet Typing Test: 
The test was used to distinguish the Staphylococcus aureus isolates among 
different sources; like human, bovine, and abboiter origin. The test is conducted and 
interpreted as described by Meyer (1967)^^' and Devriese et al (1984).-^ '^ ^ 
The medium used was nutrient agar containing 1: 100,000 crystal violet. A heavy 
inoculum of the test culture was picked up from the overnight agar culture and 
streaked on the crystal violet agar. The plates were incubated overnight at 37*'C and 
read the next day. 
The cultures were classified as per the criteria of Devriese et al (1984)^^^. 
Type A Clear yellow 
Type B Yellow with violet edge 
Type C Violet with orange coloured shading 
Type E White with a bluish violet shading 
3.6.2: Biotvping of MRSA strains: 
A biotyping scheme for MRSA proposed by Coia et al (1990)^^^, based on 4 
properties namely Tween 80 hydrolysis, pigment production on Tween 80 agar, 
Urease production and Gentamicin resistance. The isolates of MRSA have been 
divided into 4 groups (A-D), based on these properties. 
(a) Urease production: 
Nutrient broth was prepared with 2% urea and 0.0012 % phenol red as 
indicator. This media was distributed in 1 ml quantity in test tubes. The test strains 
were inoculated in this broth. The tubes were incubated at 37°C for 48 hours. 
Tubes showing pink/red colour were taken as Urease positive and those with 
yellow colour were taken as negative. These negative tubes were incubated further, 
no tube being reported negative until after 4 days of incubation. 
(b) Tween 80 hydrolysis: 
Nutrient agar with 1% (v/v) Tween 80 was prepared and distributed in sterile 
plates. The test strains were spot inoculated over a 1 cm area on the plate. The plates 
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were incubated at 37°C for up to 5 days. Strains that developed a clear halo of 
precipitated fatty acids around them were taken as positive and strains with no halo 
were taken as negative. 
ic) Pigment production: 
Spot inoculates of the test strain over 1 cm area were put on Tween 80 agar 
and the plates were incubated at 37°C for 24 hours. The plates were examined the 
next day and the pigment produced by the organism was noted as either cream or 
golden or buff. 
Table -III: The isolates were classified into 4 biotypes in the following way: 
Test biotvpe A B C D 
Tween 80 hydrolysis 
Urease 
Pigment 
Gentamicin resistance 
— 
— 
cream 
S 
— 
+ 
buff 
R 
+ 
— 
variable 
S 
+ 
+ 
gold 
S 
3.7: BACTERIOPHAGE TYPING: 
Phage typing was performed at National Phage Typing Centre, Maulana 
Azad Medical College, New Delhi, India. Typing was done by the standard method 
as described by Blair et al (1961)''" for propagating the phages, testing of phage 
filtrate and typing of strains of Staphylococcus aureus. All the strains of MSSA and 
MRSA were tested with the basic set of 23 phages along with additional set of 
MRSA phages obtained from Central Public Health Laboratory, Colindale, U.K. 
(a) Performance of phage typing: 
Selected MSSA and MRSA strains were tested with the basic set of phages 
for typing human and environmental staphylococci by human phage set at RTD and 
untypable strains were again tested at 100 RTD. The phage preparations were 
diluted to prepare RTD and 100 RTD sets which were stored at 4°C. 
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Phages of the RTD set were tested to ascertain that the titre has not lowered. 
When all the phages in the set showed near confluent lysis, it was used for typing. 
A single colony was inoculated in 5ml nutrient broth and incubated at 37°C for 4 to 
6 hr to produce a distinct turbidity. This culture was used to inoculate freshly 
prepared and dried nutrient agar plates supplemented with 2% CaCb. The nutrient 
agar plates were prepared one day prior to test and incubated overnight to check the 
sterility. The plates were flooded with broth culture to the test strains and the excess 
broth was pipetted off. These were then left for drying with lids open for one hour at 
room temperature. The phages were loaded in a block consisting of 27 wells using 
sterile Pasteur pipettes. A template to guide the position of each phage was made 
and used for placing the phages in their positions, and in reading of the lytic 
reaction. Phages were delivered from the loading chamber to the agar plate with help 
of mechanical multi-loop applicator. After each application the prongs of the 
applicator were sterilized. After the drops of phages had dried, the plates were 
incubated at 30°C for 18 hours and the readings were taken the following day. 
(b) Reading and Recording: 
The plates were first examined with naked eyes, and then reading was taken 
with the aid of 5X hand-lens. Plates were examined under indirectly transmitted 
light against dark background. 
Recording was done as follows: 
At RTD 50 or more plaques = ++ 
20 to 49 plaques = + 
1 to 19 plaques = ± 
When the number of plaque was 10 or less, it was recorded as a superscript (e.g. ±)^ 
At 100 RTD In addition to the above, the following abbreviations were also used: 
Confluent lysis = CL 
Confluent lysis with = CR/CL 
secondary growth 
Inhibition of growth, = 0 
no visible growth 
Inhibition of growth, = + ± 
with discrete plaques 
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(c) Reporting: 
The number of phages that produced ++ reaction was the typing pattern. The 
presence of additional weak reaction exceeding 10 plaques was recorded by the 
addition of a sign +. Inhibition reactions or discrete plaques occurring in areas of 
inhibition were not mentioned. But for the correct interpretation, all reactions 
including the minor reactions were reported. 
(d) Interpretation: 
Small differences in the strains thought to be epidemiologically related are 
quite common. Two strains of S.aureus were regarded as different if they differed in 
at least two strong reactions from each other, (Williams et al.l952) . 
(A)International conventional set of Phages: 
Lytic group of phages Designation of phages 
I 29, 52, 52A, 79, 80 
II 3A, 3C, 55, 71 
III 6, 42E, 47, 53, 54, 75, 77, 83A, 84, 85 
UNCLASSIFIED 81, 94, 95, 96 
(B) MRSA Phages: 
MRSA strains were phage typed using 9 supplementary phages for MRSA in same 
way. 
The 9 phages were grouped into 4 complexes: 
M3/M5 
M12/M8/MR25 
622 
C30/C33/C38 
Typing was done at RTD and 100 RTD. The plates were incubated at 30°C for 18 hr 
and readings were taken the following day. 
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3.8: Isolation of Genomic DNA for PCR: 
The protocol employed for the isolation of chromosomal DNA is a modified version 
ofSamrooketal(1989/^'^. 
Method: 
Inoculated the bacterial culture in 5 ml of medium and incubated overnight 
with shaking at 3TC temperature. 
Centrifuged at 5000 rpm for 15 min and resuspended the pellet in 400 |il of 
TE buffer. (Alternatively resuspended 1-3 loopfull of cells from a overnight 
culture plate in 400|al of TE buffer). 
Added 20 |il of freshly prepared lysostaphin solution [lysozyme (lOmg/ml) + 
lysotaphyin (lOOmg/ml) + Tris (lOmM, pH 8.0) ] 
Vortexed briefly and incubated at 37 °C for 30 min. 
Added 5 fil of proteinase K (lOmg/ml) and 40 i^l of 10% SDS. 
Vortexed briefly and incubated at 50-55° for 30 min (if cells are not lysed, 
add 420 ^l of 40% SDS and re-incubate at 37°C for 30 min.) 
Extracted DNA once by adding equal volume of equilibrated phenol: 
chloroform: isoamylalchohol (25:24:1). Mixed the contents thoroughly and 
spinned for 15 min at 10,000rpm. Remove the aqueous layer carefully and 
extract once with chloroform: isoamylalcohol (24:1).centrifuge for 15 min at 
10,000 rpm. 
Removed the aqueous layer as mentioned above. 
Repeated the above procedure until there was no white precipitate visible at 
the interphase. 
Added 0.1 volume of 3 M Sodium acetate (pH 5.2) and 0.7 volume of 
isopropanol, mixed the contents gently and spool out DNA with a sterile tip 
(centrifuged to pellet the DNA).If DNA was not visible, centrifuged at 
10,000 rpm for 20 min. 
Washed the pellets with 200 ^1 of 70% ethanol. 
Air dried the pellets and resuspend in 50 |LI1 of TE buffer. 
Added 5 \x\ of RNase (lOmg/ml) and incubated at 37°C for 20 min. 
Stored the DNA at 4T . 
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Agarose Gel Separation: 
The buffers used were as follows: 
Loading buffer: For 10 ml solution took, 
5 ml Glycerol 
0.5 ml of 1 % Bromophenol blue 
0.5 ml of 1 % Xylene cyanol 
4 ml water 
Running Buffer (5X) (Tris/Acetate/EDTA (TAB) Buffer): For 1 liter solution, 
242 g/liter Tris base 
28.55 ml Glacial acetic acid 
37.2 g/liter EDTA 
3.9: PCR ANALYSIS of 16S rDNA gene: 
The method used for the investigation or classification of the organism by 
the protocol mentioned by Harris et al (2004)''^''. Chromosomal DNA isolated from 
MRS A strains was used as a template to amplify the 16 rDNA gene. PCR was 
carried out with Taq DNA polymerase in 25 \i\ reaction volume. Each 25 \i\ reaction 
mixture consisted of approximately 100 ng of chromosomal DNA, 1 |iM of each 
primer (forward and reverse of 16rDNA gene), 200 |j,M of each dNTP's, IX PCR 
buffer consisting of lOmM Tris-HCl (pH 9.0), 50mM KCl, 0.01% gelatin, 0.1% 
Triton X-100 with 1.5 mM MgCb and lU of Taq polymerase. PCR was carried out 
using Taq DNA polymerase in 25|il reaction volume in a GeneAmp PCR system 
9700 Thermal Cycler (Applied Biosystems, USA). 
PCR-cycle program: Initial denaturation at 93.5 C for 10 min; cycle denaturation at 
93 C for 1 min, annealing at 50°C for 30 sec, and extension at 72°C for I min for 30 
cycles and final extension at 72 C for 10 min, was used. The PCR product was 
checked on 1 % agarose gel in IX TAE buffer along with 1 kb DNA ladder marker, 
run at 60 mA and visualized with ethidium bromide on a transilluminator and the 
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results were recorded using Gel documentation (Bio-Rad) 
The primers used in this study were''^ "; 
27F (bacterium specific, 5'-AGAGTTTGATCCTGGCTCAG-3') 
1492R (universal, 5'-GGTTACCTTGTTACGACTT-3') 
3.10: DNA Sequencing: 
Amplified PCR product is extracted fi-om the gel for DNA sequencing by 
Genei^ '^  Gel Extraction Kit. The procedure followed was:-
DNA band of interest was excised from ethidium bromide stained agarose gel with a 
sharp blade under UV light and transfered to eppendorf tube. Excised pieces were 
weighed (approx, 0.4gm) and crushed to small pieces. To this 2.5 volumes of 
sodium iodide solution (sp.gr. of the gel was assumed to be 1) was added. This 
solution was incubated at 4 5 ^ - 55°C for 2 to 3 min to solubilize the gel. The 
contents were mixed thoroughly and further incubated for 5 min in water bath. Then 
added 15|.il of glass solution (provided in the kit) to the sample containing 5)xg or 
less of DNA. The contents were mixed thoroughly and left at room temperature for 
10 min with occasional mixing. This allowed adsorption of DNA molecules to the 
glass solution. The solution was spinned at 12000 rpm for 30 sec and the supernatant 
was discarded. DNA bound to the glass formed a hard pellet. Then 200^ x1 of wash 
buffer was added to the pellet and vortexed for mixing followed by spinning at 
12000 rpm for 30 sec. The supernatant was discarded. The washing process was 
repeated twice. After final wash tube were kept at 37°C for 10 min to remove the 
traces of wash buffer. To elute DNA, 40|al of IX TE buffer was added and pellet 
was resuspended by mild vortexing, followed by incubation at 45°C for 5 min. This 
facilitated the DNA to unbound from the glass and elute in IX TE buffer. This 
solution was spinned at 12000rpm for 30 sec and the supernatant containing DNA 
collected in a fresh eppendorf tube. The efficiency of eluted DNA was checked on 
1% agarose gel. 
The PCR product for direct sequencing was send to M/S Macrogen Inc. Seoul, 
S.Korea. Nucleofide sequences were compared to sequences in the GenBank, 
EMBL, DDJB, and PDB database by using the BLASTN, BLASTP, and BLASTX 
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local alignment search tools.'"'^ ^ 
Nucleotide Sequence Accession Number: The sequence determined in this study 
was submitted to the EMBL/GenBank database (MRSA0C9- EU327992). 
Phylogenetic trees: Phylogenetic trees (rooted) were generated from aligned 
sequences by using maximum-likelihood methods contained in Clustal W software 
(www.ebi.ac.uk/clustalW/.) 
3.11: Multiplex PCR for SCCmec Cassette Assay: 
The optimization of the multiplex PCR followed the general principles 
described by Henegariu (1997)"* '^. Each pair of primers was first tested for 
amplification specificity and robustness at annealing ternperatures of 55 and 60°C. 
3.11.1: Muhiplex PCR for identification of structural types in selected methicillin-
resistant Staphylococcus aureus isolates was performed as described by Oliveira et 
al (2002) 153 
Table -IV: Primers used in the PCR to type the Staphylococcal cassette chromosome 
mec element (SCCmec) in methicillin-resistant Staphylococcus aureus. 
Locus Primer Oligonucleotide (5'-3') SCCwgc type Size (bp) 
A CIF2 F2 TTCGAGTTGCTGATGAAGAAGG I 495 
CIF2 R2 ATTTACCACAAGGACTACCAGC 
B KDP Fl AATCATCTGCCATTGGTGATGC 284 
KDP Rl CGAATGAATGAAAGAAAGTGG 
C MECl P2 ATCAAGACTTGCATTCAGGC II III 209 
MECIP3 GCGGTTTCAATTCACTTGTC 
R1F4 F3 GTGATTGTTCGAGATATGTGG III 243 
RIF4 R9 CGCTTTATCTGTATCTATCGC 
RIF5 FIO TTCTTAAGTACACGCTGAATCG III 414 
RIF5R13 GTCACAGTAATTCCATCAATGC 
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H IS431 P4 CAGGTCTCTTCAGATCTACG III-A 303 
pT181 Rl GAAGAATGGGGAAAGCTTCAC 
meek MECAP4 TCCAGATTACAACTTCACCAGG Internal Control 162 
MEGA P7 CCACTTCATATCTTGTAACG 
Primers were synthesized and purchased from Sigma (Sigma, USA), and 
primer sequences were checked for specificity against available S. aureus genomes 
and SCCwec with the BLAST utility available through the National Centre for 
Biotechnology Information website (www.ncbi.nlm.nih.gov). The multiplex PCR 
was performed in a 25 |il volume. Each 25 )j,l reaction mixture consisted of 
approximately 100 ng of chromosomal DNA, IX PCR buffer consisting of lOmM 
Tris-HCl (pH 9.0), 50mM KCl, 0.01% gelatin, 0.1% Triton X-100 with 2.5 mM 
MgCla, 200 )iM of each dNTP's and 1 U of Taq polymerase. 400 nM concentrations 
of primers CIF2 F2, CIF2 R2, MECIP2, MECI P3, RIF5 FIO, RIF5 R13, pT181 Rl; 
800nM concentrations of primers IS431 P4, MECA P4, MECA P7; and 200nM 
concentrations of primers RIF4 F3, RIF4 R9, KDP Fl, KDP Rl. PCR amplification 
were performed in a GeneAmp PCR system 9700 Thermal Cycler (Applied 
Biosystems, USA) with the following parameters; predenaturation for 4 min at 94°C, 
o o 
cycle denaturation at 94 C for 30 sec, annealing at 53 C for 30 sec, and extension at 
72 C for 1 min for 30 cycles and final extension at 72°C for 4 min. The PCR product 
was checked on 1 % agarose gel in 0.5X THE buffer along with 1 kb DNA ladder 
marker after electrophoresis at 60 mA and visualized with ethidium bromide on a 
transilluminator and result recorded using Gel documentation (Bio-Rad). Running 
buffer : 5X TBE ( 54gm Tris Base, 27.5gm Boric acid, 20ml of 0.5M EDTA, pH 
8.0) made up to 1 litre. 
3.11.2: Another Multiplex PCR assay using different set of primers for 
characterization and subtyping of Staphylococcus Cassette Chromosome mec 
(SCCmec) types in methicillin-resistant Staphylococcus aureus (MRSA) isolates 
from clinical, hospital, community and other environmental sources was performed 
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as described by Zhang et al (2005)''^ ^. Four Multiplex PCR assays were carried out 
by different set of primers for characterization of MRSA. 
A). Two separate PCR assay for SCCmec typing: In first multiplex PCR, a set of 
four pairs of primers for SCCmec types I, II, III, and mecK gene included for typing 
MRSA isolates. For second Multiplex PCR, a set of five pairs of primers for 
SCCwec types IVa, IVb, IVc, IVd, and mecK gene were i i,9Cluded for 
characterization of CA-MRSA isolates. '' 
B). Multiplex PCR assay for mec gene complexes: A PCR assay contained 4 
primers, mecI-F, mecI-R, IS1271-F, and mec Rl-R for wee gene complex. 
C). Multiplex PCR assay for ccr gene complexes: A PCR assay contaiiie'dTprimers, 
ccrAB-p2, ccrAB- a2, ccrAB- a3, ccrAB- a4 for ccr gene complex. 
The Primer sequences and their respective concentrations used in the PCR 
assays are listed below in Table 3.4. The oligonucleotide primers used in this study 
were synthesi;2ed and purchased from Hysel India Pvt. Ltd. All PCR assays were 
performed in 25|.tl reaction volume. Each 25 ^1 reaction mixture consisted of 
approximately 100 ng of chromosomal DNA, IX PCR buffer consisting of lOmM 
Tris-HCl (pH 9.0), 50mM KCl, 0.01% gelatin, 0.1% Triton X-100 with 1.5 mM 
MgCl2, 200 ).iM of each dNTP's and 1.5 U of Taq polymerase. The amplification 
was performed in a GeneAmp PCR system 9700 Thermal Cycler (Applied 
Biosystems, USA) beginning with an initial denaturation step at 94°C for 5 min 
followed by first hold of 10 cycles of denaturation at 94°C for 45 sec, annealing at 
65''C for 45 sec, extension at 72°C for 1.5 min and another hold of 25 cycles of 
denaturation at 94°C for 45 sec, annealing at 55°C for 45 sec, extension at 72°C for 
1.5 min, and final extension at 72T for 10 min and followed by a hold at 4°C. All 
PCR assay runs incorporated a reagent control (without template DNA). The PCR 
products were visualized using a UV light after electrophoresis on a 1%) agarose gel 
(0.5X TBE buffer, 0.5|a,g/ml ethidium bromide) along with 1 kb DNA ladder marker. 
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Table -V: Primers used in the PCR to type the Staphylococcal cassette chromosome 
mec element (SCCwec) in methicillin-resistant Staphylococcus aureus^^^. 
Primer 
Type I - F 
- R 
Type 11 - F 
- R 
Type 111 - F 
~R 
Type IVa - F 
- R 
Type IVb - F 
- R 
Type IVc - F 
- R 
Type IVd - F 
- R 
MecA 147 - F 
- R 
Mecl - F 
- R 
1S1272 - F 
Mec Rl - R 
CcrAB- P2 - F 
CcrAB- a2 - R 
CcrAB- a3 - R 
CcrAB- a4 - R 
Oligonucleotide Seq (5'-3') 
GCTTTAAAGAGTGTCGTTACAGG 
GTTCTCTCATAGTATGACGTCC 
CGTTGAAGATGATGAAGCG 
CGAAATCAATGGTTATGGACC 
CCATATTGTGTACGATGCG 
CCTTAGTTGTGGTAACAGATCG 
GCCTTATTCGAAGAAACCG 
CTACTCTTCTGAAAAGCGTCG 
TCTGGAATTACTTCAGCTGC 
AAACAATATTGCTCTCCCTC 
ACAATATTTGTATTATCGGAGAGC 
TTGGTATGAGGTATTGCTGG 
CTCAAAATACGGACCCCATACA 
TGCTCCAGTAATTGCTAAAG 
GTCAAGATATACCAAGTGATT 
ATGCGCTATAGATTGAAAGGAT 
CCCTTTTTATACAATCTCGTT 
ATATCATCTGCAGAATGGG 
TATTTTTGGGTTTCACTCGG 
CTCCACGTTAATTCCATTAATACC 
ATTGCCTTG ATA ATAG CCITCT 
AACCTATATCATCAATCAGTACGT 
TAAAGGCATCAATGCACAAACACT 
AGCTCAAAAGCAAGCAATAGAAT 
Cone 
(HM) 
0.048 
0.032 
0.04 
0.104 
0.092 
0.078 
0.28 
0.046 
0.08 
0.08 
0.08 
0.08 
0.08 
0.08 
Amplicon 
Size (bp) 
613 
398 
280 
776 
493 
200 
881 
147 
146 
1,305 
700 
1000 
1600 
Specificity 
s e c mec I 
s e c mec II 
s e c wee III 
s e c mec IVa 
s e e mec IVb 
s e c mec IVc 
s e c mec IVd 
meek 
Class A mec 
Class B mec 
Type 1 ccr 
Type 2 ccr 
Type 3 ccr 
Control Strains: NCTC10442 (type I); N315 (type II); 85/2082 (type III); CA05 
(type IVa); 8/6-3P (type IVb); MR108 (type IVc); JCSC4469 (type IVd). The 
standard strains were obtained from Dr.K. Hiramatshu and Dr.T. Ito, Juntendo 
University,Tokyo, Japan. 
3.12: Random Atnplifled Polymorphic DNA (RAPD) Analysis: 
This technique involves the random amplification of segments of target DNA 
using a small primer (of 10 bases) with an arbitrary sequence of nucleotides, that is, 
one that has no known homology with a target sequence. During PCR, this primer 
78 
'hiaterials <^ TAetfto^ 
leads to the amplification of one or more sequences of DNA, generating a set of 
fragments that work as genetic markers. This technique does not require the 
digestion of the amplified fragments (called amplicons), because various fragments 
of different sizes are generated during PCR. The number and size of these fragments 
are the basis for the typing of an isolate. Random amplification of some selected 
MSSA and MRSA isolates were conducted by the method and conditions described 
by Byun, et al. (1997)''^ ^. The 10-base oligonucleotide primer sequence used in the 
study is: OPA- 04, 5'-AATCGGGCTC-3'. 
The PCR reaction was carried out in 25)il reacfion volume. Each 25 jil 
reaction mixture consisted of approximately 100 ng of chromosomal DNA, IX PCR 
buffer consisting of lOmM Tris-HCl (pH 9.0), 50mM KCl, 0.01% gelatin, 0.1% 
Triton X-100 with 2.5 mM MgCh, 200 i^ M of each dNTP's, 1 U of Tag polymerase, 
and 10 pmole each oligonucleotide primer. The PCR amplificafion was performed in 
a GeneAmp PCR system 9700 Thermal Cycler (Applied Biosystems, USA) 
beginning with an initial denaturation step at 95°C for 5 min followed by 
denaturation at 95°C for 1 min, annealing at 36 C for 1 min, and extension at 72 C 
for 1 min for 40 cycles and final extension at 72 C for 10 min. The PCR product was 
analyzed using a UV light after electrophoresis on a 1.2%) agarose gel (0.5X TEE 
buffer, 0.5|ig/ml ethidium bromide) along with 100 bp DNA ladder marker. 
Cluster analysis was performed by unweighted pair-group arithmetic average 
analysis (UPGMA). Cluster analysis was used to produce dendrograms showing 
estimates of the distance values and to analyze the genetic relatedness among the 
processed strains. 
3.13. Protocol for Pulsed Field Gel Electrophoresis (PFGE) for Fingerprinting 
of MRSA: 
PFGE typing of clinical and carrier MRSA strains isolated during the study 
was performed as described by McDougal, et al. (2003) 
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3.13.1: Preparation of Agarose Plugs and treatment with Lysis buffer: 
The test strains were grown in 5 ml nutrient broth. Took 200|il of an 
overnight grown culture in a sterile eppendorf tube and centrifuge at 10,000 rpm for 
5 min and aspirated the supernatant. The pellet was resuspended in 200|j.l of TE 
buffer (lOmM Tris, pH 8.0; ImM EDTA, pH 8.0) and equilibrated at 2TC in water 
bath for 10 raiin. To this recombinant Lysostaphin stock solution (3|xl of Img/ml in 
20mM sodium acetate, pH 4.5) was added and mixed for 30 sec. Then 200|j,l of 2% 
(W/V) pulsed field grade low melt agarose dissolved in 1200fil TE buffer (lOmM 
Tris, pH 8.0; ImM EDTA, pH 8.0) was added to the cell suspension and mixed 
gently. The 200|a,l of the mixture was taken in a pipette and dispensed about 100|.il 
into wells of a small disposable mold. This was done quickly and carefully to avoid 
the shearing of DNA and creation of bubbles in the tube or subsequently in the plug 
mold. The plug molds were kept on ice for 30 min for the agarose to set. In a fresh 
eppendorf tube a 5|al of lOmg/ml Proteinase K solution added into 1 ml of EC lysis 
buffer (6mM Tris HC1,1 M NaCl,100mM EDTA, 0.5% Brij-58, 0.2% sodium 
deoxycholate, 0.5% sodium lauroylsarcosine). The plugs were taken out from the 
mold and dispensed into each tube. The tubes were kept for 4 hrs at 37°C in a 
stationary water bath. The EC lysis buffer was taken out and the plugs were washed 
in 1ml TE buffer 3 to 4 times for 10 to 15 min. The plugs were stored overnight at 
4°C in TE buffer. Using spatula, the plugs were removed from the storage tube and 
placed in a cutting dish. The uneven edges of the plugs were trimmed by sharp 
scalpel. The plugs were sliced to 2x10 mm size for 10-tooth comb. 
3.13.2: Restriction Digestion with Smal: 
For restriction endonuclease digestion, each sliced plugs were equilibrated in 
IX restriction buffer (120|il restriction buffer + 1080|j,l Autoclaved H2O) for 30 min. 
The IX restriction buffer (Fermantas, India) was removed and 50^1 assay mixture 
containing Smal restriction enzyme (Promega, Corporation, Madison, I Unit 
enzyme/sample) was added to each plug and incubated for 3 hr at 25°C. 
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Assay Mixture for Restriction Digestion (per plug) 
Distilled Water 43.35|al 
Ix Restriction buffer tango + BSA 05.50|xl 
Smal 01.25^1 
Total 50.00^1 
3.13.3: Pulsed Field Gel Electrophoresis: 
After DNA digestion, the agarose plugs were incubated with 1 ml of TE 
buffer at 37°C for 1 hr. The plugs were then inserted into 1.5% agarose gel in 0.5X 
TBE buffer. After insertion the wells were sealed with agarose. The restriction 
fragments were separated using a Contour-Clamped Homogeneous Electric Field 
system (CHEF-DRIII; Bio-Rad). 
Electrophoresis was performed using the following conditions: 
Initial switch time- 5 sec; Final switch time- 35 sec; Voltage- 200V or 6V/cms; 
Included angle - 120 ; Run time- 16 hrs. 
3.13.4: Staining and Visualizing gel: 
Stained the gels for 30-45 min in ethidium bromide (l[j,g/ml), visualized 
under UV transilluminator and photographed using Gel Documentation (Bio-Rad). 
The NCTC 8325 pattern on PFGE was used as a standard with assigned 
molecular weights for the interpretation of the gel, criteria mentioned by Tenover, et 
al. (1995)^ 29 
Control Strains: NCTC 8325 and HUSA 304 were kindly provided by Dr. G 
Arakere, IISc Bangalore, India. 
3.14: STATISTICAL ANALYSIS: 
Statistical analysis was done with the help of Windows based Graphical 
Software SPSS-11.4. Comparison between two groups of data was performed using 
Student's/test. 
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RESULTS 
4.1: Prevalence of Staphylococcus aureus from different ecosystem in human 
health and diseases. 
4.1.1: 
In the present study, a total of 4885 samples were collected from three different state 
out of which 1160 (23.7%) were found positive for Staphylococcus aureus 
{S. aureus). Table-1 shows the prevalence data of three state. The highest frequency 
of occurrence of 5". aureus was observed in clinical specimen of diseased group 284 
(24.4%) followed by nosocomial subjects 253 (21.8%)) and then in food specimen 
from various ecosystems 246 (21.2%)). 
4.1.2: 
Out of the various clinical sources listed in Table-2 pus culture were found to 
contain highest frequency of .S. aureus strains 113 (39.7%)) followed by respiratory 
tract infection 15 (11.9%)); concomitantly, the highest prevalence in ocular isolates 
were observed in keratitis 64 (60.9%)) followed by conjunctivitis 32 (30.4%)) and 
least in other undiagnosed infections 9 (8.5%)). 
4.1.3: 
The distribution of S .aureus in carrier state listed in Table-3, shows the frequency 
of S. aureus strains in nosocomial and community environment. In nosocomial 
settings hospitalized patients showed highest prevalence 124 (49.0%)) followed by 
hospital workers 77 (30.4%o) and least in hospital setting's 52 (20.5%)). However, in 
community personnel the incidence of S. aureus strains was 127 (22.9%)). The 
highest frequency were noted in rural personnel 62 (48.8%)) followed by O.P.D. 
personnel 36 (28.3%). 
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4.1.4: 
The frequency of S. aureus in veterinary environment is shown in Table-4. The 
prevalence of 5. aureus in mastitis catties was observed highest 48 (57.8%) followed 
by normal diary herds 21 (25.3%) whereas, in veterinary persoimel the occurrence 
was 14 (16.8%) lowest. 
4.1.5: 
The frequency of distribution of S. aureus among food and food handlers is listed in 
Table-5. The food handlers had the highest frequency of S. aureus isolates 68 
(27.6%) followed by milk (17.0%) and least in fruit chats 16 (6.5%). 
4.1.6: 
The frequency of .S". aureus occurrence from air environment in different places was 
shown in table-6. The highest prevalence observed was in homes 18 (38.2%)) 
followed by hospital wards 9 (19.1%)) and lowest was found in meat shops and 
offices 4 (8.5%). 
4.1.7: 
The prevalence of 5. aureus in water and associated personnel were found to be high 
in Washermen 7 (46.6%)) than in pond water 5 (33.3%)) and least in drinking water 3 
(20.0%) (Table-7). 
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Table 1: Occurrence of total Staphylococcus aureus strains isolated from 
different ecosystems in health and diseases. 
Source 
Disease 
Health 
Ecosystems 
Total 
Original Sources 
Clinical 
Ocular 
Nosocomial 
Community 
Veterinary 
Food 
Water 
Air 
No. of Samples 
1429 
540 
686 
553 
308 
1076 
124 
169 
4885 
No. of strains S. aureus 
isolated (%) 
284 (24.4) 
105 (9.0) 
253(21.8) 
127(10.9) 
83(7.1) 
246(21.2) 
15(1.2) 
47 (4.0) 
1160 (23.7) 
84 
ct^ 
Table -A 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
1. 
2. 
3. 
I: Incidence frequency oiStaphylococcus aureus 
clmical/infected personnel. 
Sources of sample 
Pus 
Blood 
Pleural Fluid 
Urine 
Cervical swab 
Otitis media 
Semen 
RTI* 
Tissue exudates pressure 
Total 
Eye 
Conjunctivitis 
Keratitis 
Other undiagnosed 
infection** 
Total 
No. of Samples 
289 
146 
174 
203 
92 
102 
153 
187 
83 
1429 (%) 
No. of Samples 
221 
202 
117 
540 
isolates in 
No. of 5. aureus 
strains isolated (%) 
113(39.7) 
24 (8.4) 
13 (4.5) 
23 (8.0) 
22 (7.7) 
23 (8.0) 
6(2.1) 
34(11.9) 
26 (9.1) 
284 (19.8) 
No. of 5. aureus 
strains isolated (%) 
32 (30.4)) 
64 (60.9)) 
9 (8.5)) 
105 (19.4)) 
* RTI- respiratory tract infection. 
** cellulites dacryocystitis, endophthalmitis 
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Table 3: Frequency distribution of Staphylococcus aureus isolates among 
colonized or carrier healthy personnel in hospital and community environment. 
S. No. 
1. 
2. 
3. 
Hospital environment 
Source 
Hospitalized 
Patients 
Hospital 
Worker 
Hospital* 
Settings 
Total 
No. of 
Samples 
328 
217 
141 
686 
No. of 5. 
aureus 
(%) 
124(49.0) 
77 (30.4) 
52 (20.5) 
253 (36.8) 
Community 
Source 
O.P.D. 
personnel 
Rural 
personnel 
Urban 
personnel 
Total 
No. of 
Samples 
121 
263 
169 
553 
No. of 5. 
aureus 
(%) 
36 (28.3) 
62 (48.8) 
29 (22.8) 
127 (22.9) 
*samples collected from table, stool, bed covers, bench etc. from wards (i.e; 
peadatrics, general medicine, surgery, orthopaedics, gynae, ophthalmology, ICU, 
cardiology,etc). 
Table-4: Frequency of Staphylococcus aureus from veterinary environment 
S. No Source 
1. Chnical (Mastitis)* 
2. Subclinical** 
3. Personnel*** 
Total 
No. 
90 
146 
72 
308 
of Samples No. of 
S. aureus (Vo) 
48 (57.8) 
21 (25.3) 
14(16.8) 
83 (26.9) 
* No. of Samples taken from inflamed mammary gland (skin) 
** Samples taken from normal lactating herds from skin teat. 
*** Samples of nasal and hand swabs taken from milking personnel. 
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Table -5: Occurrence frequency of Staphylococcus aureus strains from various 
foods and food handlers 
Source 
Meat (cattle) 
Meat (poultry) 
Milk 
Milk Products* 
Raw Vegetables** 
Fruit Chats *** 
Food handlers 
Total 
No. of Sample 
218 
156 
188 
78 
167 
103 
166 
1076 
No of S.aureus (%) 
39(15.8) 
33(13.4) 
42 (17.0) 
22 (8.9) 
26(10.5) 
16(6.5) 
68 (27.6) 
246 (22.8) 
* milk products includes; ice creams and cheese. 
** vegetables-; cabbage, raddish, cucumber. 
*** fruit chats contains slices of apple, banana, guava, papaya, grapes etc. 
Table-6: Frequency of Staphylococcus aureus isolates from different 
aerosol environments. 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
Environmental distribution 
Hospital wards* 
Dinning Halls* 
Dairy Farms 
Meat Shops 
Homes* 
Offices* 
Total 
No. of Samples 
41 
26 
18 
24 
42 
18 
169 
No. of Samples + 
ve for S.aureus 
9(19.1) 
6(12.7) 
6(12.7) 
4 (8.5) 
18(38.2) 
4(8.5) 
47 (27.8) 
* Indoor environment sample 
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Table-7: Prevalence of Staphylococcus aureus in water sources 
s. 
No. 
1. 
2. 
3. 
Source 
Drinking Water Supply* 
Community Pond water * * 
Washermen*** 
Total 
No of Samples 
80 
17 
27 
124 
Frequency of 
Sample +ve for 
S. aureus (%) 
3 (20.0) 
5 (33.3) 
7 (46.6) 
15 (12.6) 
* Sample taken from, hospital supply, dinning halls & roadside kiosks 
** Community ponds surrounded by resident colonies, domestic wastewater is 
dumped into two ponds, the other three ponds are used by washermen. 
***Hand & Nasal Swabs taken from washermen. 
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4.2: Biochemical and Cultural Characteristics: 
In the present study a total of 1160 Staphylococcal isolates from various 
environmental sources were identified as S. aureus on the basis of standard 
biochemical tests (Table-8). Pigmentation in different shades of cream-yellow, 
yellow, yellow-orange was observed in 859 (74.0%) on blood agar and nutrient agar, 
while as 301 (26.0%) showed no pigmentation. All isolates studied found to grow on 
mannital salt agar base but only 460 (39.6%) isolates showed hemolysis on 5% 
sheep blood agar which includes a- and P- hemolysis, whereas 700 (60.3%) isolates 
were hemolysis negative. Of the total 1160 isolates of 5". aureus all were positive for 
catalase, staphylocoagulase and DNase test. 
Out of the 1160 isolates, a total of 1113 strains (95.9%)) were positive for 
alkaline phosphatase and 25 strains (2.1%) were positive for novobiocin resistance, 
as far as P- lactamase test is concerned, 810 strains (69.8%)) were p-lactamase 
positive and 350 strains (30.8%) were negative for this enzyme. 
4.3: Age and Gender Distribution 
A total of 806 subjects were found positive for S. aureus among the infected 
and carrier personnel in the present study. The age range was from 1 month to 
above 65 years old. The overall male and female ratio was 57.6:42.3 (465: 341). The 
highest prevalence of S. aureus was found between 25 - 44 years (25.0%; n=201) 
followed by 45-64 years (22.1%; n=178). The lowest prevalence was observed in 0-
4 years (5.1%; n=41). Of the patients having wound infection (n=113) the highest 
prevalence ofS. aureus was found in the age group of 15 - 24 years (30.0%; 34/113) 
whereas lowest was observed in the age group 0-4 years (3.5%; 4/113). In the case 
of blood infection, patients with bacterimia found to have highest prevalence of S. 
aureus in the age group 5 - 1 4 years (33.3%; 5/15). The prevalence of staphylococci 
in keratitis and conjunctivitis patients was highest in the age group 45-64 years 
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(34.3%; 22/64). The prevalence of 5". aureus in carrier state among different persons 
associated to various environment was same as that of the community personnel the 
S. aureus were most prevalent in children of the age group 5-14 years (28.3%; 
36/27), whereas among healthy hospital workers the highest prevalence of the 
organism was in the age group 25^4 years (59.7%); 46/77) which was same as that 
for food handlers (29.4%; 20/68), details depicted in table -9. 
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4.4: Resistance profile of 5. aureus from various sources in health and diseases. 
4.4.1: Resistance profile of S. aureus isolates in clinical and ocular specimen. 
The resistance pattern of 5*. aureus isolates (n=284) from clinical sources to 
18 antimicrobial agents and shown in table-10. Highest resistance by S.aureus is 
shown towards Penicillin-G 258(90.8%) followed by amplicillin 231(81.3%). The 
least resistance was observed for fusidic acid 26 (9.1%) and insignificantly (P < .01) 
resistance was shown towards methicillin 89 (31.3%,)- The highest prevalence of 
MRSA was shown by pus specimen (34.5%) followed by blood samples (33.3%)) 
and respiratory tract infection (32.3%)) as shown in Table-1 la; Fig-1. 
In ocular staphylococcal isolates (n=105) similar resistance pattern was 
observed but with lesser resistance frequency to pencillin G 94 (89.5%)) followed by 
ampicillin 81(77.1%)) and significant (P < .05) methicillin resistance 12 (11.4%)) 
(Table-10). Conjunctivitis showed the highest prevalence of MRSA isolates (12.2%)) 
followed by keratitis (9.3%)) shown in table 1 lb; fig-2. 
In both clinical and ocular specimen vancomycin was shown to be most effective 
having 0% resistance. 
4.4.2: Resistance profile of S. aureus isolates from nosocomial and community 
settings. 
The resistance pattern of 5. aureus isolates (n=253) from nosocomial settings 
to 18 antimicrobial agents are shown in tabIe-12; fig-3. The highest resistance is 
shown towards penicillin-G 204(80.4%) followed by ampicillin 181 (71.5%). A 
non-significant resistance by methicillin was observed in 47 (18.5%), P < .001) 5*. 
aureus isolates. Methicillin resistance in particular to hospitalized patients vs 
hospital workers (23.3%) vs 16.8%)) was significantly different (P < .05) and hospital 
settings showed prevalence of 9.6%) (n = 5/52). Vancomycin remained the most 
effective drug with 0% resistance in nosocomial isolates, as well. 
As far as the S. aureus isolates (n=127) from community personnel in carrier 
state are concerned the resistant level was observed little lesser then clinical and 
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nosocomial isolates. For Penicillin-G highest resistance was shown 67(54.0%) 
followed by clindamycin 44(36.4%) and tetracycline 32(25.1%)). The resistance 
pattern against methicillin was 13(10.2%), P < .001) in overall community isolates; 
13.8%) (n=5/36) in out door patients; 6.8%) (n=2/29) in urban population and 9.6%) 
(n=6/62) in rural population as depicted in Table-12; Fig-4. 
A significant lower MRSA prevalence was seen in community personnel 
than nosocomial (18.5% vs 10.2%, P < .001). 
4.4.3: Resistance profile of .S. aureus isolates in veterinary subjects and personnel. 
The resistance pattern of 5. aureus (n=83) to 9 antimicrobial agents is shown 
in table-13;fig-5. Resistance profile shows highest penicillin-G resistance (57.8%o) 
followed by tetracycline 43 (51.8%)), clindamycin 42 (50.6%)) and gentamicin 35 
(42.1%)) where as the prevalence of methicillin resistance is of little significance 5 
(6.0%), P< .01). Antimicrobial resistant iS". aureus in veterinary environment was 
found higher in mastitis dairy catties with penicillin-G (60.4%)) vs normal diary 
herds (57.1%o) and in veterinary personnel 50%) (n =7/14). Methicillin resistance was 
observed higher in masthis herds (8.3%)) followed by veterinary personnel (7.1%)), 
upon comparison the difference between these two was insignificant (P> .05). No 
methicillin resistant S.aureus isolate was found in normal diary herds. 
4.4.4: Resistant pattern of S.aureus isolates from Food and Food handlers. 
The resistance pattern of antimicrobial agents to S. aureus isolates (n=246) in 
raw food and food handlers are listed in table-14;fig-6, which shows highest 
resistance to penicillin 154 (62.65%) followed by choramphenicol 121 (49.1%)), 
tetracycline 96 (36.0%)) and gentamicin 52 (21.1%)). However, methicillin resistance 
was not significant 8 (3.2%), P<.01). The highest Penicillin-G resistance was 
observed in cattle meat 69.2% (n=27/39) followed by raw vegetables 65.3%) 
(n=17/26), poultry meat 63.6%) (n=21/33) and food handlers with 58.8% (n=50/68), 
whereas, erythromycin resistance was higher in milk products 21.1% (n = 6/22) 
followed by raw milk 23.8% (n=10/42) then in cattle meat 23.0% ( n = 9/39) and 
food handlers 19.1%) (n=13/68). The carriage of methicillin resistant S.aureus in 
cattle meat was 4 (10.2%)) while lesser to it was poultry meat 3 (9.0%)) resistance and 
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from food handlers it was 1(1.4%). No methicillin resistance in S.aureus was seen in 
other sources. While maximum susceptibility (95.6%) of the isolates was seen 
towards ciprofloxacin, depicting it as the drug of choice (Table-13). 
4.4.5: Resistance Pattern ofS. aureus isolates from Air. 
The 5". aureus isolates (n=47) from air of different sites were subjected to 9 
antimicrobial agents, details depicted in table-15; fig-7. Highest resistance 34 
(92.3%) by aerosol 5". aureus was found for Penicillin-G then by clindamycin 25 
(53.1%)) followed by tetracycline 24 (51.0%)). A significant (P< .05) resistance was 
found towards methicillin 2 (4.2%). Isolates from hospital wards were resistant to all 
antimicrobial agents tested. Resistance to Penicillin-G from hospital wards was 
found 8(88.8%) followed by meat shops 3 (75.0%), homes 13(72.2%), dairy farms 
4(66.6%), dining hall 4 (58.3%) and offices 2 (30.0%). The presence of methicillin 
resistant S.aureus 2 (22.2%)) was found only in hospital wards. 
4.4.6: Resistamce frequency ofS. aureus from Water. 
Table-16; fig-8 describes the resistance pattern of S.aureus isolates (n=15) 
from drinking water, pond and washermen. Highest resistance was observed for 
Penicillin-G 11 (73.3%) then for clindamycin, co-trimoxazole and tetracycline 6 
(40.0%o) giving same value. No organism was found resistant to methicillin from any 
source. The penicillin-G resistance of S. aureus for various water and other sources 
can be summarized as pond water 5 (100%)) > drinking water 2 (66.6%) > 
washermen 4 (57.1%). 
4.4.7: Resistance profile of Methicillin -Resistant S.aureus (MRSA) among various 
sources. 
Upon the analysis of resistance profile of MRSA from various sources as 
depicted in table-17;fig-9. The P-lactam antibiotic such as Penicillin-G was found to 
give maximum resistance (100%)) followed by macrolides including erythromycin 
and clindamycin by all MRSA isolates (n=176). The resistance shown towards 
tetracycline in ocular MRSA is significantly higher (91.6%); P>0.05) with respect to 
other sources. 
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4.4.8: Common resistant pattern of MRSA strains exhibited among various 
environments. 
The resistant pattern of all MRSA (n=176) isolates from various sources are 
described in table-18. The MRSA strains from clinical sources were divided into 26 
resistant patterns followed by nosocomial MRSA isolates (22 resistant patterns). 
Frequency of resistant pattern "PGMETCl" was found to be common or frequently 
encountered in all sources with maximum MRSA isolates (n=22) followed by 
pattern "PGMETCo" (n=14) then "PGMETClCo" (n = 11) pattern. 
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Table 10: Resistance profile of Staphylococcus aureus towards antimicrobials in 
clinical subjects. 
S.No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
Antimicrobial 
Agentst4 
Ampicillin 
Amoxycillin 
Cefazolin 
Ceftazidime 
Chloramphenicol 
Ciprofloxacin 
Clindamycin 
Co-Trimoxazole* 
Erythi'omycin 
Fusidic Acid 
Gentamicin 
Imipenem 
Methicillin 
Roxythromycin 
Penicillin G 
Rifampicin 
Tetracyclin 
Vancomycin 
Clinical samples 
n=284 (%) 
231(81.3) 
99 (34.8) 
143(51.0) 
106(37.3) 
39(13.7) 
32(11.2) 
74 (26.0) 
129 (45.4) 
93 (32.7) 
26(9.1) 
131(46.1) 
48 (16.9) 
89(31.3) 
97(34.1) 
258 (90.8) 
62(21.8) 
124 (43.6) 
0 (0.00) 
Eye 
n =105 (%) 
81 (77.1) 
49 (46.6) 
52 (49.5) 
31(29.5) 
15(14.2) 
13(12.3) 
21 (20.0) 
25 (23.8) 
37(35.2) 
3 (2.8) 
66 (62.8) 
23(21.9) 
12(11.4) 
7 (6.6) 
94 (89.5) 
10(9.5) 
68 (64.7) 
0 (0.0) 
t;In accordance to Performance Standards for Antimicrobial Disk 
Susceptibility Tests, NCCLS (2000,2002)^^°'^ '^ 
J;The intermediate resistant category was included in either resistant or 
sensitive depending upon the closeness of diameter of zone of inhibition to 
either of the respective categories. *;Trimethoprim/sulphamethoxazole 
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Table 11a - Prevalence of MRSA isolates among clinical specimens. 
S. No. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
Clinical 
Source (n=284) 
Pus(n=113) 
Blood(n=24) 
Urine (n=23) 
Pleural Fluid (n=l3) 
Cervix (n=22) 
Otitis (n=23) 
Semen (n=6) 
RTI (n-34) 
Tissue Exudates (n=26) 
MRSA n=89 
(31.3%) 
34.5 
33.3 
30.4 
30.7 
22.7 
26.0 
16.6 
32.3 
30.7 
MSSA n=89 
(68.7%) 
65.5 
66.7 
69.6 
69.3 
77.3 
74.0 
83.4 
67.7 
69.37 
Tablellb - Prevalence of MRSA isolates among ocular specimen. 
S. No. 
1. 
2. 
3. 
Ocular 
Source (n=105) 
Conjunctivitis (n=32) 
Keratitis (n=64) 
Other/ undiagnosed 
infection* (n=9) 
MRSA n=12 
(11.4%) 
12.5 
9.3 
22.2 
MSSA n=93 
(88.6%) 
87.5 
90.7 
77.8 
* cellulites ,dacryocystitis, endophthalmitis 
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Fig. 1: Prevalence of MRSA among clinical specimen. 
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Fig 2: Prevalence of MRSA among Ocular specimen. 
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Fig. 4: Resistance profile of Staphylococcus aureus strains from community 
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4.5: Minimum Inhibitory Concentration (MIC) values of MRSA isolates. 
Minimum inhibitory concentration (MIC) values of MRSA isolates (n= 176) 
to methicillin are shown in table-19. Although no MRSA isolates were found with 
0.5 and 0.1|xg/ml value which is a sensitive range, but 41 (23.2%) isolates had MIC 
between 2-8 fxg/ml, which were designated as borderline (BL) resistant, whereas 
135(76.7%) isolates having MIC >16fig/ml were classified as MRSA. The majority 
43 (24.4%) of isolates showed MIC = 128 ^ig/ml, followed by MIC = 16|ag/ml, 34 
(19.3%). The MIC values of all MRSA isolates were distributed into seven ranges 
between 4 to 256 |Lig/ml varied with respect to source. 
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4.6: Biotyping. 
4.6.1: Distribution oiS. aureus isolates by crystal violet test. 
Multiple drug resistant S. aureus isolates from human personnel in carrier 
and infected states were taken for biotypic classification. 
Table-20 summaries the characteristics by which the isolated strain were 
biotyped. By virtue of their growth on crystal violet agar isolates were distributed 
into human and animal biotype. The majority of the strains from both MSSA 156 
(79.5%) and MRSA 132 (80.0%) were negative type with violet colonies on crystal 
violet agar, henceforth may be classified as human biotype-A. However, the 
production of variable pigmentation on crystal violet agar was also seen in some 
MSSA 26 (13.2%) and MRSA 32 (19.4%) which remained unclassified. Whereas, 
biotype-C with yellow colonies on agar were noted much lesser then biotype-A in 
both MSSA 16 (7.1%) and MRSA 1 (0.6%). MSSA and MRSA from group A,B,C 
and D exclusively found to have characteristics of biotype-A (human origin). 
However MSSA isolates from group F, G and H with exception to fruit vendors also 
found to posses biotype-C (animal origin).Only one isolate of MRSA from butcher 
nares was classified as biotype-C (0.6%). 
4.6.2: Biotyping of MRSA. 
By the virtue of appearance of a halo of fatty acids, pigmentation, urease 
production and gentamicin resistance marker, the biotypic characteristic of strains 
enabled the MRSA isolates (n=165) from personnel to be divided into four groups 
(A to D) as shows in table-21. The organisms biotyped as group B predominantly 
occurred in MRSA isolates 72(43.6%) followed by group D 51 (30.9%), group A 35 
(21.2%) while group C represented a small 7 (4.2%o) and less well defined group. 
Group B found to dominate clinical sources, nosocomial settings and air 
environment and group D in ocular specimens, community personnel, veterinary 
personnel and food handlers as shown in table-21. Tween-80 hydrolysis was of 
particular value in the gentamicin resistance MRSA strains designated as B and D 
for they had similar antibiogram. 
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Table 20: Biotyping: Distribution of drug - resistant Staphylococcus aureus 
isolates by the Crystal Violet Test in diseased and healthy personnel. 
S. No. 
A 
B 
C 
D 
E 
F 
(n= 
40) 
i) 
ii) 
iii) 
iv) 
V) 
vi) 
G 
H 
Sources 
Clinical Samples 
(n=124) 
Ocular 
(n = 49) 
Nosocomial 
(n = 89) 
Community 
(n=13) 
Veterinary 
Persoimel (n=7) 
Butcher (cattle) 
(n=8) 
Butcher (poultry) 
(n=6) 
Milker 
(n==9) 
Confectioner 
(n=7) 
Diiming Hall 
Personnel (n=6) 
Fruit Vendors 
(n==4) 
Washermen 
(n==4) 
Air 
(n-34) 
Total 
MSSAn=196(%) 
C*^  
~ 
~ 
~ 
~ 
! ' • 
2' 
2' 
f 
— 
V 
— 
— 
4 
14 
(7.1) 
A* 
31 
28 
37 
~ 
4 
5 
4 
5 
6 
5 
4 
4 
23 
156 
(79.5) 
NSH" 
4 
9 
5 
~ 
— 
— 
~ 
1 
1 
~ 
~ 
~ 
6 
26 
(13.1) 
MRSAn=165(%) 
C 
~ 
~ 
~ 
— 
— 
1 
~ 
~ 
~ 
~ 
~ 
~ 
— 
1 
(0.6) 
A 
76 
11 
33 
9 
1 
~ 
~ 
~ 
~ 
~ 
~ 
~ 
2 
132 
(80.0) 
NSH 
13 
1 
14 
4 
— 
~ 
~ 
~ 
~ 
~ 
~ 
~ 
— 
32 
(19.4) 
A*- violet colonies; negative, Human biotype; C**- yellow colonies; positive, 
Bovine biotype. NSH - Non-Host Specific 
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Table 21: Biotyping Patterns of Methicillin-Resistant Staphylococcus aureus 
(MRSA) by nature of source among diseased and healthy personnel. 
Sources 
Clinical 
(n=89) 
Ocular 
(n=12) 
Nosocomial 
(n=47) 
Community 
(n=13) 
Vet. Personnel 
(n=l) 
Food handlers 
(n=l) 
Air 
(n=2) 
Total 
Biotypes (n=165) 
A 
17 
4 
11 
3 
0 
0 
0 
35(21.2) 
B 
45 
3 
19 
3 
0 
0 
2 
72(43.6) 
C 
4 
0 
3 
0 
0 
0 
0 
7(4.2) 
D 
23 
5 
14 
7 
1 
1 
0 
51(30.9) 
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4.7: Bacteriophage Typing. 
A total of 302 S. aureus with methicillin sensitive and resistant were 
subjected to bacteriophage typing, details are shown in table-22. A total of 71 
MSSA strains (51.8%) and 53 MRSA strains (32.1%) were typable at RTD and 
lOOX RTD with international set of phages. As many as 66 (48.1%)) MSSA strains 
and 112 (67.8%) MRSA strains remained untypeable. Of the typable MSSA strains, 
3 (2.1%) were of phage group I, 7 (5.1%) of phage group II, 44 (32.1%)) of phage 
group III, 9 (6.5%)) of mixed phage group and 8 (5.8%)) were of phage group not 
allocated (Table-23). As described in table-23, the maximum number of MSSA 
strains from various sources was typed as Phage group III (32.1%)). Some phage 
patterns were found repeatedly amongst the isolates from clinical sources, carriers 
and environment but no particular pattern was predominant (table-24). Phage pattern 
6/75/84, 6, and 6/83A from phage group III were quite prevalent in MSSA isolates. 
Out of the 165 MRSA strains tested 22(13.3%) were typed by the 
conventional set of phages. Distribution of typable strains into phage groups was as 
phage group I 5(22.7%)); phage group II 2(9.0%)); phage group III 12(45.4%)); mixed 
phage group 3(13.6%)) and not allocated phage group 1(4.5) as shown in table-25. 
The 143 untypeable MRSA strains when tested with the MRSA phage 31 
(21.6%)) became typable into five phage patterns listed in table-26. The use of 
MRSA phages also subdivided the 23 strains already typed by conventional phages 
(table-25). MRSA strains from the clinical sources remained the most typable 
50.0% (n = 27/54) next to it were nosocomial isolates 25.9% (n = 14/54). 
The 30/33/38 phage complex was found to be the most prevalent phage 
pattern 22 (39.6%) followed by M3/M5 18(33.9%), 622 phage 8(15.0%), MR8/ 
MR12/MR25, 3(5.6%) and mixed phage group 3(5.6%). Phage complex 30/33/38 
was predominantly found in MRSA strains of every source (Table-25, 26); fig-10. 
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Table 22: Bacteriophage Typing: Phage Typability of methicillin-sensitive and 
resistant Staphylococcus aureus isolates from personnel in health and disease. 
Source 
Clinical 
Ocular 
Nosocomial 
Community 
V.Personnel* 
F.handlers 
Washermen** 
Air 
Total 
Total 
No. of 
Isolates 
(n=302) 
124 
49 
89 
16 
7 
9 
4 
4 
MSSA 
Total 
isolates 
35 
37 
42 
3^  
6 
8 
4 
2 
137 
(%) 
No.of 
isolates 
typable 
24 
16 
19 
2 
4 
3 
2 
1 
71 
(51.8) 
No.of 
Isolates 
untypable 
11 
21 
23 
1 
2 
5 
2 
1 
66 
(48.1) 
MRSA 
Total 
isolates 
89 
12 
47 
13 
1 
1 
~ 
2 
165 
(%) 
No.of 
isolates 
typable 
27 
5 
14 
6 
— 
— 
~ 
1 
53 
(32.1) 
No.of 
Isolates 
untypable 
62 
7 
33 
7 
1 
1 
— 
1 
112 
(67.8) 
* all the drug resistant isolates included in this study. 
** MSSA strain with similar antibiogram included here, 
tthree MSSA isolate randomly picked for phage typing. 
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Table 26: Phage Typing: Phage patterns of Methicillin-Resistant 
Staphylococcus aureus strains Typable by MRSA phage set. 
Reaction with the set of 
MRSA Phages 
Phage Pattern 
622 
M3/M5 
MR8/MR12/ 
MR25 
30/33/38 
Mixed 
Typable 
UnTypable 
Total MRSA 
HA-Hospital ace 
No of 
Strains 
5 
8 
2 
13 
3 
31(21.6) 
111(78.3) 
143(%) 
uired; CA-
Clinical 
Clinical 
3 
4 
1 
7 
2 
17(54.8) 
Communit 
Ocular 
~ 
1 
— 
2 
~ 
3(9.6) 
y acquirec 
Carrier 
HA 
2 
1 
1 
2 
1 
7(22.5) 
CA 
~ 
2 
~ 
1 
— 
3(9.6) 
Environment 
VP 
~ 
~ 
— 
~ 
~ 
FP 
— 
~ 
~ 
~ 
~ 
; VP- Veterinary personnel; 
Air 
-.-
-
— 
1 
~ 
1(3.2) 
FP-
Food Handlers 
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Fig. 10: Predominant Phage pattern of Typable MRSA isolates 
Phages 
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4.9: Multiplex PCR for MRSA Staphylococcus Chromosome Cassette mec 
(SCCmec) cassette typing. 
A total of 93 MRSA strains were undertaken for SCCmec cassette assay. The 
primers used for different multiplex PCR assays are listed in table-IV and -V and the 
PCR details of every strain are given in table-27. 
4.9.1: SCCmec PCR assay for Clinical MRSA isolates. 
In the multiplex PCR assay for 39 clinical MRSA strains all were found to 
possess SCCmec Type III cassette of 280 bp product as shown in figure-11. On 
second round of multiplex PCR the Type III cassettes were further differentiated 
into Type III & Type III -A variant in which absence of pT 181 gene (303 bp) was 
observed, shovm in fig-4. Thus, out of 39 MRSA strains, 11 MRSA strains were 
Type III-A variant. A 147 bp size band of mec A gene was used as an internal 
control for MRSA strains mecA gene was found absent in 3 MRSA strains as listed 
in table-27. 
4.9.2: Multiplex PCR SCCmec assay for Ocular MRSA isolates. 
A total of 6 ocular MRSA isolates from keratitis patients were screened for 
SCCmec cassette. One MRSA strain (OC-9 lane-3, Fig-12) were found to possess 
SCCmec Type II cassette of 284 bp size. Rest of the five strains had SCCmec Type 
III cassette of 243 bp size (Fig-12; Table-27). Among the 5 MRSA strains one was 
found to contain Type III - A variant (Table-27;Fig-13). All the 6 MRSA strains 
were positive for mec A gene (162 bp) (fig-12). The SCCmec cassette Type II of 
MRSA OC-9 (398bp) was reconfirmed by another set of primers listed in table-V, 
and shown in fig-11. 
4.9.3: Multiplex PCR SCCmec assay for Nosocomial MRSA isolates. 
A total of 22 MRSA strains from hospital environment listed in table-27 
were characterized for SCCmec cassette. All 22 strains contained SCCmec Type III 
cassette (Fig-14). Upon further analysis a total of 16 strains were found to have Type 
III cassette whereas 6 strains were SCCmec type III-A variant (Fig-13). One MRSA 
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strain (HAMR-15) was found mecA gene negative. However, 21 MRSA strains 
were found positive for mecK gene. 
4.9.4: Multiplex PCR SCC^gc assay for Community MRSA isolates. 
A total of 11 MRSA isolates one each from the persistent antimicrobial 
pattern mentioned in table-27 were subjected to SCCmec assay. Among the 11 
MRSA strains 9 strains were found to have SCCwec Type IVa cassette whereas 2 
were negative for Type IV cassette (Fig-15) but were found to contain SCCmec 
Type III. All the CA-MRSA strains were mec A gene positive (147 bp) 
4.9.5 Multiplex PCR SCCmec assay for MRSA strains from Veterinary environment 
A total of 5 MRSA strains from veterinary and personnel were taken into 
study of which 4 were found to possess SCCmec Type IVb cassette (493 bp), while 
one MRSA strain was negative for Type IV cassette (Fig-16). Further analysis of 
this strain showed the presence of SCCmec Type III cassette as mentioned in table-
27. All strains were mec A gene positive (147 bp). 
4.9.6: Multiplex PCR SCCmec assay for MRSA isolates from Food and Food 
handlers. 
All the 8 MRSA strains were analyzed for SCCwcc cassette. Among the 8 
MRSA strains 5 were found to possess SCCmec Type IVb (493 bp) cassette, 
whereas 3 were found negative for Type IV cassette (Fig-17) rather they had 
SCCmec Type III cassette (Table-27). For mecA gene, 6 strains were found positive 
and 2 strains negative as shown in fig-17. 
4.9.7: Multiplex PCR SCCmec assay for MRSA isolates from Air 
A total of 2 MRSA strains isolated from air were subjected for SCCmec assay. Both 
the MRSA strains were found to contain SCCmec Type III cassette and mec A gene 
positive (Fig-18). 
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Figure 11: Multiplex PCR SCCmec assay for clinical MRSA isolates. 
8 0-9* ladder 
398bp 
280bp 
147bp 
Ikb 
lOObp 
Fig 11: Lanel-85/2082(control type III); Iane2-MR73; Iane3-MR38; Iane4-MSSA 
(negative control); Iane5-MR81; Lane6-MR47; Iane7-MR7; Iane8-MR28; lane 0-9*-
Ocular MRSA (Type II). The clinical isolates were subjected to 1% agarose gel 
electrophoresis at 60mA for 45 min. 
Figure 12: Multiplex PCR SCCmec assay for Ocular MRSA isolates. 
Ladder 1 
Fig 12: Lane 1,2,4,5 & 6- OCMR-7, 2, 6,4, 1; lane3-OC-9 (Type II); lane7- MSSA; lane 8-MR8; 
lane 9- 85/2082(control type III cassette). The ocular isolates were subjected to 1% agarose gel 
electrophoresis at 60mA for 45 min. 
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Figure 13: Multiplex PCR SCCmec assay for Type 111 and Type IIl-A in MRSA 
isolates. 
414bp 
303bp 
243bp 
209bp 
1 2 3 
^ ^ 
6 7 ladder 
Fig 13: Multiplex PCR assay performed to characterize the determinants in type III cassette, erm'^  
(414 bp ), tef (303 bp), type III (243bp), mecl (209bp). Lane 1-85/2082 (control type- III); lane 2, 3 -
0C7 & MRS representative strains of Type III-A variant (absence of pT181 gene for tet"^ ); Lanes 
4,5,6,7- MR16,HA16,CA12,& F27 representative strains for Type III cassette. The PCR product of 
clinical, ocular, nosocomial strains was subjected to 1% agarose gel electrophoresis at 60mA for 
45min. Marker-lOObp DNA ladder. 
Figure 14: Multiplex PCR assay for Hospital acquired MRSA isolates. 
ladder 
280bp 
147bp 
Fig 14: Multiplex PCR assay to determine the SCCmec type III cassette in hospital MRSA isolates. 
Lane 1- 85/2082 (control type III); lane2,3,4,5,& 6-HA16,42,15,23,39 respectively, the representative 
strains for type III cassette. The PCR product of nosocomial isolates subjected to 1% agarose gel 
electrophoresis at 60mA for 45 min. Marker- lOObp ladder. 
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Figure 15: Multiplex PCR SCCmec assay for the Community MRSA isolates 
Ikb 
100 bp 
Fig 15: Multiplex PCR assay to determine SCCmec type IV cassette in community isolates. 
Lanel-CA4; Iane2-CA5; Iane3-CA6; Iane4-CA7; Iane5-CA12; Iane6-CA13; Iane7-CA9; 
ianeS-CAlO; Iane9-CA2; Ianel0-CA3; lanel 1-CAl; lanel2- CA05 (control type IVa cassette). 
Lane 8 & 9- CA10&2 negative for type IVa cassette. The community isolates subjected to 1% 
agarose gel electrophoresis at 60mA for 45min. 
Figure 16: Multiplex PCR SCCmec assay for Veterinary MRSA isolates 
Ladder 
lOObp 
Fig 16: Multiplex PCR assay to decipher SCCmec type IV cassette in veterinary MRSA. Lane 1 -
VMR5; lane 2- VMR2; lane 4-VMRl; Iane5-VMR3, represents type IVb cassette; Lane3-VMR4 
negative for type IVb. The PCR products of veterinary isolates were subjected to 1 % agarose gel 
electrophoresis at 60mA for 45 min. 
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Figure 17: Multiplex PCR SCCmec assay for Food & Food Handlers 
8 Ladder 
Ikb 
lOObp 
Fig 17: PCR assay to detect SCCmec type IV cassette in Food MRSA. LaneC- 8/6-3P (control type 
rVb cassette); lanel-FMR3; Iane2-FMR5; Iane3-FMR1; Iane7-FMR8; Iane8-FMR4, strains 
represents type IVb cassette. Lane 4- FMR6; Iane5-FMR2; Iane6-FMR7 strains negative for type IVb 
cassette. Lane 7 & 8- FMR 8 & 4 respectively mecA (147bp) negative. The PCR product of food 
isolates were subjected to 1% agarose gel electrophoresis at 60mA for 45 min. 
Figure 18: Multiplex PCR SCCmec assay for Air MRSA isolates 
1 2 ladder 
280bp 
147bp 
Ikb 
100 bp 
Fig 18: PCR assay to determine SCCmec type III cassette in air isolates. Lane 1- AMRl; lane2-
AMR2 represents SCCmec type 111 cassette. The PCR product of air isolates were subjected to 1% 
agarose gel electrophoresis at 60mA for 45 min. 
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4.9.8: PCR for typing mec gene complex. 
The mec complex is the core unit of SCCmec cassette; it is present in 
different combinations in the SCCmec cassettes, thus governs the specificity of the 
cassette. Therefore, PCR was performed to determine and confirm the SCCwec type. 
Out of 93 MRSA strains, 6 MRSA strains were found to be mec A gene negative 
hence excluded from this study. 
Out of 87 MRSA strains 70 contained SCCwec Type III cassette and one 
strain with SCCwec Type II cassette was found positive for class A mec complex of 
146 bp (Fig-19); whereas, 16 MRSA strains having SCCwec Type IV cassette were 
found positive for class B mec complex of 1305 bp (Fig-20) details of each strain is 
mentioned in table-27. 
4.9.9: PCR for typing ccr gene complex. 
PCR was performed for detection of the types of recombination systems of 
87 MRSA strains isolated from various sources with cassette chromosome 
recombinase (ccrAB). Among the tested strains 70 MRSA isolates with SCCmec 
Type III cassette were found containing ccrAB type 3 complex of 1600 bp as 
depicted in fig-21. However, one MRSA strain from ocular possessing SCCmec 
Type II cassette and 16 MRSA strains containing SCCwcc Type IV cassette 
specificity were found positive having ccrAB type 2 complex of 1000 bp (Fig-22), 
details given in table-27. 
The results show the positive correlation between SCCwec cassette type and 
mec and ccr AB gene complex in all the 87 MRSA strains. 
1 --1 o 
Figure 19: Multiplex PCR of Class A mec for Type II and III ^CCmec cassette 
8 ladder 
I46bp 
Ikb 
100 bp 
Fig 19: PCR assay to detect class A mec gene in MRSA strains containing type II & type III cassette. 
Lane 1- 85/2082 (control); lane2- MRS; lane3-OC9; lane4- HA42; laneS- CAIO; lane6- VMR4; 
Lane7-FMR2; laneS-AMRl. The PCR gene product of clinical, ocular, nosocomial, air, community, 
veterinary and food isolates was subjected to 1% agarose gel electrophoresis at 6omA at 45 min. 
Figure 20: Multiplex PCR of Class B mec for Type IV SCCwec cassette 
5 ladder 
1305bp 
Ikb 
100 bp 
Fig 20: PCR assay for class B mec gene in MRSA strains harboring type IV cassette. Lanel- CA12; 
iane2-VMR5; Iane3-FMR3; Iane4-FMR5; lane5- 8/6-3P (control). The PCR product of community, 
veterinary and food isolates was analyzed in 1% agarose gel electrophoresis at 60mA at 45 min. 
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Figure 21: Multiplex PCR assay for Type III ccr 
ladder 1 2 
1600bp 
Fig 21: PCR assay to assess the ccrAB3 complex in MRS A strains 
possessing type III cassette. Lane 1 - 85/2082 (control); lane 2- MRS, a 
representative strain for ccrAB3 type in SCCmec type III cassette. The 
PCR product of isolates subjected to 1 % agarose gel electrophoresis at 
60mA for 45 min. Marker-lOObpDNA ladder. 
Figure 22: Multiplex PCR assay for Type II & Type IV ccr 
ladder 
lOOObp 
Fig 22: PCR assay to assess ccrAB2 complex in MRSA isolates harboring SCCwec 
type II and type IV cassette. Lanel- 0C9 (type II); lane2- CA12 (type IV), the 
representative strains for ccr AB2 type in SCCmec type II & type IV cassette. The 
PCR product of ocular and community MRSA isolates subjected to 1% agarose gel 
electrophoresis for 60mA for 45 min. Marker-lOObp DNA ladder. 
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Table 27:Multiplex PCR SCC mec Assay of MRSA isolates from different 
environment isources in health and diseases. 
Resistant 
pattern* 
1. 
2. 
3 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
1. 
9. 
5. 
4. 
10. 
13 
1. 
Strain No 
MR-4 
-18 
MR-10 
-42 
MR-7 
-11 
MR-19 
-28 
MR-12 
-88 
MR -44 
-73 
MR-1 
-16 
MR-3 
-40 
MR-8 
-87 
MR-14 
-45 
MR - 29 
-47 
MR - 20 
-72 
MR-5 
-34 
MR-17 
-89 
MR -27 
-81 
MR -30 
-69 
MR-53 
-84 
MR-51 
-66 
MR-9 
-62 
MR-15 
MIC 
Hg/ml 
16 
64 
16 
8 
16 
32 
64 
4 
8 
64 
128 
64 
32 
16 
128 
64 
8 
128 
256 
2 
64 
64 
16 
128 
32 
8 
128 
16 
16 
256 
2 
64 
64 
128 
32 
16 
16 
8 
128 
Ocular MRSA Isolates 
OCMR-7 
OCMR-4 
OCMR-2 
OCMR-9 
OCMR-1 
OCMR-6 
64 
8 
16 
16 
32 
16 
Hospital Acquired MRS/ 
HA -38 
HA -42 
32 
8 
SCC mec 
specificity 
T y p e III 
III 
HI 
III 
I I I - A 
III 
III 
III 
III 
HI 
HI 
H I - A 
HI 
HI 
III 
H I - A 
H I - A 
HI 
I I I - A 
III 
III 
HI 
III 
III 
H I - A 
H I - A 
HI 
HI 
I I I -A 
HI 
HI 
HI 
HI 
HI 
HI 
I I l -A 
I I I - A 
III 
I I I - A 
I I I - A 
HI 
Hi 
11 
111 
HI 
V I s o l a t e s 
I I I - A 
III 
mec A 
gene" 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
4-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
mec 
complex 
Class A 
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
Not tested 
Class A 
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
Not tested 
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
Not tested 
Class A 
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
-do-
Class A 
- d o -
- d o -
- d o -
- d o -
- d o -
Class A 
-do-
ccf AB 
complex 
Type 3 
-do -
- d o -
- d o -
-do -
- d o -
-do-
Not tested 
Type 3 
-do -
- d o -
- d o -
-do -
-do -
- d o -
- d o -
- d o -
- d o -
-do-
Not tested 
Type 3 
- d o -
- d o -
- d o -
- d o -
- d o -
-do -
- d o -
- d o -
-do -
Not tested 
Type 3 
- d o -
- d o -
- d o -
- d o -
-do -
- d o -
-do-
Type 3 
-do-
-do -
Type 2 
Type 3 
-do-
Type 3 
- d o -
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2. 
4. 
5. 
6. 
7. 
8. 
9, 
10. 
11, 
12. 
13. 
14. 
15. 
1. 
4. 
5. 
7 
27 
10. 
13. 
27. 
16. 
21. 
1. 
4 
30. 
27. 
11. 
1. 
4. 
7. 
15. 
30. 
21. 
23. 
1. 
7. 
HA-8 
-19 
HA-13 
-18 
HA-21 
-44 
HA-24 
HA-2 
-37 
HA-31 
HA-15 
-23 
HA-10 
-39 
HA-16 
HA-33 
HA-12 
HA-9 
-47 
HA-14 
64 
8 
32 
16 
128 
64 
256 
8 
16 
16 
4 
32 
16 
256 
64 
16 
16 
64 
64 
16 
III 
III 
III 
III 
III 
III-A 
III-A 
III 
III 
III 
III-A 
III 
III 
III 
III 
III-A 
III 
III-A 
III 
III 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
-do-
- d o -
- d o -
-do-
Not tested 
Class A 
- d o -
- d o -
-do-
-do-
-do-
-do-
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
- d o -
-do-
- d o -
-do -
-do-
Not tested 
Type 3 
- d o -
- d o -
-do-
-do-
-do-
-do-
-do -
- d o -
Community Acquired MRSA Isolates 
CA-2 
-5 
CA-3 
CA-6 
CA-9 
-13 
CA-12 
CA-1 
CA-4 
-10 
CA-7 
128 
32 
64 
8 
32 
128 
8 
128 
16 
32 
128 
III 
IVa 
IVa 
IVa 
IVa 
IVa 
IVa 
IVa 
IVa 
III 
IVa 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Ciass A 
Class B 
- d o -
- d o -
- d o -
- d o -
-do-
-do-
-do-
Class A 
Class B 
Type 3 
Type 2 
-do-
-do-
- d o -
-do -
-do-
-do-
-do-
Type 3 
Type 2 
Veterinary environment MRSA Isolates 
VMR-5 
VMR -2 
VMR -4 
-1 
VMR -3 
64 
16 
64 
8 
8 
IVb 
IVb 
III 
IVb 
IVb 
+ 
+ 
+ 
+ 
+ 
Class B 
-do-
Class A 
Class B 
-do-
Type 2 
-do-
Type 3 
Type 2 
-do-
Food and Food Handlers MRSA Isolates 
FMR-3 
-5 
FMR-1 
FMR-6 
FMR-2 
-7 
FMR-8 
FMR-4 
16 
64 
16 
128 
16 
64 
8 
2 
IVb 
IVb 
IVb 
III 
III 
III 
IVb 
IVb 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
Class B 
-do-
-do-
Class A 
-do-
-do-
Not tested 
Not tested 
Type 2 
-do-
-do-
Type 3 
-do -
- d o -
Not tested 
Not tested 
Air environment MRSA Isolates 
AMR-1 
AMR- 2 
16 
16 
III 
III 
+ 
+ 
Class A 
-do-
Type 3 
-do-
!! = +, mec A positive; -, mec A absent. 
* = antibiotic resistant pattern mentioned to corresponding number in table -18. 
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4.10: Random Amplified Polymorphic DNA (RAPD) assay. 
PCR with primers OPA-4 produced multiple fragments of DNA in sizes 
ranging 0.2 to 1.4 kb. A total of 6 Eps were found among the 15 MRSA strains 
studied (fig-23) and details of each tested strains are listed in table-28. 
The dendogram shown in fig 14 B represents the similarity relationships 
between the different Eps found. As can be seen from this phenogram, two major 
groups were formed indicating a less variability among the MRSA strains. They are 
identified in fig-23 A as I and II. Cluster-I formed at a level of similarity of 0.72. 
Cluster-II includes two smaller cluster 'a' and 'b' which are formed at a level of 
similarity of 0.78. Twelve strains were found within the large cluster-II. RAPD 
pattern ' 1' consisting of same antibiogram were observed to be predominant with 9 
MRSA isolates. 
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Figure 23: RAPD - PCR amplification pattern of selected MRSA isolates. 
ladder 
lOObi 
Fig23: Lane- 1,2,3,4,5 & 6- represent the pattern achieved in 15 MRSA isolates. 
The isolates subjected to 1.2% agarose gel at 60niA for 45 min. 
Fig 23A: Dendogram analysis of RAPD pattern of selected MRSA isolates. 
n 
a 
b 
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ti 
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1«» (l«0 t y 0 't 
Coefficient 
Fig 23a: Similarity relationship between 15 MRSA isolates. The phenogram of fingerprinting 
generated from a simple matching similarity matrix by means of the unweighted pair-group 
arithmetic average (UPGMA) clustering method. A similarity of 1 indicates 100% identity between 
strains. 
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Table 28: General characteristics and RAPD-PCR analysis of MRSA isolates. 
S.No 
1 
2 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
Strain 
No. 
OC-7 
MR-4 
MR-18 
HA-42 
HA-38 
CA-2 
CA-12 
CA-10 
VMR-4 
VMR-5 
FMR-6 
FMR-2 
FMR-7 
FMR-3 
AMR-1 
Source 
Ocular 
Clinical 
Clinical 
Nosocomial 
Nosocomial 
Community 
Community 
Community 
Veterinary 
Veterinary 
Foods 
Foods 
Foods 
Foods 
Air 
Antibiotype 
PGMETCl 
PGMETCl 
PGMETCl 
PGMETCl 
PGMETCl 
PGMETCl 
PGMETClCCo 
PMETClCo 
PMEClCoC 
PGMETCl 
PGMETClCo 
PGMETCo Cf 
PMEClCoC 
PGMETCl 
PGMETCl 
SCCmec 
specificity 
Type III-A 
Type III 
Type III 
Type III 
Type III-A 
Type III 
Type IVa 
Type III 
Type III 
Type IVb 
Type III 
Type 111 
Type III 
Type IVb 
Type III 
RAPD 
pattern 
1 
1 
1 
1 
1 
1 
4 
3 
5 
1 
6 
2 
5 
1 
1 
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4.11: Pulsed Field Gel Electrophoresis (PFGE) Profile of MRS A isolates. 
Nine common MRS A patterns were identified among 71 strains of MRS A 
having SCCwec Type III & II cassette (fig-24), details for every strain is listed in 
table-29. The patterns were designated by the letters A to I based on the differences 
in banding pattern. Pattern D was shown by highest numbers of MRSA strains 
(n=14) next to it was pattern C (n-12), whereas pattern I was shown by only one 
MRSA isolate. MRSA isolates of Pattern B (n=7) were found to show maximum 
similarity to the Hungarian clone (HUSA 304). 
The three different PFGE banding patterns were observed in 6 selected MRSA 
strains possessing SCCwec type IV (IVa/IVb) cassette. One subtype of three PFGE 
pattern differing by only single band were found between rural and urban (A,A1); 
milkman and dairy cattle (B,BI); food handler and meat (C,CI) as shown in fig-25; 
thereby, reflected a close clonal similarity. 
4.12: Phylogenetic analysis of 16S rDNA gene. 
The 16S rDNA gene of MRSA OC-9 (SCCwec Type II cassette) showed 
maximum (>99%) homology with N315 (Type II), as shown figure-26. 
The 16S rDNA gene of 5 selective MRSA strains had been found to show 
genetic similarity above 99% to each other. Maximum homology was observed 
between clinical, nosocomial, and community strains (Fig-27). 
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Figure 24: Pulsed Field Gel Electrophoresis (PFGE) Profile of MRSA isolates 
1 2 3 4 5 6 7 8 9 10 11 12 
<80 
A B C D E F G H I B 
Fig 24: Macrorestriction Smal digest fingerprinting Pulsed field pattern of 71 MRSA 
isolates from infected, carrier and environment sources carrying SCCmec Type II & 
Type III cassette. Lane 1 &12- NCTC 8325 control with known molecular weight. 
Lane 2 to 10 is representative MRSA strains constituting 9 PFGE patterns (A to I). 
Lane II- HUSA 304 (Hungarian epidemic clone). 1.5% agarose gel; Initial switch 
time- 5 sec; Final switch time- 35 sec; Voltage- 200V or 6V/cms; Included angle -
120 ; Runtime- 16hrs 
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Table 29: Pulsed Field Gel Electrophoresis Patterns of selected 71 MRS A 
strains (Type III & II cassette) 
S.No 
1 
2 
4 
5 
6 
7 
8 
9 
PFGE Type 
A 
B 
C 
D 
E 
F 
G 
H 
I 
Strain No. 
MR-1,19,34,40,62,89 
HA-14,23,24 
MR-18,47,72,82 
HA-2,39 
AMR-2 
MR-3,5,7,29,81 
OC-4,6 
HA-13,44 
CA-2 
FMR-6,7 
MR-4,10,11,27,42,69 
OC-1 
HA-12,31,33,42 
CA-10 
VMR-4 
FMR-2 
MR-12,14,17,51 
HA-9,10,47 
AMR-1 
MR-9,15,34,73 
HA-18 
MR-16,84 
OC-7 
CA-12 
HA-38,15,28 
MR-8,20,44,53,66 
OC-2 
HA-8,16,19,37 
AMR-2 
OC-9 
No. of Isolates 
9 
7 
12 
14 
8 
5 
6 
11 
1 
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Figure 25: Pulsed Field Gel Electrophoresis of MRSA from community and 
different environments 
674 
361 
324 
262 
208 
175 
135 
117 
>80 
B CI Al Bl 
Fig 25: Macrorestriction Smal digest Pulsed Field Gel Electrophoresis (PFGE) 
generated 3 banding pattern ( A,B,C) with one subtype of each pattern (A1,B1,C1) 
by one band difference in 6 MRSA isolates. Lane 1& 8- NCTC 8325 strain with 
known molecular weight. Lane 2-CA2(rural); lane 3-VMR5(milkman);Lane 4-
FMR3 (human); lane 5- VMR2 (cattle); lane 6- CA3(urban); lane 7-FMRl(meat). 
1.5% agarose gel; Initial switch time- 5 sec; Final switch time- 35 sec; Voltage-
200V or 6V/cms; Included angle -120 ; Run time-16 hrs 
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Figure-26: Phylogenetic tree illustrating the genetic relationship of ocular 
strain (MRSAOC-9) with other MRSA strains. 
rMOOmiMO 
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Fig-26: Phylogenetic tree illustrating the genetic relationship of ocular MRSAOC-9 
(EU247992) strain generated by CLUSTALW software with other reported MRSA 
strains available with GenBank database. 
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Figure 27: Phylogenetic tree illustrating genetic similarity between MRSA 
strains of diverse group. 
M 
Fig- 27: The phylogenetic tree showing homogeneity among MRSA strains of 
different 
environmental sources. The cluster analysis was done using CLUSTALW software. 
MRS (clinical); HA2 (nosocomial); CA12 (community); VMR5 (veterinary); FMR3 
(food). 
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DISCUSSION 
The epidemiology of antimicrobial resistance began in the modem era with 
penicillin resistant Staphylococcus aureus. Resistance actually began several million 
years ago, as bacteria were exposed to naturally occurring antimicrobial agents and 
thus developed resistance mechanisms. Many of these resistance mechanisms lie 
dormant awaiting the introduction of new antimicrobials. Introduction and 
successful development of therapeutic class of agents represents a significant 
medical achievement, this success had also led to complacency within both society 
at large and the scientific community with regard to the development of bacterial 
resistance. In spite of the increased understanding of the factors contributing to the 
development of resistance over the last 60 years, the extent of this problem has not 
decreased with time and is currently among the strongest global threats to the 
treatment of infectious diseases. The degree to which this problem has progressed is 
demonstrated by the fact that resistance has developed against all available classes 
of antibiotics which results in arising number of antibiotic resistant strains in every 
ecological niche. This has, therefore, become a great public health problem 
worldwide.'^ ''^ '^ ^ 
Among the resistant pathogens, methicillin- resistance Staphylococcus 
aureus (MRSA) is of great concern because of the predominance of this organism 
that causes various clinical infections, including those acquired in the community or 
hospitals 6,7.467,468,469.470 j ^ j ^ ^ ^ ^ j^^ ^^^^ established in veterinary science '^ •^ '^•''^ ^^  
foods and food initiated outbreaks '4.473,474^  ^-j. 16,475,476 and ^^^^^ ecosystem.'^ 
In view of the emergence of alarming antibiotic-resistance among microbial 
population worldwide specially among MRSA • • > the present study was 
undertaken with the aim of determining the spread of most prevalent antibiotic 
resistant Staphylococcus aureus strains from different ecosystems to human beings 
in health as well as disease conditions. 
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Uiscussion 
These studies have been particularly focused on S. aureus especially MRSAs spread 
and thus, a total of 4885 samples were initially obtained which yielded as many as 
1160 5*. aureus strains from diverse sources including various ecosystems and 
clinical environment. The strains, under study, were examined by the standard 
methods (Table-8) and most popular antibiotics in use. 
EPIDEMIOLOGICAL APPROACHES: 
Incidence/Spread of Staphylococcus aureus, especially Methicillin-Resistant 
Staphylococcus aureus (MRSA) in different environments: 
Clinical specimen:-
A considerable number 284 (24.4%) of 5*. aureus strains were recovered 
from clinical source. Out of examined S. aureus isolates from clinical specimen, a 
frequency of 31.3% exhibited resistance to methicillin. Among these MRSA isolates 
the highest number was found in pus (34.5%o) followed by blood (33.3%)) and 
respiratory tract infection (32.3%)). The incidence of MRSA isolates being 
drastically high in wound infections appeared to be alarming. The open wounds and 
the frequent dressings often necessitate a dressing team or multiple persons coming 
in contact to the patients, immunosupression of such wound patients might lead to 
MRSA colonization/spread from the wounds. The present study further confirmed 
that frequency of MRSA occurrence from wound remained consistently higher from 
this tertiary hospital care as reported from our laboratory (35.5%)) earlier. 
Ocular environment:-
The characterization of bacterial ocular flora and its susceptibility pattern is 
highly justified as it gives powerful tool to help in the prophylactic surgery 
treatment''^ '^'*^^ Recent reports, '^^'^'^^'^^'^^'^' of catastrophic eye infections caused by 
MRSA have led us to pay attention separately from other clinical specimens in order 
to know their molecular epidemiology. The proportion of S. aureus infections 
resistant to methicillin in ocular environment varied from 3%o to 30%) in earlier 
reports' '''*^ .^ The overall resistance to methicillin in our ocular S. aureus was found 
to be about 11.2%) which is in agreement with these reports"''*^^. Interestingly, the 
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prevalence of 5*. aureus in the present study was found higher in cases of keratitis 
(60.9%) than conjunctivitis (30.4%) but MRSA involvement in keratitis patients was 
less (9.3%) than conjunctivitis (12.5%). Similar observation was made by Freildin et 
al , where they have reported a total of 78.0% patients with MRSA had 
blephariconjunctivitis and 14.8% had keratitis. As expected, people of older ages 
were found more prone to the MRSA infections. The ratio of eye involvement in 
male was higher than female in this study, but was not clinically significant. 
Our data have shown that rapidly growing proportion of ocular isolates of 
S.aureus was resistant to P-lactam antibiotics tested. The MRSA isolates showed 
low ciprofloxacin and high tertacycline resistance in contrast to earlier study, which 
ART 
reported high ciprofloxacin and low tetracycline resistance . The susceptibility 
profile further suggests vancomycin to be the best choice to treat MRSA infection in 
ocular environment as no case resistant to this was found. 
Hospital Environment:-
The relevant nosocomial pathogens can persist for months on dry inmates 
surfaces. In addition to this, factors like low temperature, high humidity also helps in 
longer persistence of 5*. aureus^'^'^''^^^''^^'^''^'^^''^^^. In hospitals, surfaces with hand 
contact are often contaminated with nosocomial pathogens and may, therefore, serve 
as vectors for cross transmission. Compliance rates of healthcare workers in hand 
hygiene are known to be around 50% and leads to the transfer of infection to patients 
or environmental surfaces '*'' ''^ '^. During outbreaks, the environment is known to 
play a significant role in transmission of MRSA '*^ '*'''^ ^ The presence of MRSA in 
wards from various inanimate objects {9.6%) and settle plates (22%) indicated the 
potential source of airborne transmission as well as spread through direct contact. 
Since MRSA isolates have been recovered from many sites, including floors, linens, 
O Q 
medical equipments and hospital furnishing ' , thus the transmission via inanimate 
environments poses significant risk to the personnel. Shiomeric et al."*^ ^ mentioned 
that MRSA counts remained elevated for upto 15 min after bed making was 
complete. The contribution of bed making to the shedding of MRSA from colonized 
or infected patients may also be exacerbated by inadequate ward or patient's space. 
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The anterior nares are said to be the ecological niche for 5". aureus 
microorganisms from where the bacteria can spread to other parts of the body'l^^'^^. 
When preventive strategies were applied to eliminate nasal S. aureus by topical 
treatment with antibiotics, the organism disappeared from other sites of the body in 
most cases'^ . In view of this fact, there is overall agreement that sensitivity of nose 
swabs in detecting MRSA carriage was reasonably high.'^ '^ ''*^ '^'^ ^^  thus our study is 
confined to nasal specimens for reason of accessibility, compliance and consistency 
alongwith other investigations. Patients with only MRSA colonization can be 
significant source for the spread of MRSA in hospitals.^ °°'^ '"'^ ° '^^ ''^  
The overall prevalence of MRSA (18.5%) from this study is in agreement 
with earlier reports, where the reported incidence of MRSA in India was found 
between 6.9 to 51.6%.^"'' A significant difference was observed in the nasal carriage 
between hospital inpatients and health care workers. Perhaps this result can be 
attributed to the patient's longer stays in hospital, age, underline risk factors, drug 
dependency, infection and close contact with the surroundings. We could not detect 
major difference in resistance profile of MRSA carriage in patients and health care 
worker. The MRSAs from hospital environment were known to be resistant to 
multiple antimicrobial agents and our finding is in agreement to previous studies"''''^  
In general elevated rates of multi-drug resistance may emerge from diverse isolates 
of S. aureus under antimicrobial pressure or as a result of widespread person-to-
person transmission of multidrug- resistant isolates . 
CommunitySetlings:-
Traditionally, MRSA has been considered a major nosocomial pathogens in 
health care facilifies, but in the past decade it has been observed emerging in the 
community as well •^^ •^ °''. The hospital is the principal source of medical care and the 
place where people receive expanded spectrum antibiotics. But, scenario is changed 
nowadays because the patients are receiving potent antibiotics at homes too, both 
intravenously and orally. Besides, some patients undergo surgery in out-patient 
centers where they receive antibiotics. Similarly, the physician's office and other 
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care environments are important places where patients are given many antimicrobial 
drugs. 
Infections caused by community associated MRSA (CA-MRSA) in patients 
generally lacking traditional MRSA risk factors with onset outside healthcare setting 
had been increased globally . Clinical syndromes caused by these MRSA range 
from skin and soft tissue infections to necrotizing pneumonia ' ' ' and 
sepsis.^ ^^ ^^ "^  
The reason for the infection with CA-MRSA typically known to occur in 
settings is multiple and can be due to prolonged close contacts between individuals, 
such as families, schools, hospital nurseries and sport teams and in situation where 
hygiene is poor such as facilities for homeless persons^^"*'^ '^'^ " '^^ "'^ '^ . Henceforth, in 
our studies, the prevalence of S. aureus nasal colonization in community 
environment was recorded to be 22.9% and the rate of MRSA strains among the S. 
aureus isolates was 10.2% which is in agreement to the findings of Lu et al . 
However, contrary to this, higher prevalence rate upto 48.6%) of MRSA has been 
reported in community from Turkey.^ '"* 
Children were known as heavy colonizer of CA-MRSA strains with or 
without risks factors than adults ' ' . Similarly, age is found to play a significant 
role for S. aureus colonization in subjects under 15 years and old age in this study. 
The carriage rates of S. aureus varied among different ethnic groups and are 
dependent on age'' 56,5i5,5i6,5i7 jj^^ ^^^^ of resistance, to all the antimicrobials tested 
except vancomycin among our MRSA isolates, was higher than that in a previous 
study^'^.The rates of multiple drug resistance among MRSA were also higher than 
those presented in other reports'^ '''^ ^ '^^ '^ . The prevalence results were similar to the 
finding of Lu et al. and Boyle-Vavra et al.^ ^ . Much of our current understanding 
of MRSA in rural communities comes from reports of outbreaks or smaller case 
series^^ '^^ '^'. In some rural areas the MRSA incidence approaches or exceeds what 
has been reported from larger hospitals in urban areas. Stevenson et al. have 
reported 44%) of CA-MRSA incidence in rural communities, similar trend was 
observed here too, where, the prevalence of MRSA in rural population (9.2%)) was 
higher than the urban population (6.8%)). A mere speculation could be drawn that the 
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poor health hygiene in rural community may contribute to higher MRSA 
colonization/carriage. We observed that the rate of MRSA colonization (13.8%) in 
Out Patient Door unit (OPD) of tertiary care hospital was higher than the rural and 
urban community population. The reason could be the more antibiotic within the 
hospital settings and possible exchange of clones through contact with the health 
care workers. 
Veterinary Environment:-
Its an established fact that animals may serve as reservoirs for infections of 
human beings '^ ''* '^ and the transfer of resistant bacteria from farm animals to 
farmers has been demonstrated in several studies. ' 
The goal of this study was, therefore, to determine the proportion oiS. aureus 
isolates from dairy herds that were methicillin resistant and to look into the clonal 
spread of MRSA isolates, if any, between the dairy herds and personnel coming in 
contact with them. 
The present investigation, considered bovine mastitis which is the single 
most common cause for the antibacterial use in lactating dairy cattle .Therapy 
treating this disease is also the most common source of illegal antibacterial residues 
in market milk^ "^^ . Antibacterial therapy of bacteria induced diseases in cattle has 
been incriminated as a catalyst for the resistance in bacteria isolated from treated 
animals, other animals within the herd and food derived from cattle for human 
consumption. 
A recent comparison of pig farmers and non-farming controls had postulated 
that farmers were at significantly greater risk for colonization . Our study, 
however, demonstrated a frequency upto 16.8% of 5. aureus colonization in dairy 
personnel. Comparison of MRSA carriage rates reported in different studies is 
difficult since various sampling strategies and isolation methods are used for 
assessing staphylococcal carriage. 
The S. aureus isolates of clinical herds displayed significantly higher degree 
of antimicrobial resistance than isolates from normal dairy herds against the drugs 
tested. This finding infers the use of antibiotic therapy in clinical dairy herds, the 
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following inference can be justified by previous study .^ The MRSA prevalence in 
dairy cattle were known to range between 2.2% to 22.7%.^"'"^ We, therefore, 
found 8.3% MRSA prevalence in clinical herds and one MRSA strain from dairy 
personal which is in broad agreement with earlier reports^^ '^^ '^'. There was no 
statistical difference in the resistance profile exhibited by MRSA isolates from 
mastitis herds and personnel. Kaszanyitzky et al.'^ were also able to demonstrate a 
similar ratio of MRSA colonization between dairy herds and personnel where they 
had found a total 27 bovine and one human MRSA isolate only and all tested strains 
showed the same susceptibility pattern. 
Three possible explanations mat be given for the presence of resistant 
bacteria in farmers than in non farmers. Firstly, farmers may come in contact with 
more antimicrobial-resistant bacteria from farm animals; these bacteria are then 
transferred to the farmers if a few/no precautions are taken during contact with 
animal feces. Second, farmers may be in frequent contact with antimicrobial agents 
themselves or antimicrobial residues that are given to the animals in the workplace. 
The third possibility is that farmers receive more antimicrobial agents for other 
medical reasons. 
Foods :-
Despite its ubiquity as health care acquired pathogens and its increasing 
reports of community acquired infections, MRSAs have not been previously 
reported as a cause of outbreaks of gastroenteritis until 2002'* '^'. Food has also been 
implicated as a source of spread of MRSA in one reported outbreak in hospitalized 
immunocompromised patients''^ '*. Gorman et al.^ ^^  have shown the ability of food 
borne disease microorganism to become disseminated from naturally contaminated 
foods, such as fresh chickens to various hands and food contact surfaces in the 
domestic kitchen. Consumer awareness is of paramount importance in the handling, 
preparation, cooking and storage of foods. 
Our finding could not demonstrate the presence of any MRSA from sample 
size taken from raw vegetables, fruits chats, milk products and milk, but the 
prevalence of MRSA (10.2%) from cattle meat and (9.0%)) from chicken meat was 
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observed. In congruence of our observation, Lee et al. "^  have documented the 
occurrence of MRSA in dairy cattle and chicken. All MRSA isolates were resistant 
to (3-lactam antibiotics and exhibited less susceptibility to erythromycin (87.5%), 
and gentamicin (87.5%). Such profiles of antibiotic resistance occurred rather 
frequently in many of the MRSA '^'^ '^ ^^ . Surprisingly, higher resistance to Co-
trimoxazole (49.1 %) has been shown by these MRSA isolates. The apparent reason 
may be the use of drug in this geographical region during the time of our sampling. 
Interestingly, similar antibiogram "PGMETCl" were observed in organism isolated 
from butcher and cattle meat samples tested. This is a very strong indication 
showing a possible spread of multiresistant bacteria including MRSA between 
human and animals. Another strong evidence comes from the history of the use of 
antibiotics for growth promotion in Europe . At first Denmark and then the 
European Union banned the use of antibiotics for growth promotion, thereby, 
prevalence of resistant bacteria declined in farm animals, in retail meat and pouhry, 
and within the general human population"" . 
Water Ecosystem:-
The S. aureus and other staphylococci have been considered better organisms 
for evaluating the hygienic quality of drinking water supply, community pond water 
and other water resources for several reasons. They are consistently shed from the 
skin, mouths, nose, and throat of bathers and are opportunistic pathogens that cause 
a variety of infections, including boils, carbuncle, skin rashes and eye infections as 
well. They are 5 to 20 times more resistant to chlorine than coli forms and also are 
more resistant to other halogens disinfectants which results in a longer survival 
time' "^  "' \ The prevalence of antibiotic resistant S. aureus in water environment 
has been reported earlier."^'""''"'' 
In the present study conducted on variety of water samples, the incidence of 
antibiotic resistant .S*. aureus in pond water (33.3%) was higher in comparison to 
drinking water (20.2%). The higher percentage of occurrence might be due to the 
surrounding environment of the ponds since these ponds were located in different 
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residential community, and were receiving domestic waste continuously besides 
being these used for washing purposes. 
In the present investigation, we could not detect any MRSA strains in water 
sources as well as in nasal samples of washermen. Although, community pond water 
yielded methicillin sensitive S. aureus (MSSA) isolates which showed similar 
antibiotic pattern with nasal specimen. Crystal violet test for these isolates revealed 
their host specificity to biotype A (human origin) suggesting their similar origin. 
Bacteriophage results depicted the typable isolates were of same phage type; group 
III- phage 6 common in MSSA isolates. These results suggested the possible clonal 
spread of MSSA between pond water and washermen. 
As regards the location of the site of pond, the source is situated near the 
University Medical College and is used for washing hospital clothes. Although, 
there is no direct proof of the origin of these strains; they might have traveled 
through hospital clothes to water during washing and to washermen. Some 
investigations have also detected no nasal colonization with MRSA isolates "~ . 
Similar to this finding, MSSA strains were isolated in communal whirlpool water 
associated with professional football team which is again an example of cross 
transmission of infection '"*. The contaminated whirlpool water was implicated as 
the route of transmission of MRSA in a college football team as reported by Begier 
etal'l 
Air Environment:-
The ambient airborne transmission of this organism in non- hospital 
envirormients was demonstrated by the increasing prevalence of methicillin-
resistant S. aureus infections in the community ''^' . In view of these facts, we, 
therefore, air sampled S. aureus from different sites including hospital wards, 
dinning halls, meat shops, dairy farms, homes and offices, to assess the possible role 
of airway transmission of drug resistant S. aureus between person to person and 
from persons to associated environment and vice versa. In the present study it was 
found that the frequency of .S'. aureus is higher in indoor environment than outdoor. 
The recovery of bioaerosols S. aureus in higher frequency from indoor environment 
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than outdoor, it is assumed that elevated concentrations of S. aureus remained 
indoors compared to outdoors due to human activities'*^ . The health risks associated 
with occupant exposure are difficult to calculate because of the few studies that have 
reported bacterial aerosol concentrations in indoor air and the resultant lack of 
epidemiologic data available for typical indoor environment. ^ ''^  
The antimicrobial susceptibility patterns suggested that the prevalence of 
MRSA was restricted to hospital environment in our finding. The resistance to 
penicillin-G was as high as 72.3% in overall isolates which is in agreement with the 
previous findings ^^ . The presence of both biotype A and C of human and animal 
origin in settle plates, suggesting the possible shedding of the S. aureus from body 
parts by both human and animals in their respective environment. In the light of this 
finding, Gibbs et al.^ '*' drawn a conclusion that resistant bacterial forms found inside 
and downwind of the animal (eg; swine) confinement facilities indicated that 
resistant organism were being produced and released from these facilifies which, 
could cause a potential human health hazard. The two MRSA isolates, however, 
were confined to biotype-A (human origin). The mechanism of dispersal of these 
MRSA into air is not clear from this investigation, but it can be speculated that the 
probably nose, clothes and the skin might have played a role in its dispersion into 
the environment. Therefore, MRSA in the form of bioaerosol can contaminate the sir 
and cause airborne infectious diseases'^. 
In order to differentiate the real methicillin-resistant staphylococcal strains 
from those showing only phenotypic methicillin resistance, strains presumably 
having mecA were examined for MIC. The MIC value of oxacillin for MRSA 
(n=176) isolates was found to range between 4-256|il/ml, henceforth broadly 
distributing into borderline resistant strains (32.2%) and methicillin resistant strains 
(76.6%) in accordance to the NCCLS'*''^  recommendations. Both these resuhs were 
characteristically significant for the determination of MRSA. 
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PHENOTYPIC APPROACHES: 
Biotyping:-
The 5*. aureus biotyping has been useful tool in tracing or estimating the 
origin of this organism^""'^ '^''''*^ and also in epidemiological investigation of food-
poisoning outbreaks '^*^ In order to explore the possibility of spread of organism and 
consequently genes, from \'arious environments studied we were able to detect 
overall 7.1% of MSSA isolates and only 0.6% of MRSA isolates as crystal violet 
positive biotype-C (animal origin) from personnel, which provided insight to our 
results, indicating a possible transmission of the organism from dairy herds to 
human beings. Though, high percentage of MSSA (79.5%) and MRSA (80.0%) 
isolates remained host specific. The host specificity to higher extent has also been 
shown by Hemiekinne et al . 
The biotyping scheme for MRSA in epidemiological monitoring within 
hospital group was proposed by Coia et aP^ .^ Surveillance study carried out by 
Gupta et al^ '^ showed that all MRSA strains belonged to the same biotype B. 
Vedhani et al.^ '^ "* reported typeability of MRSA by biotyping to be 91.2%), maximum 
number of isolates belonged to biotype B (49.5%) followed by biotype D (34.2%). 
These scientists had isolated MRSA only from hospital environment, while we have 
extended our search to many other sources including community, veterinary, foods, 
and air. We too could biotype our 165 MRSA isolates into four groups (A, B, C & 
D) and observed highest (43.6%)) prevalence of MRSA biotype B which indicated 
that these strains exclusively belonged to orthopeadic and burn unit wards. The 
occurrence of MRSA strains exhibiting biotype D was viewed as the most frequently 
encountered strain within the hospital environment. Our studies have also indicated 
a considerable percentage (30.9%) of such MRSA strains belonging to biotype D, 
indicating that these were frequently encountered from hospital as well as in external 
environment. 
Bacteriophage Typing:-
For decades, bacteriophage typing was the standard method for typing of 
S. aureus. The phage typing is still widely used today, despite a number of 
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drawbacks ' '^ '^  ' . Typing of staphylococci is an important approach in 
epidemiology, in order to find the similarities and differences of the strains obtained 
from different sources and also to evaluate the significance of these strains for 
diverse sources in human infection pathology. 
In the present investigation, of the 137 MSSA strains and 165 MRS A strains, 
51.8% and 32.1% respectively were totally typable by international set of phages. 
The typeability attained by these isolates was, however, slightly lower than reported 
earlier^^^ wherein 79.1% of MSSA and 43.8% MRSA were typable. 
The Phage group III has been known to be predominant in Indian isolates as 
per studies conducted by National Phage Typing Centre, New Delhi . Similar types 
of results have also been obtained in our studies, as we could also get as much as 
32.1% of MSSAs and 45.5% of MRSAs belonging to this phage group III. It may be 
seen that predominance of particular phage group could vary from country to 
. 549.550 
country. 
Normally, a large percentage of MRSA isolates remains non-typable by the 
convenfional set of phages'" '^'^ ^ .^ We also found 13.1% typeability attained by 
MRSA isolates. Mathur et al.^ ^ ,^ however, have shown that the use of MRSA phages 
had increased the percentage of typeability of MRSA strains from 17.6% with 
conventional set to 45.6% with MRSA phage set. Upon subjecting our MRSA 
strains to MRSA phages a comparatively high typeability (21.6%) could be 
achieved. 
Various predominant phage patterns amongst the individual groups are 
usually observed in different studies. As indicated by the phage pattern 80/47/54/ 
and 47/54 reported from Belgian epidemic MRSA strains^^l Daugeliene at al."'' 
found group III/77 phage type in MRSA strains and MSSA to 6, 42E and 83A were 
most frequently encountered. In the present study some phage patterns repeatedly 
observed amongst the isolates from clinical sources, carriers and environment 
sources, but no particular pattern was predominant. In case of MSSA strains 6/75/84, 
6, 6/83A phage patterns were predominant and 6 phage type attained by maximum 
numbers of MSSA isolates. Similarly, in MRSA strains 30/33/38 complex was 
found predominant. Moreover, distribution of Phage type III strains and 30/33/38 
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complex strains among clinical, ocular, nosocomial, community, vet personnel, food 
handlers, and washermen indicated that these strains of S. aureus including both 
MSSAs and MRS As were somehow, related to each other and, therefore, we could 
speculate a possible transmission of these organisms from one source to another 
source. This belief is supported by the assumption of Morrison et al.^ ^^  where they 
had indicated on the basis of phage typing that animals may be a source of infection 
for human population. Further, Boyce et al.'"''' reported an outbreak of MRS A in the 
burns unit, where they showed that all the isolates had identical or similar phage 
reactions (29/52/52A/80/6/47/53/54/81). Mathur et al.^ ^^ however, had shown a 
single MRSA phage (phage 622) dominance in MRSA isolates from National capital 
region indicating the isolates were clonally related to each other. 
Biochemical and Molecular Approaches: 
Staphylococcal Cassette Chromosome mec (SCCmec) Typing:-
Determining the SCCwec cassette in MRSA isolates is of great value to 
understand the epidemiology of these strains .The SCCwec cassette typing allowed 
us to better identify the clonal nature of the MRSA strains circulating in the 
particular geographical region during the present study. The origin of SCCiwec 
cassette is still unknown and there has been no report of SCCmec in bacteria other 
than staphylococci^ . The mechanism(s) responsible for mecA transfer is still 
obscure but evidence supports horizontal transfer of mec DNA between 
staphylococcal species and of the mecA gene between different Gram positive 
genera^^ .^ It was assumed that the ccr and mec genes were brought together in 
coagulase negative staphylococci (CoNS) from unknown source^^ '^^ ^ '^'^ '^^ ^ ,^ where 
deletion in the mec regulatory genes occured, before the genes were transferred into 
S. aureus to finally generate MRSA '40,558,559,561 g^ ^^^ ^^^^ different types of 
SCCmec (I-V) have been defined by particular combination of the ccr complex and 
mec complex'" '^'"^ '^^ ^^ beside, several subtypes II A to E and subtypes IVa to IVg 
150,152.562,563 ^j^^ sCCwec types I, II, and III are predominantly found in hospital -
acquired MRSA (HA-MRSA) strains, whereas the SCCmec types IV and V are 
mainly associated with community-acquired MRSA (CA-MRSA) throughout the 
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world '35,149,564,565 ^j^^ SCCwec typing and genotyping have provided strong 
evidence for knowing the independent origins of health care associated MRSA and 
community acquired MRSA''^ ^ '^'^ ^. Further, the numerous epidemiological studies 
have demonstrated that most HA-MRSA infections are due to a relatively small 
number of epidemic MRSA clones spread worldwide, namely, the Iberian {^CCmec 
I), the New York/Japan (SCCwec II), the Brazilian/ Hungarian (SCCwec IIIA/III) 
and the Pediatric (SCCmec iv)'^'-^^^'^^^ Upon analysis of 117 CA-MRSA isolates 
from three continents suggested the spread of a limited number of clones, which are 
associated with a particular geographic origin.^ ^ '^ ^^  
Infact, little work has been done about the SCCwjec cassette of Indian 
isolates until recently only few MRSA strains are typed^^ '^^ ^°, this further generated 
interests to explore the epidemiological aspects of MRSA clones from Indian origin. 
In the present study, a selected group of MRSA (n=93) isolates were screened for 
the determination of the occurrence of SCCwec cassette, which revealed three major 
SCCw<2c cassette type II, III and IV. 
The significant finding of the present investigation was the detection of 
SCCmec cassette in a total of six ocular MRSA isolates revealing the presence of 
SCCmec type II cassette in one strain (OCMR-9). To the best of our knowledge the 
presence of SCCwec type II cassette in MRSA from the eye specimen has not been 
observed earlier from Indian MRSA isolates and therefore, possibly this is the first 
study in India, atleast as far as ocular MRSA are concerned. However, SCCwec type 
II cassette has been more frequently isolated from Japanese and Korean MRSA 
strains^''". The New Yorli/Japan (type II) clone was found to be a predominant clone 
in the Unites States''^'*'"''"^, Canada^^^ as well as in Finland, Ireland and United 
Kingdom''^ ^. 
The SCC/wec Type III cassette with III-A [ptl81- a tet*^  gene absent] variant 
was found prevalent in nosocomial isolates and clinical specimens in our study. The 
presence of ^CCmec type III cassette both in air MRSA isolates (AMR-1,2) 
suggested that the strains are linked to nosocomial environment. The presence of 
two MRSA strains (CA-2,10) with SCCmec type III cassette in community 
personnel indicates that the origin of nosocomial strains into community had taken 
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place. Now the question is whether hospital-origin clones been transmitted into 
community environment? Simor et al.^ ^^ '^ '^* in this context had evidently revealed 
that MRSA harboring SCCmec type II cassette which was related to the New 
York/Japan clone having a hospital- origin was the most common cause of 
community- onset infection among the people in Canada. Thereby, reflecting the 
movement of CA-MRSA-II from hospital into the community. Moreover, the 
presence of SCCmec type III cassette clones (VMR4) in dairy herds and major food 
animals (FMR2,6,7) suggested that, either the animals may have acquired SCCmec 
type III cassette endogenously when put on drug previously or might have acquired 
from some other source. 
Further, the investigation of community MRSA isolates, revealed the 
presence of SCCmec type IVa which remained confined to personnel in urban and 
rural residential community. The presence of SCCmec type IVa cassette has also 
been reported from ethnic community of Malay, Chinese, Indian, and Filipino from 
Asian continent^^^. It was also known to be quite prevalent in France^^^ and 
Australia"^ The CA-MRSA strains were remarkably uniform in their SCCmec. Of 
the vast majority of CA-MRSA strains studied so far, most harbored SCCmec type 
IVa, suggesting that in the Indian community environment, this is the most-
transmissible and best adapted type of SCCmec cassette. However, how, and from 
where the SCCmec has been acquired is yet to be determined. From epidemiological 
prospective, recovery of SCCmec type IVa cassette (CA-4,5,6,7) in Out Patient Door 
unit (OPD) indicates the spread of clones to hospital environment as well in this 
particular geographical region. Because, the patients infected or colonized with 
MRSA return to the hospital, this gives much less clear cut distinction between 
hospital acquired infections and community- acquired infections . Once introduced 
into a hospital, the SCCmec type IV strains may present a competitive advantage 
over the predominant endemic multiresistant MRSA clones. It has been suggested 
that their multiplication and transmission rates are superior to MRSA strains with 
SCCmec type I, II and III cassetted The term "community-acquired" however, may 
need to be modified, since MRSA strains carrying SCCmec type IV or V are now 
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introduced from their community site of origin into the hospital setting with the 
potential to cause nosocomial spread.^ ^ '^^ ^°'^ '^ 
Surprisingly, the presence of common SCCwec type IVb cassette among 
dairy herds (VMR-1,2,3) dairy personnel (VMR-5), major food animals and food 
handlers (FMR-3,5,1,8,4) indicated the prevalence of same clonal spread of this 
CO") 
organism. Similar to our finding, Weese et al. showed that all tested isolates from 
horses with clinical infection contained SCC/nec type IV and similar MRSA clones 
were predominant in colonized horse personnel in North America, thereby, 
indicating the relatively widespread transmission of similar clones. While, in their 
another fmding^^^ these workers have identified a concurrent colonization with 
MRSA harboring SCCwec type II cassette between domestic pets and human from 
six different case studies at different time interval, strongly suggesting a possible 
clonal exchange between interspecies and also a predominance of similar clones 
(CA-MRSA-II) in a particular Canadian geographical region. 
Detection of the mec complex and ccr complex were essentially important 
for the classification and characterization of structural types SCCwec in MRSA 
strains. As different SCCmec cassettes carry distinct combinations of mec and ccr 
gene complexes, the type of SCCwec was determined with these two elements'^ ^ .^ 
All the MRSA isolates under study except six mecA negative MRSA strains were, 
therefore studied for the presence of mec complex and ccr complex. It was found 
that the tested strains stayed to their specificity with respective cassette ie; type II 
SCCmec (type leer and class A mec), type III/III-A SCCwec (type 3 ccr and class 
A mec) and type IV ^CCmec ( type 2 ccr and class B mec) as mentioned in 
y. . 153.462,584 
literature. 
Further, we observed that six of the MRSA strains with borderline resistance 
failed to produce meek gene were subjected to PCR. The probability of this finding 
can be understood that these low MIC bearing isolates probably did not actually 
harbor meek gene but the resistance to oxacillin was conferred by the 
overexpression of the PBP2a (penicillin binding protein 2a) protein which lead to 
the intrinsic resistance"^^ '^''^ ^ In agreement to this assumption, meek negative strains 
at low MIC value have also been reported by Lee et al,''^ in dairy cattie and food 
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animal isolates where, only 15 out of 28 specimens were found positive by PCR for 
mecK gene. Tai et al.^ ^^ have also found 10 mecA negative MRSA strains out of 68 
in PCR assay. Japoni et al. in clinical isolates, showed the absence of mecA. gene 
band at low (2|il/ml - 4|il/ml) MIC values, which further supports our belief that 
mec A gene was not present in such strains at low MIC values. 
Randomly Amplified Polymorphic DNA (RAPD) assay:-
In view of the heterogeneity in the natural population of S. aureus, RAPD-
PCR technique constitutes a valuable tool for tracing the sources of S. aureus 
infections of either human or animal origin'^ *''^ '^'^ "'^ '^ and also has been widely used 
in tracing the outbreaks in nosocomial settings.''^ '''^ ^^ 
In the present study, 15 selected MRSA isolates were grouped into 6 
different patterns in single primer based study. It was observed that isolates from 
clinical (MR-4,18), community (CA-2), ocular(OC-7), nosocomial (HA-42,48), air 
(AMR-1), and one each from bovine (VMR-5) and food (FMR-3) shared single 
pattern (pattern!). Further, isolates with the same RAPD type (pattern 1) were within 
the same antibiotype categories, whereas variation in the antibiogram generated 
different pattern. In support of this finding, Lee at al.''* had documented the RAPD 
patterns of six of the isolates from animals which were identical to the patterns of 
clinical isolates from humans. The antibiotypes of the six animal isolates were 
similar to those of the human isolates. 
One community isolates (CA-12) shared a same cluster of group T with 
bovine (VMR-4) and food (FMR-7) isolates at a homogeneity of above 75%, genetic 
similarity suggested that human and bovine isolates were genetically linked. The 
genetic similarity of human and bovine isolates between 30% to 80%) was observed 
by Reinoso et al^ ^ .^ A study conducted by Pereira et al.^ *^^  showed two strains of 
human origin and one of bovine origin sharing the same amplification profile in 
RAPD. 
Despite of harboring S,CCmec type IV cassette but with similar antibiotype 
"PGMETCl" by two MRSA isolates one each from bovine (VMR-5) and food 
(FMR-3) were found clustered in pattern T with human isolates. To achieve higher 
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discrimination of such strains, a combined DNA fingerprints with 3 primers or 
primer pairs may be required which is a Hmitation of this study. Our data at-least in 
VMR-5 and FMR-3 strains suggested that genome of the bovine and food isolates 
were identical to the patterns of certain human MRSA isolates, and were a possible 
source of human infection caused by consuming contaminated food products made 
from these animals. Once interspecies transfer has occurred, such isolates might 
become widespread in the environment posing a potential threat to human health. 
Pulsed Field Gel Electrophoresis (PFGE):-
Pulsed Field Gel Electrophoresis has been known for its great discriminatory 
power and high degree of specimen typeability, thus it has been accepted as the gold 
standard for the molecular typing of S. aureus isolates''^ '^'*^^ '^ ^^ '^ '^*. It has also been 
successfully used to study the epidemiology of S. aureus nosocomial infection and 
prevalence of methicillin resistance.^ ^ '^^ ^ '^^ ^ '^^ ^^ 
In the present study, the total of 71 strains of MRSA (possessing type II, III 
cassette) were undertaken for PFGE typing, and a total of 9 PFGE patterns of these 
strains could be obtained. It was observed that PFGE pattern (A to H) comprised of 
similar type of MRSA strains with indiscriminate banding pattern. This suggests that 
most of the MRSA have been acquired by personnel during their current contact to 
its respective surroundings. PFGE pattern I of OC-9 (harboring type II) had shown 
unique banding pattern. 
As much as seven MRSA (type III) isolates of pulsotype-B showed 
indistinguishable banding pattern to Hungarian (HUSA 304) epidemic clone. The 
clonal similarity of type III to Hungarian clone (HUSA 304) had been also reported 
from two hospitals of South India'^". Although we have looked at a limited number 
of strains from Aligarh city (North India), but on the basis of PFGE it was clear that 
the isolates related to Hungarian epidemic clones had made their appearance in 
India. Furthermiore, the present findings suggested that MRSA isolates of pulsotype-
B from the hospitalized patients and medical staff (HA-2,39), the air (AMR-2) and 
MRSA isolates of pulsotype-E constituted with the nosocomial (HA-9,10,47), and 
tne air (AMR-1) might share a common origin, thereby, indicating that such strains 
164 
"Discussion 
recirculated among these sources. Henceforth, we presumed firmly that MRSA 
could be acquired by medical staff and patients through air. 
The close association of clinical specimens (n-36) with hospital acquired 
MRSAs (n=22) constituted in PFGE pattern A to H indicated that nosocomial 
infections can originate from clinically ill patients. Moreover, the PFGE pattern D 
constitute almost every source undertaken in the present study, including clinical, 
ocular, nococomial, community, bovine and foods which further suggested that these 
MRSA strains representing pulsotype-D were widely spread in this particular 
geographical region. 
Moreover, PFGE pattern of 6 MRSA isolates (type IVa and IVb cassette) 
from community (CA-12,3), bovine (VMR-5,2) and food (FMR1,3) sources 
generated 3 pulsotype with one subtype each by one band difference, suggesting the 
close clonal relatedness of clones within the source and possible transmission of 
clones had taken place between them at some point of time. Similarly, the 
indistinguishable but unique banding pattern of the human and three bovine isolates 
from the same farm, combined with epidemiological temporal-spatial link between 
the disease in farmer and his cows, provided evidence of a common clonal, aetiology 
in one episode of disease in both^^ .^ Similarly, Kaszanyitzky et al.'^ found 
indistinguishable PFGE pattern in 7 mecA-positive bovine strains and one human 
mecA-positive isolate in the same maimer. 
In the light of PFGE pattern we can say that persons in close contact with 
MRSA-infected catties including veterinarians, farmers, milkman and persons 
working in slaughterhouses may become colonized from the bovine source in due 
course of time. 
Phylogenetic Analysis:-
In order to further know the homology between our test MRSA strains from 
different environment a phylogenetic analysis of 16S rRNA gene was undertaken. 
Interestingly, the sequence of 16S rRNA of one of our ocular isolate MRSA 
OC-9 (SCCmec Type II) was phylogenetically linked to show more than 99% 
homology to referral strain (N315, Japan). Similar observation was reported when 
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whole genome sequences carried out on two health-care-associated MRSA strains, 
N315 (type 11) and Mu50 (Vancomycin resistant S.aureus) and one community-
acquired MRSA strain MW2 (MW standing for mid-west USA)'^^''^^ showed that 
there were 99.7% nucleotide sequence identity between N315 and Mu50, 94.8% 
between MW2 and N315, and 94.7% between MW2 and Mu50. 
Some of the selected MRSA strains corresponded with minor variation 
(>99% homology) between clinical (MRS), bovine (VMR3), nosocomial (HA2), 
community (CA12), food (FMR3) sources. Hanssen et al^  however, have obtained 
99%) homology between staphylococcal species. 
The percent homology has further suggested that inspite of different 
antibiotic pressure, the isolates were able to maintain their conserved sequences. 
The following conclusions can be drawn from the present study: 
• The resistance undoubtedly emerged in men and animals probably due to 
indiscriminate use of antibiotics in most of Indian settings against normal as 
well as pathogenic S. aureus. 
• An alarming increase in the resistance patterns against P-lactam antibiotics, 
especially the penicillin-G was recorded among S. aureus strains isolated 
almost from all sources undertaken. High incidence of prevailing resistance 
among such S. aureus isolates, including MRSAs from hospital and other 
human associated environments clearly indicated the existence of 
corresponding genes mediating such resistance and thereby exploring their 
possibility of spread between them. 
• Environmental sources such as air, water appeared to act as potential 
reservoir for the transmission of antibiotic resistant S. aureus including 
MRSA strains to human beings, and being re-circulated among the patients, 
the air and the inanimate objects in hospital environment. 
• Biotyping of the test S. aureus isolates of diverse origin exhibited a high 
percentage of both MSSA and MRSA strains to be host specific, probably 
revealing the origin from their corresponding source. Further, the MRSA 
166 
'Discussion 
biotyping scheme by and large, explored the prevailing clonal similarity 
within their cluster group. 
Use of conventional set of phages and MRSA phage set, though, rendered 
most of the S. aureus population untypable, yet, the phage grouping of the 
typable strains could clearly establish their clonal similarity existing in their 
sources of origin. 
The emergence and spread of MRSA strains in hospital and community 
settings appeared to be at an alarming state. Molecular/biochemical 
approaches including SCCwec complex evidently established a trend to and 
fro dissemination of hospital and community evolved MRSA strains between 
these environments. 
The approach of SCCmec cassette determination among MRSAs of eye 
origin yielded the presence of SCCwec type II which might be a first report 
of its kind to the best of our knowledge. This finding further increased our 
thrust to explore new cassette, if any, existing in the ocular environment at 
genetic level. The incidence of variants of SCCwec type IV (a & b) cassette 
in our MRSA collection further indicated that Northern Indian region might 
probably be their best adapted environment for existence. 
During PFGE studies, the indiscriminate band patterns obtained in some of 
selected MRSA isolates with a standard Hungarian epidemic clone further 
strengthened our view about the existing fact that the spread of a relatively 
small number of epidemic MRSA clones usually takes place world wide and 
thus in India too. Moreover, the appearance of similar patterns among MRSA 
isolates from hospital alongwith most of the human associated environments 
studied suggested strong dissemination of such clones between infected/ 
colonized human beings and the surroundings, thus, showing a possible 
exchange of genes again. Thus, virtually patients with MRSA infection or 
colonization appeared to acquire their strains from external sources. 
The homogeneity attained by RAPD on some of the MRSAs could 
demonstrate a close relationship of human community as a whole with 
bovine and its products. The risk for the spread of MRSA from bovine 
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sources into the human population was, however, low. The persons in close 
contact with MRSA-infected cattle seemed to disseminate the organisms to 
farmers, milkmen, and butchers working in meat shops due to colonization. 
• A limited number of MRSA isolates one each from five different 
environments when subjected to the determination of 16S rDNA gene 
sequencing, revealed them to be homologous to each other suggesting that 
their gene remained conserved inspite of enormous antibiotic pressures in 
these environments. 
• Extensive future research in this area is required to know much about the 
reservoirs of resistance genes so as to curb their dissemination from various 
ecosystems to human beings or viva versa. 
Finally, a comprehensive flow chart was proposed to depict a possible transfer of 
genes governing resistance among S. aureus isolates. The spread of these drug 
resistant S. aureus organisms between different environmental sources might be 
finally reaching to human beings through either routes depicted. The 
epidemiological studies on the spread of resistant pathogenic/ normal 5'. aureus 
isolates were indicative of the spread of corresponding genes governing antibiotic 
resistance especially among MRSA population, posing a potential threat to human 
being and its surrounding environments. 
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"Discussion 
CONTROL AND PREVENTION OF THE TRANSMISSION OF MRSA: 
The spread of infection from patients to patients by contaminated healthcare 
workers was noted over 150 years ago by Homles and Semmilweis. Although gloves 
greatly reduce the risk of hand contamination, they do not obviate the need for hand 
washing after their removal. Use of a mask may be of some benefit in preventing 
nasal acquisition of MRSA by healthcare workers. It is difficult in many out-patients 
practices to identify MRSA. The establishment of electronic medical record systems 
may aid in this endeavor. 
Prescribed treatment regimens should be appropriate in both dose and 
duration, because inadequate dose or excessive duration of therapy may cause 
development of resistance. Steps should be taken to decrease the occurrence of new 
resistant strains by adhering to guidelines advocating against the routine 
prophylactic use of vancomycin for MRSA infection. Although, vancomycin is 
certainly the standard for MRSA infection control at present, but wide scale use is 
risk factor for reduced susceptibility and frank resistance in S. aureus. New 
antibiotic classes with good activity against Gram-positive organisms such as 
ketolides and oxazolidinones which have shown promise in the treatment of MRSA 
should be used. 
In view of development of resistance against any newly introduced drug over 
the period of time a physicians/epidemiologists, therefore, need to turn to 
alternative agents also for the treatment of staphylococcal infections including; (i) 
Antiseptic benzethonium chloride 0.02%. (ii) Lysostaphin, a zinc metalloproteinase 
extracted from S. simulans that lyses S.aureus by disrupting its peptoglycan layer, 
(iii) An enzyme Las A protease (staphylolysin) a staphylolytic endopeptidase 
secreted by P. aeruginosa which also targets the peptoglycan of S. aureus have 
proved effective in the treatment oiS. aureus infections. 
Traditional antimicrobial susceptibility test methods require at least 24 hrs to 
perform. Polymerase chain reaction (PCR) analysis has been used to detect 
contamination with MRSA more rapidly than conventional culture methods. 
However, PCR is not routinely used by most clinical diagnostic laboratories. Newer 
detection methods for MRSA including the BBL Crystal MRSA ID system, 
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Velogene Rapid MRSA Identification Assay, MRSA-Screen, a Slide Latex 
Agglutination Test, will give promising results within 4hrs or just in 15 min. 
Therefore, such kits may provide early and accurate detection of colonized 
individuals which further helps to prevent the spread. 
Efforts should be concentrated on minimizing the transmission of all food-
borne pathogens regardless of their antibiotic susceptibility, by insistence on good 
hygiene practices on farms, in abattoirs (poultry), during distribution and marketing 
of food, in food preparations and finally, by the consumers. 
Whatever is done, competent surveillance of disease and antibiotic resistance as well 
as repeated refinement of risk analysis is a necessity. 
FUTURE PERSPECTIVES: 
The Staphylococcal genome is under continuous change, with genetic 
elements moving in and out. Therefore, new variants of SCCmec will emerge that 
are not detected by the existing simplex or multiplex PCR methods. This will lead to 
a revision of PCR methods every time a new variant is discovered. Detailed 
SCCwec typing is unsuitable for the routine laboratory, but important for 
epidemiological purposes, especially since SCCwec is part of the nomenclature of 
international MRSA clones. The significance of SCC/nec variants should also be 
investigated, perhaps by SCCwec-typing from larger collection of isolates. Very 
little is known about the potential donors, recipients, mechanisms or direction of 
SCC/wec transfer. There is a need to continue the search for the origin of SCCmec 
and to identify the route and mechanism of transfer as there is a common agreement 
that SCCmec in MRSA has been transferred from coagulase-negafive staphylococci. 
PFGE proved to be the most satisfactory method on the basis of its 
discriminatory ability and reproducibility. The major disadvantage of PFGE and 
other methods that compare DNA fragments on gels is the difficulty of comparing 
the results obtained in different laboratories, even when reagents and conditions are 
standardized. Secondly, it works well for local and short term epidemiological 
investigation. For this reason, the recent advances in bacterial genomics, 
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bioinformatics, and DNA sequencing have enriched the molecular tools for better 
understanding of the origins and spread of MRS A clones 
Spa typing and multilocus sequence typing (MLST) techniques which has an 
advantage in terms of speed, interpretations and interlaboratory comparisons can be 
brought into use for further studies to establish a clonal relationship to nationally and 
internationally spread clones. The low mutations rate of the seven housekeeping 
genes of MLST and polymorphic X-region of the protein A gene {Spa) requires a 
long term and global epidemiological study. The data obtained would help in 
simulation central database on the World Wide Web, along with associated data, 
which can be accessed via the internet. The determination of Spa types was 
simplified by software http://spaserver.ridom.de. And the seven gene fragments of 
an S. aureus isolates could be submitted to the MLST website http://mlst.ox.ac.uk. 
where data can be compared with all of the MRSA and MSSA isolates maintained in 
the database. 
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SUMMARY 
The present study was undertaken with the aim to determine the spread of 
methicillin resistant Staphylococcus aureus gene from different ecosystems to 
human beings in particular during infectious and heahhy state. 
Of the total 4885 sampling we isolated 1160 S.aureus strains, the prevalence 
of methicillin resistant (MRSA) among these isolates was 176 (15.1%). The 
distribution of MRSA in various specimen studied can be summarized as follows: 
clinical specimen (31.4%) > nosocomial (18.5%)) > ocular specimen (11.45) > 
community personnel (10.2%)) > veterinary (5.4%)) > food and food handlers (3.2%) 
> air (2.1%). The highest prevalence was found in clinical specimen and lowest in 
air, while no MRSA was found in water sources. 
According to the results obtained highest resistance was found to penicillin-
G, while zero resistance was found to vancomycin when applied to selective 
sources. Muhiple drug resistance in all 5*. aureus (n=1160) and MRSA (n=176) 
isolates were detected. 
The demographic result showed the carriage of iS*. aureus was higher in males than 
females (57.6%): 42.3%)) while, children in the community were the higher colonizer 
(28.3%)). The ocular patients of 45 years and above were found to have higher rate of 
infection. 
The results indicated that major reservoir of MRSA in nosocomial infections 
are colonized/ infected inpatients and colonized health care workers with carriers at 
risk for developing endogenous infection or cross transmitting MRSA to health care 
workers and patients. The rate of colonization of MRSA in community personnel 
was found lower than nosocomial MRSA prevalence (10.2% vs 18.5%)). Highest 
percentage of MRSA (8.3%) was found in clinical dairy herd while carriage rate of 
MRSA in dairy personnel was insignificant. Major food animals such as cattle meat 
(10.2%) and chicken (9.0%)) were found to be the source of MRSA prevalence. No 
MRSA dispersion was seen in air from different environment except hospital wards 
(22.2%, 2/9). 
The MIC values of Oxacillin was observed between 4fxl/ml to 256|il/ml in 
which 23.2% MRSA isolates were borderline resistance (2-8|il/ml) and 76.7%) were 
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methicillin resistant (>16|xl/ml). The most common resistance pattern "PGMETCl" 
(n=22) in MRS A isolates was frequently encountered in various sources. 
Biotyping: Selective methicillin sensitive S. aureus (n=196) and MRS A 
(n=176) were subjected to crystal violet test biotying. The majority of the isolates 
MSSA (79.5%) and MRSA (80.0%) were classified into human biotype -A, 
whereas, only 7.1% of MSSA and 0.6% of MRSA of biotype -C (animal origin) was 
seen among personnel. Biotypic distribution of MRSA (n=165) as described by Coia 
et al. resulted into 4 groups. Maximum strains represented biotype B group 
(43.6%) followed by group D (30.9%). 
Bacteriophage typing: A total of 302 S. aureus with methicillin sensitive and 
resistant were subjected to bacteriophage typing as many as 51.8%) of MSSA and 
32.1% of MRSA was found typable at RTD and 100 RTD. Phage group III was 
predominant in both MSSA and MRSA isolates. Phage patterns 6/75/84, 6, 6/83A 
(phage group III) were found prevalent in MSSA and 30/33/38 MRSA phage 
complex resulted predominantly in MRSA isolates of every source. 
SCCwec typing: A selective 93 MRSA isolates were subjected to 
Staphylococcal cassette chromosome mec complex (SCCwec complex). The 
SCCwec Type III cassette with Type III-A variant was predominantly found in 
clinical and ocular specimen and nosocomial isolates. However, few MRSA isolates 
possessing Type III cassette from community, veterinary and foods sources were 
resulted. SCCmec Type IV variant IVa was observed in community MRSA isolates 
and IVb variant was found in veterinary and food MRSA isolates. The results 
showed that, by and large these, SCCwec cassette complexes were mostly confined 
to their respective environments. One MRSA isolate from ocular specimen was 
found to contain ^CCmec Type II cassette. The PCR results also showed the positive 
correlation between MIC values and meek gene. A 6 MRSA strains with low MIC 
value were found mecA gene negative. 
Furthermore, 70 MRSA strains (Type III) and one MRSA isolate (Type II) 
were confirmed by specificity of mec gene complex to Class A complex, and 16 
MRSA isolates (Type IV) were found to possess Class B complex. The cassette 
chromosome recombinase {ccrAS) typing, showed 70 MRSA isolates (Type III) 
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containing ccrAB type 3 complex, and 16 MRS A (Type IV) and one MRS A (Type 
II) possessing ccrAB type 2 complex. The mec complex and ccrAB complex typing 
showed a positive correlation with SCCwec cassette. 
Random Amplified Polymorphic DNA assay (RAPD): The RAPD analysis 
of selective 15 MRS A isolates resulted into two cluster. Pattern I with 9 MRSA 
isolates of same antibiogram predominated in our finding. 
Pulsed Field Gel Eletrophoresis (PFGE): Nine PFGE patterns were identified 
among 71 MRSA (Type III & II) strains. The largest similarity in diverse sources 
was found in Pattern D (n=14) followed by pattern C (n=12). The results of 
pulsotype B (n=7) depicted clonal similarity to the Hungarian clone (Type III). 
The 16S rDNA gene analysis of ocular isolate OC-9 (Type II) had showed 
>99% homology to N315 (Type II) referral strain. Furthermore, phylogenetic 
analysis of 16S rDNA gene of 5 selecfive MRSA strains (Type III) one each from 
clinical, nosocomial, community, veterinary and food were found to be above 99% 
similar. Isolates of clinical, nosocomial and community were observed in one 
cluster, indicating maximum homology among them. 
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